<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83867</article-id><article-id pub-id-type="doi">10.7554/eLife.83867</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>High-grade serous ovarian carcinoma organoids as models of chromosomal instability</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-294593"><name><surname>Vias</surname><given-names>Maria</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4955-0102</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-294349"><name><surname>Morrill Gavarró</surname><given-names>Lena</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2242-4010</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-294594"><name><surname>Sauer</surname><given-names>Carolin M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2168-6630</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-294595"><name><surname>Sanders</surname><given-names>Deborah A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-294596"><name><surname>Piskorz</surname><given-names>Anna M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-294597"><name><surname>Couturier</surname><given-names>Dominique-Laurent</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-316197"><name><surname>Ballereau</surname><given-names>Stéphane</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-294599"><name><surname>Hernando</surname><given-names>Bárbara</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-310366"><name><surname>Schneider</surname><given-names>Michael P</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6331-2357</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-294600"><name><surname>Hall</surname><given-names>James</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8124-5434</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-294601"><name><surname>Correia-Martins</surname><given-names>Filipe</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-109852"><name><surname>Markowetz</surname><given-names>Florian</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2784-5308</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-294602"><name><surname>Macintyre</surname><given-names>Geoff</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-163988"><name><surname>Brenton</surname><given-names>James D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-5738-6683</contrib-id><email>james.brenton@cruk.cam.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf2"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/013meh722</institution-id><institution>Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre</institution></institution-wrap><addr-line><named-content content-type="city">Cambridge</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01q496a73</institution-id><institution>The MRC Weatherall Institute of Molecular Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Oxford</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00bvhmc43</institution-id><institution>Centro Nacional de Investigaciones Oncológicas, C/Melchor Fernández Almagro</institution></institution-wrap><addr-line><named-content content-type="city">Madrid</named-content></addr-line><country>Spain</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yang</surname><given-names>Qifeng</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/056ef9489</institution-id><institution>Qilu Hospital of Shandong University</institution></institution-wrap><country>China</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Ng</surname><given-names>Tony</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0220mzb33</institution-id><institution>King's College London</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>11</day><month>05</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>12</volume><elocation-id>e83867</elocation-id><history><date date-type="received" iso-8601-date="2022-09-30"><day>30</day><month>09</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2023-04-24"><day>24</day><month>04</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-09-02"><day>02</day><month>09</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.09.01.506155"/></event></pub-history><permissions><copyright-statement>© 2023, Vias, Morrill Gavarró et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Vias, Morrill Gavarró et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83867-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-83867-figures-v1.pdf"/><abstract><p>High-grade serous ovarian carcinoma (HGSOC) is the most genomically complex cancer, characterized by ubiquitous <italic>TP53</italic> mutation, profound chromosomal instability, and heterogeneity. The mutational processes driving chromosomal instability in HGSOC can be distinguished by specific copy number signatures. To develop clinically relevant models of these mutational processes we derived 15 continuous HGSOC patient-derived organoids (PDOs) and characterized them using bulk transcriptomic, bulk genomic, single-cell genomic, and drug sensitivity assays. We show that HGSOC PDOs comprise communities of different clonal populations and represent models of different causes of chromosomal instability including homologous recombination deficiency, chromothripsis, tandem-duplicator phenotype, and whole genome duplication. We also show that these PDOs can be used as exploratory tools to study transcriptional effects of copy number alterations as well as compound-sensitivity tests. In summary, HGSOC PDO cultures provide validated genomic models for studies of specific mutational processes and precision therapeutics.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>organoids</kwd><kwd>high-grade serous ovarian cancer</kwd><kwd>chromosomal instability</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100004440</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>RG92770</award-id><principal-award-recipient><name><surname>Morrill Gavarró</surname><given-names>Lena</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100018694</institution-id><institution>Marie Sklodowska-Curie Actions</institution></institution-wrap></funding-source><award-id>766030-CONTRA-H2020-MSCA-ITN-2017</award-id><principal-award-recipient><name><surname>Schneider</surname><given-names>Michael P</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100022011</institution-id><institution>Cancer Research UK Cambridge Institute, University of Cambridge</institution></institution-wrap></funding-source><award-id>A22905</award-id><principal-award-recipient><name><surname>Brenton</surname><given-names>James D</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100022011</institution-id><institution>Cancer Research UK Cambridge Institute, University of Cambridge</institution></institution-wrap></funding-source><award-id>A29580</award-id><principal-award-recipient><name><surname>Brenton</surname><given-names>James D</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100022011</institution-id><institution>Cancer Research UK Cambridge Institute, University of Cambridge</institution></institution-wrap></funding-source><award-id>A25117</award-id><principal-award-recipient><name><surname>Brenton</surname><given-names>James D</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100018956</institution-id><institution>NIHR Cambridge Biomedical Research Centre</institution></institution-wrap></funding-source><award-id>BRC‐1215‐20014</award-id><principal-award-recipient><name><surname>Brenton</surname><given-names>James D</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. For the purpose of Open Access, the authors have applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Fifteen continuous high-grade serous ovarian carcinoma patient-derived organoids are characterized by transcriptomic, genomic, and drug sensitivity assays to reveal that they comprise communities of clonal populations and represent models of different causes of chromosomal instability and degrees of genome complexity.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>HGSOC is a heterogeneous, chromosomally unstable cancer with predominant somatic copy number alterations (SCNAs) and other structural variants including large-scale chromosomal rearrangements (<xref ref-type="bibr" rid="bib40">Li et al., 2020</xref>; <xref ref-type="bibr" rid="bib15">Drews et al., 2022</xref>). Oncogenic mutations are rare and recurrent somatic substitutions involve less than 10 driver genes (<xref ref-type="bibr" rid="bib2">Ahmed et al., 2010</xref>; <xref ref-type="bibr" rid="bib10">Cancer Genome Atlas Research Network, 2011</xref>; <xref ref-type="bibr" rid="bib23">Gerstung et al., 2020</xref>; <xref ref-type="bibr" rid="bib1">Aaltonen et al., 2020</xref>). Loss of p53 function and <italic>TP53</italic> mutation have been defined as the earliest driver events permitting the development of diverse chromosomal instability (CIN) phenotypes that are apparent in pre-invasive lesions in the fallopian tubal epithelium (<xref ref-type="bibr" rid="bib2">Ahmed et al., 2010</xref>; <xref ref-type="bibr" rid="bib34">Labidi-Galy et al., 2017</xref>). Mutational signatures are genomic patterns that are the imprint of mutagenic processes accumulated over the lifetime of a cancer cell (<xref ref-type="bibr" rid="bib55">Petljak et al., 2019</xref>). Genome-wide patterns of single nucleotide (SNV) (<xref ref-type="bibr" rid="bib3">Alexandrov et al., 2013</xref>) and structural variants (SV) (<xref ref-type="bibr" rid="bib14">Davies et al., 2017</xref>) showed that these mutational spectra could identify specific mutational processes with the majority of cancers having multiple signatures. We have previously shown that shallow whole genome sequencing (sWGS) methods can stratify HGSOC based on the distributions of six copy number features that encode patterns of different causes of CIN (<xref ref-type="bibr" rid="bib46">Macintyre et al., 2018</xref>; <xref ref-type="bibr" rid="bib12">Cheng et al., 2022</xref>). These copy number signatures are able to recapitulate the major defining elements of HGSOC genomes, including defective homologous recombination (<xref ref-type="bibr" rid="bib10">Cancer Genome Atlas Research Network, 2011</xref>), <italic>CCNE1</italic> amplification (<xref ref-type="bibr" rid="bib16">Etemadmoghadam et al., 2009</xref>), amplification-associated fold-back inversions (<xref ref-type="bibr" rid="bib66">Wang et al., 2017</xref>) and are associated with distinct tumor-immune microenvironments (<xref ref-type="bibr" rid="bib30">Jiménez-Sánchez et al., 2019</xref>). These methods have also been applied to molecular stratification of testicular germ cell tumors and multiple myeloma (<xref ref-type="bibr" rid="bib42">Loveday et al., 2020</xref>; <xref ref-type="bibr" rid="bib47">Maclachlan et al., 2021</xref>). This work provides the first generalized classifier for HGSOC that focuses on the mechanistic basis of CIN (<xref ref-type="bibr" rid="bib15">Drews et al., 2022</xref>; <xref ref-type="bibr" rid="bib46">Macintyre et al., 2018</xref>).</p><p>CIN drives clinically relevant genetic and cellular phenotypes including extrachromosomal DNA and micronuclei (<xref ref-type="bibr" rid="bib64">Turner et al., 2017</xref>; <xref ref-type="bibr" rid="bib69">Zhang et al., 2015</xref>), activation of innate immune signalling (<xref ref-type="bibr" rid="bib4">Bakhoum and Cantley, 2018</xref>), metastasis (<xref ref-type="bibr" rid="bib5">Bakhoum et al., 2018</xref>; <xref ref-type="bibr" rid="bib63">Turajlic et al., 2018</xref>), and therapeutic resistance (<xref ref-type="bibr" rid="bib29">Ippolito et al., 2021</xref>; <xref ref-type="bibr" rid="bib43">Lukow et al., 2021</xref>). CIN has complex causes including mitotic chromosome mis-segregation (<xref ref-type="bibr" rid="bib60">Thompson et al., 2010</xref>), homologous recombination defects (<xref ref-type="bibr" rid="bib38">Li and Heyer, 2008</xref>), telomere crisis (<xref ref-type="bibr" rid="bib44">Maciejowski et al., 2015</xref>; <xref ref-type="bibr" rid="bib45">Maciejowski et al., 2020</xref>), breakage-fusion-bridge cycles (<xref ref-type="bibr" rid="bib24">Gisselsson et al., 2000</xref>), DNA replication stress (<xref ref-type="bibr" rid="bib9">Burrell et al., 2013</xref>; <xref ref-type="bibr" rid="bib6">Bester et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Tamura et al., 2020</xref>), as well as others. Improving outcomes in HGSOC will depend on having well-characterized and validated pre-clinical <italic>in vitro</italic> models that accurately represent the CIN patterns observed in patients. However, currently available 2D models have multiple shortcomings such as changes in cell morphology, loss of diverse genotype and polarity, as well as other limitations. Patient-derived organoids (PDOs) offer improved pre-clinical cancer models and generally are molecularly representative of the donor, have good clinical annotation, and can represent tumoral intra-heterogeneity (<xref ref-type="bibr" rid="bib65">Vlachogiannis et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Li et al., 2018</xref>; <xref ref-type="bibr" rid="bib36">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib32">Kopper et al., 2019</xref>). PDOs can be cultured for short periods (<xref ref-type="bibr" rid="bib53">Nelson et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Hill et al., 2018</xref>) but continuous HGSOC PDOs have only been generated for 27 models (<xref ref-type="bibr" rid="bib32">Kopper et al., 2019</xref>; <xref ref-type="bibr" rid="bib28">Hoffmann et al., 2020</xref>; <xref ref-type="bibr" rid="bib49">Maenhoudt et al., 2020</xref>) and these models lack detailed genomic characterization to determine whether they adequately represent the genomic landscape of HGSOC.</p><p>Current pre-clinical models may significantly underrepresent common mutational processes observed in patients. Approximately 50% of HGSOC patients have impaired homologous recombination (HR) DNA repair, including approximately 15% of cases that have a loss of function and epigenetic events in <italic>BRCA1</italic> and <italic>BRCA2 (</italic><xref ref-type="bibr" rid="bib10">Cancer Genome Atlas Research Network, 2011</xref>). Consequently, homologous-recombination deficiency (HRD) is the major genomic classifier in the clinic and stratifies patients for outcome after treatment with PARP inhibitors (<xref ref-type="bibr" rid="bib22">Gelmon et al., 2011</xref>; <xref ref-type="bibr" rid="bib58">Swisher et al., 2017</xref>). Despite the relatively high prevalence of HRD and <italic>BRCA1/2</italic> mutations in the clinic, there are only very few relevant models. This suggests that cell lines and PDOs that carry <italic>BRCA1</italic> and <italic>BRCA2</italic> deleterious mutations are selected against. In addition, there is an urgent unmet clinical need for therapies for patients with HGSOC that are homologous recombination proficient (HRP). Several distinctive patterns of structural variation have been described in HRP tumors including chromothripsis, tandem duplication (TD), whole-genome duplication (WGD), and <italic>CCNE1</italic> amplification (<xref ref-type="bibr" rid="bib1">Aaltonen et al., 2020</xref>). Apart from the description of <italic>CCNE1</italic> amplification, it is unknown if the HGSOC organoids described to date display any of these genomic features and most cell line publications only refer to <italic>BRCA1</italic> and <italic>BRCA2</italic> mutations. These shortcomings highlight the lack of a systematic approach to characterize CIN and copy number signatures in PDO models.</p><p>To address these challenges, we developed HGSOC PDOs and characterized their genomes, transcriptomes, drug sensitivity, and intra-tumoral heterogeneity. Using copy number signatures, we show that our models comprehensively recapitulate clinically relevant genomic features across the whole spectrum of CIN observed in HGSOC patients. PDOs showed strong copy number-driven gene expression and transcriptional heterogeneity. Drug sensitivity was reproducible compared to parental tissues and the ability of these models to grow <italic>in vivo</italic>. Single-cell DNA sequencing showed copy number features at a subclonal level and distinct clonal populations. The PDO models we present thus shed light on the ongoing chromosomal instability of HGSOC and can have clinical relevance for guiding treatment decisions.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>HGSOC organoid culture derivation</title><p>To establish HGSOC organoids we used cells obtained from patient-derived ascites (n=43), solid tumors (n=10), and patient-derived xenografts (n=15) (<xref ref-type="fig" rid="fig1">Figure 1a</xref>). Most ascites cultures were derived from patients with recurrent HGSOC and clinical summaries are provided in <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. We tested the effect of two published (<xref ref-type="bibr" rid="bib32">Kopper et al., 2019</xref>; <xref ref-type="bibr" rid="bib31">Kessler et al., 2015</xref>) media compositions on 15 independent cultures and found similar PDO viability (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1a</xref>). We, therefore, performed subsequent derivations using the less complex fallopian tube media (<xref ref-type="bibr" rid="bib31">Kessler et al., 2015</xref>). The efficiency of establishing PDOs was dependent on the type of tissue sample used for derivation (p&lt;0.0001, log-rank test; n=86; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1b</xref>) and the highest success rate for short-term cultures (passage number between 1 and 4) was obtained using ascites and dissociated xenograft tissues (65%). We defined continuous PDO cultures as those that could be serially passaged &gt;5 times followed by cryopreservation and successful re-culture; all data in this paper was generated between passages 5–15. Using these criteria, PDOs were established for 15/18 organoid lines (PDO16, PDO17, and PDO18 were finite culture models). Four PDOs were able to grow as continuous 2D cell lines in conventional tissue culture media (CIOV7 from PDO1; CIOV5 from PDO2; CIOV4 from PDO3; and CIOV6 from PDO7).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Chromosomal instability features of patient-derived organoids (PDOs).</title><p>(<bold>a</bold>) Schematic of the sample collection workflow used in this study. (<bold>b</bold>) Stacked bar plots show copy number signature activities ranked by signature s1 (PDO16, PDO17, and PDO18 were not continuous models). Brackets indicate PDOs derived from the same individual. (<bold>c</bold>) Stacked bar plots show copy number signature activities for organoids and the matched ascites sample from which they were derived. (<bold>d</bold>) Unsupervised hierarchical clustering of copy number signature for PDO and 692 high-grade serous ovarian carcinoma (HGSOC) cases using Aitchison’s distance with complete linkage function. Stacked barplots in the lower panel show copy number signature activities.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Organoid survival analysis.</title><p>(<bold>a</bold>) Survival analysis based on the type of media used to grow organoids. Two media were tested: a formulation used in the Clevers lab for growing ovarian cancer tissues and a formulation used to grow fallopian tube tissue in the Meyers’s lab. p-value was derived from the log-rank test. (<bold>b</bold>) Kaplan-Meier survival curves showing the association between the type of tissue sample used for organoid derivation and survival of cultures. Survival probability is displayed as a function of time in days. Shading indicates the 95% confidence interval for each group. Hazard ratio and p-value were obtained from a log-rank test. Crosses correspond to censored observations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Clinical data.</title><p>Patient timeline summarising clinical data: CA125 levels, chemotherapy regimens, and computerized tomography (CT) scans. CT scan outcomes are represented as follows: Baseline as the first scan before treatment, PR as partial response, CR as complete response, SD as stable disease, and PD as progressive disease. Treatment lines are represented in different colors (information on the specific treatment regimens is available in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) and the patient date of death is shown as DOD. Date of ascites collection for organoid derivation is shown with the name of the organoid.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Mutation analysis of patient-derived organoid (PDO) and patient samples.</title><p>(<bold>a</bold>) Plot showing the percentage of mutations found within each gene across all samples (<bold>b</bold>) Oncoplot showing mutation status on a specific gene panel. P represents pathogenic mutation, LP - likely-pathogenic, and LB - likely-benign.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig1-figsupp3-v1.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>Tissue and patient-derived organoids (PDOs) morphological structures and p53 status.</title><p>Tissue and PDO sections were both Hematoxylin and Eosin and p53 stained. High grade serous ovarian carcinoma tissues contain specific structures that PDOs mimicked (e.g. PDO1 showing glandular and micropapillary growth patterns). The mutant p53 prevalence observed in high-grade serous ovarian carcinoma (HGSOC) patients was reflected in the organoids with only one model displaying wild-type p53 expression patterns, some with no expression and most of them with intense nuclear staining. Microscope lens with 20x magnification was used for both tissues and organoids. Scale bars  = 200 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig1-figsupp4-v1.tif"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 5.</label><caption><title>Orthotopic implantation of patient-derived organoid (PDO).</title><p>PDOs were implanted peritoneally into immunodeficient mice and disease progression was monitored by weighing the mice. Some mice developed ascites while others had disease in the liver or peritoneum. Haematoxylin and Eosin (H&amp;E) and p53 immunostained sections are shown for each tissue collected. Scale bars = 200 µm.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig1-figsupp5-v1.tif"/></fig><fig id="fig1s6" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 6.</label><caption><title>Patient-derived organoids' (PDOs) genome-wide absolute copy number alteration analysis.</title><p>Absolute copy number profiles at 30 kb bin size are presented for all the PDOs (PDO16, PDO17, and PDO18 were not continuous models).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig1-figsupp6-v1.tif"/></fig><fig id="fig1s7" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 7.</label><caption><title>Copy number features of PDO and samples from public data sets.</title><p>Comparison of genomic features between patient-derived organoid (PDO) and high-grade serous ovarian carcinoma (HGSOC) cases in public data sets (<bold>a and b</bold>) Ordered barplots show the distribution of the number of copy number segments and ploidy for organoids (labeled black bars) and 692 HGSOC tumors from the publicly available datasets of TCGA, PCAWG, and BriTROC-1 (pink bars) (<bold>c</bold>) Tumor datasets used for comparison to PDOs (green bars) included TCGA (purple), BriTROC (orange) and PCAWG (blue). All genomic features are presented in a log scale. Welch Two Sample <italic>t</italic>-test p-value on log-transformed data: number of breakpoints per 10 MB (p=0.61), segment size (p=0.45), oscillating copy number (p=0.72), number of breakpoints per chromosome arm (p=0.60), number of changepoints (p=0.85), and copy number of the segments (p=0.73).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig1-figsupp7-v1.tif"/></fig></fig-group><p>PDOs were screened for mutations enriched in HGSOC using an in-house tagged amplicon sequencing panel (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>) and were highly comparable to mutational profiles and p53 immunostaining from the original patient sample (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). All PDOs had a <italic>TP53</italic> mutation allele fraction between 80–95% essentially excluding co-culture of non-cancer cells. Pathogenic somatic <italic>BRCA1</italic> or <italic>BRCA2</italic> mutations were present in PDO4, PDO7, PDO8, and PDO9. Germline DNA sequencing for 11 of the PDO donors (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>) showed <italic>BRCA1/2</italic> germline mutations with unknown clinical significance or benign variants in patients OV04-297 (PDO13), OV04-409 (PDO14), and OV04-627 (PDO5 and PDO6).</p><p>To assess the feasibility of the PDOs for <italic>in vivo</italic> modeling, we implanted eight PDO models into immunodeficient mice using intraperitoneal injection to simulate peritoneal metastasis. All eight PDOs efficiently established PDX models and 7/8 resulted in solid implants on peritoneal surfaces and/or liver infiltration (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5</xref>).</p></sec><sec id="s2-2"><title>Genomic characterization of patient-derived organoids</title><p>We characterized the genomic landscape of the PDOs using sWGS and derived copy number signatures to characterize the diversity of causes of CIN (<xref ref-type="fig" rid="fig1">Figure 1b</xref> and <xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6</xref>). We used our published framework for copy number signature extraction (<xref ref-type="bibr" rid="bib46">Macintyre et al., 2018</xref>) based on non-negative matrix factorization (NMF) of feature-summarized copy number data to find the mutational processes behind the observed copy number profiles. We used the seven previously identified copy number signatures in ovarian cancer that represent different putative causes of CIN: s1: mitotic errors, s2: replication stress causing tandem duplication, s3 and s7: homologous recombination deficiency, s4: whole-genome duplication, s5: unknown etiology leading to chromothripsis, and s6: replication stress leading to focal amplification. The finite lines PDO16, PDO17, and PDO18 are included here for comparison only.</p><p>PDO1 and PDO11 showed high levels of signature s1 and are thus appropriate models of mitotic errors. PDO4 exhibited high activity of a signature of replication stress-induced tandem duplication (s2) but did not have a canonical <italic>CDK12</italic> mutation suggesting this may represent an alternative model of tandem duplication (see also below) (<xref ref-type="bibr" rid="bib51">Menghi et al., 2016</xref>; <xref ref-type="bibr" rid="bib67">Willis et al., 2017</xref>). Thirteen of the organoids showed evidence of s3 and can be considered as having HRD. Of these, pathogenic somatic <italic>BRCA1</italic> and <italic>BRCA2</italic> mutations were present in PDO4, PDO7, PDO8, and PDO9 (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref> and <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>); a novel non-synonymous secondary mutation was observed in <italic>BRCA1</italic> (c.1367T&gt;C) in PDO8 which was cultured after progression on PARP inhibitor therapy (paired with PDO7); <italic>BRCA1/2</italic> mutations were not detected in the remaining PDOs with s3 (PDO2, PDO3, PDO10, PDO12, PDO15) suggesting these may be models of other mechanisms of HRD. PDO1 and PDO11 showed low signature s3 activity making them suitable models for HRP ovarian cancer. Ten of the PDOs showed s4 activity making them suitable to study the effects of WGD. Signature s5, with unknown etiology that results in chromothripsis, had generally low activity in all PDOs consistent with previous observations suggesting that canonical chromothripsis is a rare event in HGSOC (<xref ref-type="bibr" rid="bib13">Cortés-Ciriano et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Zack et al., 2013</xref>; <xref ref-type="bibr" rid="bib54">Patch et al., 2015</xref>). s6, a signature of replication stress resulting in focal amplification, was high in PDO3, PDO5, PDO6, PDO9, and PDO14, indicating these are good models to study both the cause and consequence of focal amplification events. Finally, a number of organoids showed s7 making them good models to study the effects of HRD following WGD.</p></sec><sec id="s2-3"><title>Organoids represent the spectrum of human high-grade serous ovarian cancers</title><p>We next compared copy number signatures from donor patient tissues and matched PDO (<xref ref-type="fig" rid="fig1">Figure 1c</xref>) and found that they were highly consistent except for PDO12 (OV04-467). We tested for the differential abundance of the signatures between donor samples and matching PDO using previous described statistical modeling (<xref ref-type="bibr" rid="bib12">Cheng et al., 2022</xref>). For the patients who contributed two samples, a single sample was selected at random. The results indicated no differential abundance (Wald test on log-ratios of signatures, p-value=0.99 using a model with no correlations between signatures given that the total number of observations is low). For PDO12, the parental <italic>CDK12</italic> mutation present in the ascites specimen was not recovered after culture, suggesting selection for a subclonal population with distinct copy number signatures (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>).</p><p>Both PDO culture and derivation of PDX models may negatively select against specific molecular subtypes of HGSOC—which may explain the low number of <italic>BRCA1/2</italic> models. To test whether the PDOs were representative of the wider population of HGSOC cases, we compared PDO copy number features to those of publicly available patient cohorts (n=692 samples from the TCGA, PCAWG, and BriTROC-1 studies) (<xref ref-type="fig" rid="fig1">Figure 1d</xref>). The number of copy number segments (<xref ref-type="fig" rid="fig1s7">Figure 1—figure supplement 7a</xref>) did not significantly differ between PDOs (169 ± 77) and HGSOC tissues from TCGA, PCAWG, and BriTROC-1 (200 ± 134) (p=0.22, negative binomial likelihood ratio test). Ploidy was found to be bimodal in both groups, with centers at average ploidies 2 and 3.5 (<xref ref-type="fig" rid="fig1s7">Figure 1—figure supplement 7b</xref>). There were also no significant differences in other copy number features (<xref ref-type="fig" rid="fig1s7">Figure 1—figure supplement 7c</xref>).</p><p>We next clustered copy number activity profiles (<xref ref-type="fig" rid="fig1">Figure 1d</xref>) from TCGA, PCAWG, and BriTROC (n=692) and compared these with the PDO profiles. Unsupervised hierarchical clustering of the clinical samples showed two main groups with the major group characterized by high activities for s4 and low activities for s3 suggesting frequent WGD and consistent with previous observations (<xref ref-type="bibr" rid="bib1">Aaltonen et al., 2020</xref>; <xref ref-type="bibr" rid="bib12">Cheng et al., 2022</xref>). The smaller group was predominantly composed of s1 mitotic errors and s3 HRD and may represent near diploid tumors. PDOs were well distributed across the two groups but there were three small subclusters that were underrepresented: those presenting a lack of s2 and s4, a lack of s2 and s3, and a lack of s3 together with high s4. PDOs derived from the same patient (PDO3 and PDO9, PDO5 and PDO6, and PDO7 and PDO8) were clustered together. Taken together, these data indicate that PDOs represents the copy number mutational landscape observed in HGSOC patients.</p></sec><sec id="s2-4"><title>Effect of CNAs at the gene expression level</title><p>To understand how PDO absolute copy number alterations (CNAs) could alter the gene expression of corresponding genes, we first tested whether PDOs displayed known HGSOC-associated amplifications (<xref ref-type="fig" rid="fig2">Figure 2a</xref>) and which genes were highly amplified when averaged over all PDOs (<xref ref-type="fig" rid="fig2">Figure 2b</xref>), including the well-characterized copy number drivers <italic>MYC</italic> and <italic>CCNE1</italic>. We performed RNA-Seq on the PDOs and compared their transcriptome to the TCGA primary tissue cohort and found highly similar cell-autonomous transcriptional profiles. As expected, we observed significant under-expression of genes relating to the tumor microenvironment (<xref ref-type="fig" rid="fig3">Figure 3a</xref>) which is not represented in the organoid cultures. Principal component analysis on the scaled and centered DESeq2 counts showed that PDOs derived from the same patient PDO5 and PDO6 - the transcriptome of which is nearly identical - cluster together, but that PDO7 and PDO8, which are distinguished by a secondary <italic>BRCA1</italic> mutation following progression after PARP therapy, differ from each other (<xref ref-type="fig" rid="fig3">Figure 3b</xref>). As PDOs are characterized by high <italic>TP53</italic> allele fractions in line with those seen in patient tumors, strongly indicating that they mostly consist of tumor cells, we assessed the correlation between gene copy number changes and their expression using two metrics. The first metric shows whether, on average, PDOs with lower copy number values in genes have a lower gene expression, in order to capture nonlinear relationships between copy number and gene expression. We computed the average gene expression values for the three PDOs of the lowest copy number and calculated the fraction of remaining PDOs with higher gene expression values than this average (<xref ref-type="fig" rid="fig3">Figure 3c</xref>). The second metric used was the R<sup>2</sup> of the correlation between DESeq2 count values and absolute copy number in each gene across PDOs. For both metrics, higher values indicate stronger evidence for copy number-driven gene expression (<xref ref-type="fig" rid="fig3">Figure 3d</xref>). The most highly variable areas in the genome are located within chromosomes 8, 10, 11, 12, 17, and 1 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1a</xref>), where we found the most highly correlated genes. <italic>MYC</italic> showed a good correlation between copy number and gene expression and was also the gene with the highest absolute copy number in our PDO cohort, followed by <italic>ZWINT</italic> (<xref ref-type="fig" rid="fig2">Figure 2b</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Absolute gene copy number in patient-derived organoids (PDOs).</title><p>(<bold>a</bold>) Absolute gene copy number for a set of important high-grade serous ovarian cancer genes. (<bold>b</bold>) Absolute gene copy number for the most amplified genes when averaged across all patient-derived organoids.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Whole genome correlation between absolute gene copy number and expression.</title><p>(<bold>a</bold>) Scatterplot assessing the agreement between copy number and gene expression in genes of high copy number variability across different chromosomes. For each gene, we computed the average expression of the three organoids with the lowest copy number value where the metric is the fraction of remaining organoids that have higher gene expression value than this average. The second metric we computed is the R<sup>2</sup> value. In both cases, higher values indicate greater agreement between copy number and gene expression between organoids across different chromosomes. (<bold>b</bold>) Genes with the highest values for both metrics have been labeled in red across different chromosomes and the top 20 are labeled in blue. Chromosomes 14, 15, 16, 18, and 21 had no highly variable regions. Chromosomes 2 and 13 contained highly variable regions with low correlation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig2-figsupp1-v1.tif"/></fig></fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Transcriptomic analysis of high-grade serous ovarian carcinoma (HGSOC) organoids.</title><p>(<bold>a</bold>) Scatterplots show correlation for the average counts, in transcripts per million (TPM) for each gene in the TCGA and the patient-derived organoid cohorts. Consensus TME genes represent non-tumor genes expressed in the tumor microenvironment (<xref ref-type="bibr" rid="bib30">Jiménez-Sánchez et al., 2019</xref>). The dashed line corresponds to the identity line. (<bold>b</bold>) Principal component analysis based on DESeq2 counts for 11 organoids. (<bold>c</bold>) Scatterplot and contour plot of the Pearson correlation coefficient for copy number and gene expression, and average absolute copy number for each gene. <italic>MYC</italic> and <italic>ZWINT</italic> are shown as highly correlated genes. (<bold>d</bold>) Scatterplot of two metrics for assessing the agreement between copy number and gene expression. For each gene, we computed the average expression of the three organoids with the lowest copy number value. The metric is the fraction of remaining organoids that have higher gene expression value than this average, and takes values between 0/8 and 8/8, with higher values indicating greater agreement between copy number and gene expression across organoids. This is shown in the x-axis. On the y-axis we display the R<sup>2</sup> value for the correlation between copy number state and gene expression. We have labeled genes of interest. The blue curve indicates the median R<sup>2</sup> values in each group of the metric along the x-axis, and boxplots indicate the interquartile range. (<bold>e</bold>) DNA damage response KEGG pathway analysis from RNA-Seq on 11 PDOs. PDO10, and PDO15 show high enrichment scores for homologous recombination compared to other PDOs. Mismatch and base excision repair pathways also show high scores in these models. PDO8, which has the lowest HR score, contains a loss of function mutation in <italic>BRCA1</italic>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig3-v1.tif"/></fig><p>As defects in DNA damage response pathways are clinically important for treatment, we tested for enrichment scores across the PDOs. PDO10 and PDO15 have a high enrichment score for homologous recombination deficiency (<xref ref-type="fig" rid="fig3">Figure 3e</xref>), present nearly identical signature activities, and are the two PDOs with the highest s7 activity (<xref ref-type="fig" rid="fig1">Figure 1b</xref>).</p></sec><sec id="s2-5"><title>PDO drug screening</title><p>We compared drug sensitivity between five PDOs and their parental uncultured patient-ascites. Using 12 anti-cancer compounds dispensed in an 8-point half-log dilution series, we found a moderate to a high correlation between the drug area under the curve (AUC) of PDO and their corresponding patient-derived ascites (<xref ref-type="fig" rid="fig4">Figure 4a</xref>). We then tested all the PDOs using the standard of care chemotherapy (oxaliplatin, paclitaxel, gemcitabine, and doxorubicin) (<xref ref-type="fig" rid="fig4">Figure 4b</xref>) as we observed no effect with the targeted therapies at the concentrations used in this study. Based on the median AUC we divided PDOs into two groups of samples passing RNA-Seq quality control: sensitive (PDO1, PDO2, PDO3, PDO11, PDO12) and resistant (PDO5, PDO6, PDO7, PDO8, PDO10) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>) and performed differential gene expression and pathway analysis (<xref ref-type="fig" rid="fig4">Figure 4c</xref>) to infer mechanisms of resistance. Sensitive PDOs showed increases in <italic>MYC</italic> targets and interferon alpha and gamma responses while resistant PDOs had an increase in hypoxia, <italic>KRAS</italic> signaling, and epithelial-mesenchymal transition (EMT) pathways. We compared both groups for ploidy and number of copy number segments and we did not observe any significant differences (the average number of segments is 167 for sensitive and 183 resistant PDOs, and the average ploidies are 2.8 for sensitive and 2.46 for resistant PDOs; p-value=0.7441 and p-value=0.2374, respectively; Welch Two Sample <italic>t</italic>-test).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Patient-derived organoids are clinically relevant models.</title><p>(<bold>a</bold>) Correlation of drug response between uncultured patient cells and the patient-derived organoids (PDOs) derived from them using 12 compounds (PDO14: cor. 0.49, p-value 0.1; PDO11: cor. 0.82, p-value 0.001; PDO3: cor. 0.995, p-value 2.3e-11; PDO10: cor. 0.81, p-value 0.001; PDO12: cor.0.32, p-value 0.31). (<bold>b</bold>) Organoid drug responses to standard-of-care chemotherapies. The observed dose-response relationships were not always compatible with the Hill dose-response model assuming a sigmoidal decrease so that five-parameter logistic model fits were preferred, explaining area under the curve (AUC) estimates greater than one. Sensitive PDOs are labeled with a blue dot and resistant PDOs with a red one. (<bold>c</bold>) Significant pathways based on adjusted p-value (padj) after performing Gene Set Enrichment Analysis (GSEA) with rank based on significance level between the two PDO groups sensitive and resistant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Patient-derived organoids (PDOs) can be classified into two groups according to their drug sensitivity.</title><p>Plot shows area under the curve (AUC) (y-axis) of each drug (lines and points) for each sample (x-axis) ordered in increasing mean AUC values. Black line reports the mean AUC and the vertical dotted line suggests a split by mean AUC. The blue dashed line indicates the standard deviation of AUC. We grouped the samples into resistant and sensitive based on the mean AUC for our differential gene expression analysis.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-6"><title>Organoid intratumoral heterogeneity</title><p>In order to assess genomic heterogeneity within PDOs, we performed single-cell whole genome sequencing on three of the models, selected arbitrarily to represent both fast-growing (PDO2, n=76 cells, and PDO3, n=145 cells) and slow-growing models (PDO6, n=355 cells) (<xref ref-type="fig" rid="fig5">Figure 5</xref>). We did not observe any normal copy number profiles indicating the presence of non-cancer cells. Copy number changes at single-cell resolution revealed widespread clonal loss of heterozygosity (LOH) in large regions spanning up to entire chromosomes that were PDO specific (e.g. chromosome 13 in PDO6). Subclonal LOH, although less common, was also present in all three organoids. Amplification events were more common than losses; for example, chromosomes 2, 3, and 20 are clonally amplified in PDO2 and PDO3 whereas chromosomes 6 and 11 showed large, amplified regions shared between PDO3 and PDO6. All three PDOs present non-focal amplifications in chromosomes 1, 5, 12, and 20 as well as deletions in chromosome 13. This analysis also provided strong evidence for clonal amplification of candidate driver copy number aberrations: <italic>CCNE1</italic> in PDO2 and PDO3, an early chromothriptic event at <italic>MYC</italic> in PDO3 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>), and <italic>AKT2</italic> in PDO2 and PDO6. PDO6 showed early clonal loss of <italic>RB1</italic>.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Genomic heterogeneity in three high-grade serous carcinoma patient-derived organoids (PDOs).</title><p>(<bold>a–c</bold>) Single-cell DNA (scDNA) copy number where cells have been clustered using hierarchical clustering on Euclidean distance. Each row within the scDNA plots represents a cell across the different chromosomes in the x-axis and the copy number state (20 kb bins) is indicated in colors. Loss of heterozygosity and amplification events are common in all three patient-derived organoids. (<bold>d-f</bold>) Bulk absolute copy number profiles.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Chromothripsis in chromosome 8 of PDO3.</title><p>Step plot of the absolute copy number from sWGS for PDO3, along chromosome 8. The extreme values towards the end of the chromosome indicate a chromothriptic event. Diploid state is represented by the blue dotted line.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Major clades of cells in three organoids determined by copy number alterations from single-cell DNA-Seq.</title><p>PDO2 contains two major clades of 42 and 30 cells. These clades are characterized by changes in chromosome 7 (triplicated in the first clade and diploid in the second, in accordance with the copy number of roughly 2.75 from bulk sequencing) and chromosome 10 (showing the opposite trend). Few subclonal losses are observed, except for those in chromosome 13 p. In PDO3, the two clades are comprised of 48 and 92 cells, with the second clade containing two subclades of 40 and 52 cells. The largest differences are in chromosomes 1, 4 and 5, 10, and 11. There is an loss of heterozygosity (LOH) region at the start of chromosome 5 in the second clade, in all other chromosomes there are further copy number gains in regions where the first clade already shows amplifications. The two subclades contain differences in chromosomes 1, 4, and 5. PDO6 contains two clades of 49 and 303 cells (the second clade is split into subclades of 158 and 145 cells). The differences in the first split are in chromosomes 3, 4, 6, and 10, in which the extent of amplifications varies, and in chromosome 13, which presents large regions of single copy loss in the second clade. The greatest difference between the subclades is a large triplication of chromosome 2 in the first subclade.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig5-figsupp2-v1.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>95% confidence intervals of the centered copy number, along the genome, across single-cells from organoids.</title><p>The color of the dots indicates whether the CN value is shared between cells, and, therefore, clonal (in red), or whether there is subclonal heterogeneity in the bin (in blue) according to a Chi-squared test of the variance in copy number among cells and correcting for ploidy.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-fig5-figsupp3-v1.tif"/></fig></fig-group><p>We also identified regions of clonal heterogeneity in all three PDOs (<xref ref-type="fig" rid="fig5">Figure 5</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). We quantified the heterogeneity observed in each PDO by comparing the observed copy number variance to the expected copy number variance (Methods), and found that, globally, PDO3 showed the highest subclonal heterogeneity, with 48% of the genome presenting subclonal heterogeneity, followed by PDO6 (29%) and PDO2 (26%) (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our analysis of copy number features and mutational signatures shows that HGSOC PDOs recapitulate the broad mutational landscape of patient samples. The organoid models contained a mixture of signatures indicating the influence of multiple mutational processes. Although their copy number signatures are well spread across the range seen in patient samples, certain copy number combinations are underrepresented (high s4 and s7, high s3 and s5, and high s6). Critically, we show that PDOs are also vital models to study heterogeneity at the single-cell level and we found that, although all models tested showed genomic heterogeneity, the level of complexity varies. This suggests that different mutational processes may have different abilities to drive evolutionary change and PDOs now provide tools for lineage tracing experiments to test this. Further analysis of clonal populations with PDO also has the potential to define the active mutational processes by sequential single-cell cloning as recently described (<xref ref-type="bibr" rid="bib55">Petljak et al., 2019</xref>). Lastly, these models also provide important insights into the genomic etiology of HGSOC, including evidence for chromothripsis as an early initiation event in HGSOC by targeting <italic>MYC</italic> and indicating that tandem duplication can occur in the absence of either <italic>BRCA1</italic> or <italic>CDK12</italic> mutation.</p><p>The development of high-quality pre-clinical tumor models is of high importance for therapeutic discovery in HGSOC. Existing cell-based and PDX models have not been characterized in detail and their relationship to the diversity of CIN seen in patient tissue samples is unknown. Derivation of continuous cell lines has proven difficult for HGSOC, and although new cell lines are being developed (<xref ref-type="bibr" rid="bib62">Thu et al., 2017</xref>; <xref ref-type="bibr" rid="bib37">Létourneau et al., 2012</xref>; <xref ref-type="bibr" rid="bib18">Fleury et al., 2015</xref>) success rates are comparatively low and the number of available models has not significantly increased over the past 10 years. With the wider use of organoid culture, ovarian cancer models have been developed both as short and long-term cultures (<xref ref-type="bibr" rid="bib32">Kopper et al., 2019</xref>; <xref ref-type="bibr" rid="bib53">Nelson et al., 2020</xref>; <xref ref-type="bibr" rid="bib27">Hill et al., 2018</xref>; <xref ref-type="bibr" rid="bib28">Hoffmann et al., 2020</xref>; <xref ref-type="bibr" rid="bib49">Maenhoudt et al., 2020</xref>) but with variable information about success rates and survival in culture. We demonstrated that short-term HGSOC organoid derivation from human ascites samples and PDX tissues can be achieved with good efficiency. However, as indicated by our time-to-event analyses, further improvements in media and culture conditions are needed to improve success rates, particularly from solid tissue samples.</p><p>Although SCNAs have been shown to affect gene expression levels for the most abundantly expressed human genes indicating global gene dosage sensitivity (<xref ref-type="bibr" rid="bib17">Fehrmann et al., 2015</xref>), it has also been described that this correlation does not always translate proportionally due to transcriptional adaptive mechanisms (<xref ref-type="bibr" rid="bib7">Bhattacharya et al., 2020</xref>). In our study we compared PDO gene expression to TCGA patient samples and corroborated that gene transcript levels are highly correlated, providing ideal models to study tumor cell-intrinsic associations. We have previously found that the correlation between SCNA and gene expression is higher for cancer driver genes that are frequently amplified and identified co-dependencies between amplification of <italic>MYC</italic> and genes from the <italic>PI3K</italic> pathway which have therapeutic potential (<xref ref-type="bibr" rid="bib50">Martins et al., 2022</xref>). We corroborated, using novel ways of correlating absolute SCNA with transcriptomics, that in our organoid models, the correlation was highest for <italic>MYC</italic>, <italic>PIK3CA,</italic> and <italic>AKT2</italic> reinforcing their putative role as potential targetable cancer drivers.</p><p>Genetic alterations in HGSOC are extraordinarily diverse therefore the development of a truly personalized treatment requires genomically annotated individual patient avatars for therapeutics. In this study, we showed the potential of HGSOC PDOs as a new preclinical cancer model representing individual patients. Consistent with studies in ovarian cancer and other tissue types (<xref ref-type="bibr" rid="bib36">Lee et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Gao et al., 2014</xref>; <xref ref-type="bibr" rid="bib8">Broutier et al., 2017</xref>; <xref ref-type="bibr" rid="bib20">Francies et al., 2016</xref>) our results confirm the feasibility of using PDOs for testing drug sensitivity in HGSOC. Future studies should account for doubling-time confounding errors using different metrics such as Growth Rate (GR) metrics (<xref ref-type="bibr" rid="bib25">Hafner et al., 2016</xref>).</p><p>This study has shown that HGSOC PDOs faithfully represent the high variability in copy number genotypes observed in HGSOC patients and together with their associated clinical, phenotypic, and genomic characterizations will provide an important resource for pre-clinical and translational studies investigating genomic biomarkers for treatment stratification and further our understanding of tumor heterogeneity and clonality.</p></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Ethical approval and clinical data collection</title><p>Clinical data and tissue samples for the patients were collected on the prospective cohort study Cambridge Translational Cancer Research Ovarian Study 04 (CTCR-OV04), with IRAS project ID 4853, and which was approved by the Institutional Ethics Committee (REC reference number 08 /H0306/61). Clinical decisions were made by a clinical multidisciplinary team (MDT) and researchers were not directly involved. Patients provided written, informed consent for participation in this study and for the use of their donated tissue for the laboratory studies carried out in this work and its publication. Clinical data for all the patients is provided in Supplementary Information.</p></sec><sec id="s4-2"><title>Sample collection and processing</title><p>Samples were obtained from surgical resection, therapeutic drainage, or surgical washings. Solid tumors were assessed by a pathologist and only tumor samples with ≥50% cellularity were attempted to grow. A small portion of each sample was kept at −80 °C until used for genomic profiling.</p></sec><sec id="s4-3"><title>Organoid derivation</title><p>Tumor samples were washed in PBS, minced into 2 mm pieces using scalpels, and incubated with gentamicin (50 μg/ml), Bovine Serum Albumin Fraction V (1.5%), insulin (5 μg/mL), collagenase A (1 mg/mL) and hyaluronidase (100 U/ml) for 1–2 hr at 37 °C. Following incubation, the mixture was filtered and the cell suspension was spun down and washed with PBS. Ascites fluid was centrifuged at 450 g for 5 min. Cells were then washed with PBS and centrifuged at 400 g for 5 min.</p><p>The isolated cells were resuspended in 7.5 mg/ml basement membrane matrix (Cultrex BME RGF type 2 (BME-2), Amsbio) supplemented with complete media and plated as 20 μl droplets in a six-well plate. After allowing the BME-2 to polymerize, complete media was added and the cells were left at 37 °C. We used published culture conditions for normal fallopian tube growth (<xref ref-type="bibr" rid="bib31">Kessler et al., 2015</xref>) as follows: AdDMEM/F12 medium supplemented with HEPES (1×, Invitrogen), Glutamax (1×, Invitrogen), penicillin/streptomycin (1×, Invitrogen), B27 (1×, Invitrogen), N2 (1×, Invitrogen), Wnt3a-conditioned medium (25% v/v), RSPO1-conditioned medium (25% v/v), recombinant Noggin protein (100 ng/ml, Peprotech), epidermal growth factor (EGF, 10 ng/ml, Peprotech), fibroblast growth factor 10 (FGF10, 100 ng/ml, Peprotech), nicotinamide (1 mM, Sigma), SB431542 (0.5 μM, Cambridge Biosciences), and Y27632 (9 μM, Abmole).</p></sec><sec id="s4-4"><title>Organoid culture</title><p>Organoid culture medium was refreshed every 2 days. To passage the organoids, the domes were scraped and collected in a falcon tube, TrypLE (Invitrogen) was added and incubated at 37 °C for approximately 10 min. The suspension was centrifuged at 800 g for 2 min and the cell pellet was resuspended in 7.5 mg/ml BME-2 supplemented with complete media and plated as 20 μl droplets in a six-well plate. After allowing the BME-2 to polymerize, complete media was added, and cells were incubated at 37 °C. The commonest cause of culture failure was growth arrest or fibroblast overgrowth. We considered an organoid line to be continuously established when it had been serially passaged &gt;5 times followed by cryopreservation and successful re-culture. By these criteria, 15/18 PDO lines were continuous.</p></sec><sec id="s4-5"><title>Immunohistochemistry</title><p>Haematoxylin and Eosin (H&amp;E) slides were stained according to the Harris H&amp;E staining protocol and using a Leica ST5020 multi-stainer instrument. Paraffin-embedded sections of 3 μm were stained using Leica Bond Max fully automated IHC system. Briefly, slides were retrieved using sodium citrate for 30 min and p53 antibody (D07, 1:1000, Dako) was applied for 30 min. Bond Polymer Refine Detection System (Leica Microsystems) was used to visualize the brown precipitate from the chromogenic substrate, 3,3’-Diaminobenzidine tetrahydrochloride (DAB).</p></sec><sec id="s4-6"><title>Nucleic acid isolation</title><p>DNA and RNA were extracted at the same time from the same cells. Extraction was performed using the DNeasy Blood &amp; Tissue Kit (QIAGEN) according to manufacturer instructions.</p></sec><sec id="s4-7"><title>Bulk shallow whole-genome sequencing and absolute copy number signature analysis</title><p>Whole genome libraries were prepared using the TruSeq Nano Kit according to manufacturer instructions. Each library was quantified using the KAPA Library Quantification kit (kappa Biosystems) and 10 nM of each library was combined in a pool of 21 samples and sequenced on the Illumina HiSeq 4000 machine using single-end 150 bp reads. Reads were aligned against the human genome assembly GRCh37 using the BWA-MEM algorithm (v0.7.12). Duplicates were marked using the Picard Tool (v1.47) and copy number was assessed using the Bioconductor package QDNAseq (v1.6.1) (<xref ref-type="bibr" rid="bib57">Scheinin et al., 2014</xref>). Shallow whole-genome samples have an approximate coverage of 0.25–0.3, assuming that the sample is diploid.</p><p>Copy number signatures for the organoid cultures were calculated as previously described (<xref ref-type="bibr" rid="bib46">Macintyre et al., 2018</xref>).</p></sec><sec id="s4-8"><title>Comparison of organoid copy number signatures to those of TCGA, BriTROC-1, and PCAWG</title><p>Signature activities of organoids were compared to those previously described in three HGSOC cohorts: TCGA and BriTROC-1 (<xref ref-type="bibr" rid="bib46">Macintyre et al., 2018</xref>) (sWGS-based signatures) and PCAWG (<xref ref-type="bibr" rid="bib1">Aaltonen et al., 2020</xref>) (WGS-based signatures). Copy number signature activities were transformed using the centered log-ratio transformation with an imputation value of 10<sup>–2</sup> to consider that they are compositional data that sample-wise add up to one. Organoid and primary tissue samples were clustered using hierarchical clustering with complete linkage on this transformed space. We performed additional analyses to confirm that our conclusions – namely, that the signature activities of organoids are representative of the activities of primary tissue, and in determining which activities are underrepresented in the organoids – were robust to the imputation value. Using imputation values between 0.001 and 0.1 we show that the dendrogram in <xref ref-type="fig" rid="fig1">Figure 1d</xref> is similar to the dendrograms generated using both higher and lower imputation values, and that the underrepresented clades are robust to changes in the imputation values. A more detailed report of the differences in dendrograms as we vary the imputation values can be found in the GitHub repository (see below).</p></sec><sec id="s4-9"><title>Comparison of copy number signatures between ascites and organoids</title><p>Signature exposures between ascites and organoids are compared using the same method as in a previous CN paper (<xref ref-type="bibr" rid="bib12">Cheng et al., 2022</xref>), in which the model is detailed. Briefly, the model used is a multivariate model on isometric log-ratio (ILR)-transformed exposures that accounts for data compositionality, by modeling these transformed quantities as a non-correlated multivariate normal distribution, and testing for a difference in the mean of the two groups.</p></sec><sec id="s4-10"><title>Single-cell sWGS</title><p>Organoids were dissociated into single cells using TrypLE, washed twice with PBS, and counted. Single-cell solution was filtered using a 70 μm Flowmi filter to remove any duplets or triplets. With the aim of getting around 300 cells for library preparation, 4000 single cells were loaded onto the chip. Single-cell 10 x CNV libraries were prepared according to the manufacturer’s protocol (10 X Genomics) and multiplexed in equal molarity to achieve 2.4 million reads per cell. Single-cell 10 X CNV constructed libraries were sequenced on the Illumina Novaseq6000 S4 platform using PE- 150 modes. The Cell Ranger pipeline was used for quality control, trimming, and alignment.</p></sec><sec id="s4-11"><title>Metric for copy number subclonal heterogeneity in single-cell</title><p>The metric for copy number subclonal heterogeneity is defined as follows. Independently, for each of the three organoids, we fitted a linear model of the standard deviation of the absolute copy number across organoids predicted by its mean, using bins of 500 kb. Copy number data were handled using the R package GenomicRanges (<xref ref-type="bibr" rid="bib35">Lawrence et al., 2013</xref>). The marked positive correlation indicated that the data were heteroscedastic. For each bin, we computed its expected variance from the model, <inline-formula><mml:math id="inf1"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>E</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mstyle></mml:math></inline-formula>, and compared it to the observed variance <inline-formula><mml:math id="inf2"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:msup><mml:mi>S</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mstyle></mml:math></inline-formula>  with a Chi-Squared test with alternative hypothesis <inline-formula><mml:math id="inf3"><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mrow><mml:mi>E</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mi>σ</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:mo stretchy="false">)</mml:mo><mml:mo>&lt;</mml:mo><mml:msup><mml:mi>S</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mstyle></mml:math></inline-formula>. A statistically significant result indicates that we see a greater variance than expected in the copy number values of this bin, and that, therefore, there is subclonal heterogeneity.</p></sec><sec id="s4-12"><title>Clade analysis of single-cell copy number data</title><p>Single-cell clades for each organoid were identified by performing hierarchical clustering using complete linkage on Euclidean distance of copy number values on 500 kb-binned genomes. Only clades with more than three cells were kept in the analysis. PDO2 had four major clades, two of which encompassed most cells (clade A: 42 cells, clade B: 30 cells), PDO3 had seven major clades, three of which with more than two cells (clade A: 40 cells, clade B: 52 cells, clade C: 48 cells). PDO6 had six clades, three of which contained more than one cell (clade A: 158 cells, clade B: 145 cells, clade C: 49 cells). The copy number profile comparison of the two clades of PDO2, and of the two pairwise comparisons of clades of PDO3 and PDO4, were carried out using the 20 kb-binned copy number profile. Bins of distinct copy numbers between cells in different clades were detected using a Holm–Bonferroni-adjusted <italic>t</italic>-test on the absolute copy number value.</p></sec><sec id="s4-13"><title>Tagged-amplicon sequencing</title><p>Coding sequences of <italic>TP53, PTEN, NF1, BRCA1, BRCA2, MLH1, MSH2, MSH6, PMS2, RAD51C, RAD51B, RAD51D</italic>, and hot spots for <italic>EGFR</italic>, <italic>KRAS</italic>, <italic>BRAF</italic>, <italic>PIK3CA</italic> were sequenced using tagged amplicon sequencing on the Fluidigm Access Array 48.48 platform as previously described (<xref ref-type="bibr" rid="bib19">Forshew et al., 2012</xref>). Libraries were sequenced on the MiSeq platform using paired-end 125 bp reads. Variant calling from sequencing data was performed using an in-house analysis pipeline and IGV software (<xref ref-type="bibr" rid="bib61">Thorvaldsdóttir et al., 2013</xref>).</p></sec><sec id="s4-14"><title>RNA-Seq</title><p>RNA quality control was performed using Tapestation according to manufacturer instructions and samples were processed using Illumina’s TruSeq stranded mRNA kit with 12 PCR cycles according to manufacturer’s instructions. Quality control of libraries was performed using Tapestation and Clariostar before normalizing and pooling. Samples were sequenced using two lanes of SE50 on a HiSeq 4000 instrument. The analysis was performed using an in-house DESeq2 (<xref ref-type="bibr" rid="bib41">Love et al., 2014</xref>) pipeline.</p><p>TCGA gene expression values were downloaded as HTSeq count files of Genome Build GRCh38 for 240 ovarian samples of either progressive disease, or complete remission or response. The counts were normalized using the DESeq2 method, based on gene-specific geometric means. The subset of genes relating to the tumor microenvironment was taken from the Consensus<sup>TME</sup> list (<ext-link ext-link-type="uri" xlink:href="https://github.com/cansysbio/ConsensusTME">https://github.com/cansysbio/ConsensusTME</ext-link>, <xref ref-type="bibr" rid="bib11">Cast, 2023</xref>). The normalized expression of all genes was used to create the PCA.</p></sec><sec id="s4-15"><title>Effect of CNAs at the gene expression level</title><p>We computed the average gene expression values for the three PDOs of the lowest copy number. Three organoids, out of eleven, with the lowest expression were selected in order not to include solely outliers, as well as leaving out a high enough number of organoid samples (eight) in which we can observe the variability in their copy number and gene expression. We explored using the two, and four, PDOs and the lowest copy number, which yielded similar results - there is a very high correlation between these averaged GE values when using the lowest three organoids, and when using the lowest two, or four.</p></sec><sec id="s4-16"><title>Pathway enrichment analysis</title><p>Using our transcriptomic data, we computed enrichment scores for KEGG pathways of interest using ssGSEA, implemented in the R package GSVA (<xref ref-type="bibr" rid="bib26">Hänzelmann et al., 2013</xref>), and using gene sets from the package GSVAdata (<xref ref-type="bibr" rid="bib26">Hänzelmann et al., 2013</xref>). To determine which pathways were overrepresented in the differential expression analysis between sensitive and resistant samples we used the R package fgsea (<xref ref-type="bibr" rid="bib33">Korotkevich et al., 2021</xref>) and selected the top ten pathways according to their adjusted p-value (Benjamini-Hochberg correction), using the Hallmark gene sets from MSigDBv5p2.</p></sec><sec id="s4-17"><title>Drug sensitivity</title><p>An eight-point half-log dilution series of each compound was dispensed into 384 well plates using an Echo 550 acoustic liquid handler instrument (Labcyte) and kept at –20 °C until used. Prior to use plates were spun down and 50 µl of organoid suspension is added per well using a Multidrop Combi Reagent Dispenser (Thermo-Fisher). Following 5 days of drug incubation cell viability was assayed using 30 µl of CellTiter-Glo (Promega). Screens were performed in technical triplicate.</p><p>Drug response measures were standardized by dividing the original values by the median drug response observed in the control group of each drug and sample and then modeled as a function of the dose (on the log scale) by means of a 4<sup>th</sup>-degree polynomial robust regression, fitted by means of the function lmrob of the R package robustbase (<xref ref-type="bibr" rid="bib48">Maechler et al., 2023</xref>). Drug response measures that obtained robust weights smaller than 0.4 (out of a range which spreads from 0 for outliers to 1 for non-outliers) were considered as outliers. After excluding outliers, we modeled the standardized drug response measures as a function of the dose (on the log scale) by means of the five-parameter log-logistic model (drm function of the drc R package [<xref ref-type="bibr" rid="bib56">Ritz et al., 2015</xref>] with fct argument set to LL2.5). Area under the curve estimates was finally obtained by integrating the expected standardized drug response given the dose on the dose range of interest (on the log scale). Note that the use of M-splines instead of a log-logistic model led to similar AUC estimates.</p><p>Compounds used in this study included standard-of-care chemotherapeutics paclitaxel (Sigma), oxaliplatin (Selleck), doxorubicin (Selleck), and gemcitabine (Selleck); and targeted compounds provided by AstraZeneca: AZD0156, AZD2014, AZD6738, AZD2281, AZD1775, AZD8835, AZD5363, and AZD8185. Maximum drug concentration in the assay was 30 μM apart from paclitaxel (0.3 μM) and oxaliplatin (300 μM).</p></sec><sec id="s4-18"><title><italic>In vivo</italic> growth</title><p>Animal procedures were conducted in accordance with the ethical regulations and guidelines of AWERB, NACWO, and UK Home Office (Animals Scientific Procedures Act 1986). It was approved by the CRUK CI Animal Welfare and Ethics Review Board (Home Office Project Licence number: PP7478310). 1.5 × 105 organoids were resuspended in 150 μl of PBS and injected intraperitoneally into NOD-scid IL2Rγ(null) (NSG) mice. Tumor growth was monitored by palpation and weighing the mice weekly.</p></sec><sec id="s4-19"><title>Code availability</title><p>All the analysis code is at <ext-link ext-link-type="uri" xlink:href="https://github.com/lm687/Organoids_Compositional_Analysis">https://github.com/lm687/Organoids_Compositional_Analysis</ext-link> (copy archived at <xref ref-type="bibr" rid="bib52">Morrill, 2023</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>GM, FM, AMP and JDB are founders and shareholders of Tailor Bio Ltd</p></fn><fn fn-type="COI-statement" id="conf3"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Formal analysis, Supervision, Validation, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Resources, Data curation, Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con5"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Formal analysis, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Data curation, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Data curation, Methodology</p></fn><fn fn-type="con" id="con10"><p>Resources, Investigation, Methodology</p></fn><fn fn-type="con" id="con11"><p>Resources, Data curation, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con12"><p>Conceptualization, Supervision, Writing – review and editing</p></fn><fn fn-type="con" id="con13"><p>Conceptualization, Formal analysis, Supervision, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con14"><p>Conceptualization, Supervision, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Clinical data and tissue samples for the patients were collected on the prospective cohort study Cambridge Translational Cancer Research Ovarian Study 04 (CTCR-OV04), with IRAS project ID 4853, and which was approved by the Institutional Ethics Committee (REC reference number 08/H0306/61). Clinical decisions were made by a clinical multidisciplinary team (MDT) and researchers were not directly involved. Patients provided written, informed consent for participation in this study and for the use of their donated tissue for the laboratory studies carried out in this work and its publication.</p></fn><fn fn-type="other"><p>Animal procedures were conducted in accordance with the ethical regulations and guidelines of AWERB, NACWO and UK Home Office (Animals Scientific Procedures Act 1986). It was approved the CRUK CI Animal Welfare and Ethics Review Board (Home Office Project Licence number: PP7478310).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Summary of patient chemotherapy treatment.</title></caption><media xlink:href="elife-83867-supp1-v1.csv" mimetype="application" mime-subtype="octet-stream"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Mutation analysis of patient and PDO samples.</title></caption><media xlink:href="elife-83867-supp2-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Patient germline BRCA mutation status.</title></caption><media xlink:href="elife-83867-supp3-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-83867-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>RNA-Seq data are available at the Gene Expression Omnibus (GEO) under accession number GSE208216, and sWGS and scDNA data are available at the EGA European Genome-Phenome Archive (EGA) under accession number EGAS00001007189. These data are available for non-commercial academic use only.</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Vias</surname><given-names>M</given-names></name><name><surname>Gavarró</surname><given-names>LM</given-names></name><name><surname>Sauer</surname><given-names>CM</given-names></name><name><surname>Sanders</surname><given-names>D</given-names></name><name><surname>Piskorz</surname><given-names>AM</given-names></name><name><surname>Couturier</surname><given-names>D</given-names></name><name><surname>Ballereau</surname><given-names>S</given-names></name><name><surname>Hernando</surname><given-names>B</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Correia-Martins</surname><given-names>F</given-names></name><name><surname>Markowetz</surname><given-names>F</given-names></name><name><surname>Macintyre</surname><given-names>G</given-names></name><name><surname>Brenton</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>High grade serous ovarian cancer organoids as models of chromosomal instability</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE208216">GSE208216</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Vias</surname><given-names>M</given-names></name><name><surname>Gavarró</surname><given-names>LM</given-names></name><name><surname>Sauer</surname><given-names>CM</given-names></name><name><surname>Sanders</surname><given-names>D</given-names></name><name><surname>Piskorz</surname><given-names>AM</given-names></name><name><surname>Couturier</surname><given-names>D</given-names></name><name><surname>Ballereau</surname><given-names>S</given-names></name><name><surname>Hernando</surname><given-names>B</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Correia-Martins</surname><given-names>F</given-names></name><name><surname>Markowetz</surname><given-names>F</given-names></name><name><surname>Brenton</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>HGSOC organoid sequencing study</data-title><source>European Genome-Phenome Archive</source><pub-id pub-id-type="accession" xlink:href="https://ega-archive.org/studies/EGAS00001007189">EGAS00001007189</pub-id></element-citation></p><p>The following previously published dataset was used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><collab>Macintyre et al.</collab></person-group><year iso-8601-date="2017">2017</year><data-title>Copy number signatures and mutational processes in ovarian carcinoma</data-title><source>European Genome-Phenome Archive</source><pub-id pub-id-type="accession" xlink:href="https://ega-archive.org/studies/EGAS00001002557">EGAS00001002557</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank all patients who participated in and donated tissue samples to this study. The Addenbrooke’s Human Research Tissue Bank is supported by the NIHR Cambridge Biomedical Research Centre. We also thank Karen Hosking, Mercedes Jimenez-Linan, and the OV04 study team for their help with clinical tissue samples. We also thank staff from the Cancer Molecular Diagnostics Laboratory for performing blood and ascites collections. We would like to thank the Cancer Research UK Cambridge Institute Genomics, IT &amp; Scientific Computing, Biological Resource Unit, Compliance &amp; Biobanking, Research Instrumentation and Cell Services, and Bioinformatics core facilities for their support with various aspects of this study. The results shown here are in part based upon data generated by the TCGA Research Network: <ext-link ext-link-type="uri" xlink:href="https://www.cancer.gov/tcga">https://www.cancer.gov/tcga</ext-link>. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. We thank Susana Ros, Thomas Bradley, and Hayley Frances for critically reading the manuscript. We would like to thank the Clevers Laboratory (University of Utrecht) for hosting Maria Vias for a CRUK Travel Award. We thank the reviewers and the editors.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aaltonen</surname><given-names>LA</given-names></name><name><surname>Abascal</surname><given-names>F</given-names></name><name><surname>Abeshouse</surname><given-names>A</given-names></name><name><surname>Aburatani</surname><given-names>H</given-names></name><name><surname>Adams</surname><given-names>DJ</given-names></name><name><surname>Agrawal</surname><given-names>N</given-names></name><name><surname>Ahn</surname><given-names>KS</given-names></name><name><surname>Ahn</surname><given-names>S-M</given-names></name><name><surname>Aikata</surname><given-names>H</given-names></name><name><surname>Akbani</surname><given-names>R</given-names></name><name><surname>Akdemir</surname><given-names>KC</given-names></name><name><surname>Al-Ahmadie</surname><given-names>H</given-names></name><name><surname>Al-Sedairy</surname><given-names>ST</given-names></name><name><surname>Al-Shahrour</surname><given-names>F</given-names></name><name><surname>Alawi</surname><given-names>M</given-names></name><name><surname>Albert</surname><given-names>M</given-names></name><name><surname>Aldape</surname><given-names>K</given-names></name><name><surname>Alexandrov</surname><given-names>LB</given-names></name><name><surname>Ally</surname><given-names>A</given-names></name><name><surname>Alsop</surname><given-names>K</given-names></name><name><surname>Alvarez</surname><given-names>EG</given-names></name><name><surname>Amary</surname><given-names>F</given-names></name><name><surname>Amin</surname><given-names>SB</given-names></name><name><surname>Aminou</surname><given-names>B</given-names></name><name><surname>Ammerpohl</surname><given-names>O</given-names></name><name><surname>Anderson</surname><given-names>MJ</given-names></name><name><surname>Ang</surname><given-names>Y</given-names></name><name><surname>Antonello</surname><given-names>D</given-names></name><name><surname>Anur</surname><given-names>P</given-names></name><name><surname>Aparicio</surname><given-names>S</given-names></name><name><surname>Appelbaum</surname><given-names>EL</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Aretz</surname><given-names>A</given-names></name><name><surname>Arihiro</surname><given-names>K</given-names></name><name><surname>Ariizumi</surname><given-names>S</given-names></name><name><surname>Armenia</surname><given-names>J</given-names></name><name><surname>Arnould</surname><given-names>L</given-names></name><name><surname>Asa</surname><given-names>S</given-names></name><name><surname>Assenov</surname><given-names>Y</given-names></name><name><surname>Atwal</surname><given-names>G</given-names></name><name><surname>Aukema</surname><given-names>S</given-names></name><name><surname>Auman</surname><given-names>JT</given-names></name><name><surname>Aure</surname><given-names>MRR</given-names></name><name><surname>Awadalla</surname><given-names>P</given-names></name><name><surname>Aymerich</surname><given-names>M</given-names></name><name><surname>Bader</surname><given-names>GD</given-names></name><name><surname>Baez-Ortega</surname><given-names>A</given-names></name><name><surname>Bailey</surname><given-names>MH</given-names></name><name><surname>Bailey</surname><given-names>PJ</given-names></name><name><surname>Balasundaram</surname><given-names>M</given-names></name><name><surname>Balu</surname><given-names>S</given-names></name><name><surname>Bandopadhayay</surname><given-names>P</given-names></name><name><surname>Banks</surname><given-names>RE</given-names></name><name><surname>Barbi</surname><given-names>S</given-names></name><name><surname>Barbour</surname><given-names>AP</given-names></name><name><surname>Barenboim</surname><given-names>J</given-names></name><name><surname>Barnholtz-Sloan</surname><given-names>J</given-names></name><name><surname>Barr</surname><given-names>H</given-names></name><name><surname>Barrera</surname><given-names>E</given-names></name><name><surname>Bartlett</surname><given-names>J</given-names></name><name><surname>Bartolome</surname><given-names>J</given-names></name><name><surname>Bassi</surname><given-names>C</given-names></name><name><surname>Bathe</surname><given-names>OF</given-names></name><name><surname>Baumhoer</surname><given-names>D</given-names></name><name><surname>Bavi</surname><given-names>P</given-names></name><name><surname>Baylin</surname><given-names>SB</given-names></name><name><surname>Bazant</surname><given-names>W</given-names></name><name><surname>Beardsmore</surname><given-names>D</given-names></name><name><surname>Beck</surname><given-names>TA</given-names></name><name><surname>Behjati</surname><given-names>S</given-names></name><name><surname>Behren</surname><given-names>A</given-names></name><name><surname>Niu</surname><given-names>B</given-names></name><name><surname>Bell</surname><given-names>C</given-names></name><name><surname>Beltran</surname><given-names>S</given-names></name><name><surname>Benz</surname><given-names>C</given-names></name><name><surname>Berchuck</surname><given-names>A</given-names></name><name><surname>Bergmann</surname><given-names>AK</given-names></name><name><surname>Bergstrom</surname><given-names>EN</given-names></name><name><surname>Berman</surname><given-names>BP</given-names></name><name><surname>Berney</surname><given-names>DM</given-names></name><name><surname>Bernhart</surname><given-names>SH</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Berrios</surname><given-names>M</given-names></name><name><surname>Bersani</surname><given-names>S</given-names></name><name><surname>Bertl</surname><given-names>J</given-names></name><name><surname>Betancourt</surname><given-names>M</given-names></name><name><surname>Bhandari</surname><given-names>V</given-names></name><name><surname>Bhosle</surname><given-names>SG</given-names></name><name><surname>Biankin</surname><given-names>AV</given-names></name><name><surname>Bieg</surname><given-names>M</given-names></name><name><surname>Bigner</surname><given-names>D</given-names></name><name><surname>Binder</surname><given-names>H</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Birrer</surname><given-names>M</given-names></name><name><surname>Biswas</surname><given-names>NK</given-names></name><name><surname>Bjerkehagen</surname><given-names>B</given-names></name><name><surname>Bodenheimer</surname><given-names>T</given-names></name><name><surname>Boice</surname><given-names>L</given-names></name><name><surname>Bonizzato</surname><given-names>G</given-names></name><name><surname>De Bono</surname><given-names>JS</given-names></name><name><surname>Boot</surname><given-names>A</given-names></name><name><surname>Bootwalla</surname><given-names>MS</given-names></name><name><surname>Borg</surname><given-names>A</given-names></name><name><surname>Borkhardt</surname><given-names>A</given-names></name><name><surname>Boroevich</surname><given-names>KA</given-names></name><name><surname>Borozan</surname><given-names>I</given-names></name><name><surname>Borst</surname><given-names>C</given-names></name><name><surname>Bosenberg</surname><given-names>M</given-names></name><name><surname>Bosio</surname><given-names>M</given-names></name><name><surname>Boultwood</surname><given-names>J</given-names></name><name><surname>Bourque</surname><given-names>G</given-names></name><name><surname>Boutros</surname><given-names>PC</given-names></name><name><surname>Bova</surname><given-names>GS</given-names></name><name><surname>Bowen</surname><given-names>DT</given-names></name><name><surname>Bowlby</surname><given-names>R</given-names></name><name><surname>Bowtell</surname><given-names>DDL</given-names></name><name><surname>Boyault</surname><given-names>S</given-names></name><name><surname>Boyce</surname><given-names>R</given-names></name><name><surname>Boyd</surname><given-names>J</given-names></name><name><surname>Brazma</surname><given-names>A</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Brewer</surname><given-names>DS</given-names></name><name><surname>Brinkman</surname><given-names>AB</given-names></name><name><surname>Bristow</surname><given-names>RG</given-names></name><name><surname>Broaddus</surname><given-names>RR</given-names></name><name><surname>Brock</surname><given-names>JE</given-names></name><name><surname>Brock</surname><given-names>M</given-names></name><name><surname>Broeks</surname><given-names>A</given-names></name><name><surname>Brooks</surname><given-names>AN</given-names></name><name><surname>Brooks</surname><given-names>D</given-names></name><name><surname>Brors</surname><given-names>B</given-names></name><name><surname>Brunak</surname><given-names>S</given-names></name><name><surname>Bruxner</surname><given-names>TJC</given-names></name><name><surname>Bruzos</surname><given-names>AL</given-names></name><name><surname>Buchanan</surname><given-names>A</given-names></name><name><surname>Buchhalter</surname><given-names>I</given-names></name><name><surname>Buchholz</surname><given-names>C</given-names></name><name><surname>Bullman</surname><given-names>S</given-names></name><name><surname>Burke</surname><given-names>H</given-names></name><name><surname>Burkhardt</surname><given-names>B</given-names></name><name><surname>Burns</surname><given-names>KH</given-names></name><name><surname>Busanovich</surname><given-names>J</given-names></name><name><surname>Bustamante</surname><given-names>CD</given-names></name><name><surname>Butler</surname><given-names>AP</given-names></name><name><surname>Butte</surname><given-names>AJ</given-names></name><name><surname>Byrne</surname><given-names>NJ</given-names></name><name><surname>Børresen-Dale</surname><given-names>A-L</given-names></name><name><surname>Caesar-Johnson</surname><given-names>SJ</given-names></name><name><surname>Cafferkey</surname><given-names>A</given-names></name><name><surname>Cahill</surname><given-names>D</given-names></name><name><surname>Calabrese</surname><given-names>C</given-names></name><name><surname>Caldas</surname><given-names>C</given-names></name><name><surname>Calvo</surname><given-names>F</given-names></name><name><surname>Camacho</surname><given-names>N</given-names></name><name><surname>Campbell</surname><given-names>PJ</given-names></name><name><surname>Campo</surname><given-names>E</given-names></name><name><surname>Cantù</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>S</given-names></name><name><surname>Carey</surname><given-names>TE</given-names></name><name><surname>Carlevaro-Fita</surname><given-names>J</given-names></name><name><surname>Carlsen</surname><given-names>R</given-names></name><name><surname>Cataldo</surname><given-names>I</given-names></name><name><surname>Cazzola</surname><given-names>M</given-names></name><name><surname>Cebon</surname><given-names>J</given-names></name><name><surname>Cerfolio</surname><given-names>R</given-names></name><name><surname>Chadwick</surname><given-names>DE</given-names></name><name><surname>Chakravarty</surname><given-names>D</given-names></name><name><surname>Chalmers</surname><given-names>D</given-names></name><name><surname>Chan</surname><given-names>CWY</given-names></name><name><surname>Chan</surname><given-names>K</given-names></name><name><surname>Chan-Seng-Yue</surname><given-names>M</given-names></name><name><surname>Chandan</surname><given-names>VS</given-names></name><name><surname>Chang</surname><given-names>DK</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><name><surname>Chantrill</surname><given-names>LA</given-names></name><name><surname>Chateigner</surname><given-names>A</given-names></name><name><surname>Chatterjee</surname><given-names>N</given-names></name><name><surname>Chayama</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>H-W</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Cherniack</surname><given-names>AD</given-names></name><name><surname>Chien</surname><given-names>J</given-names></name><name><surname>Chiew</surname><given-names>Y-E</given-names></name><name><surname>Chin</surname><given-names>S-F</given-names></name><name><surname>Cho</surname><given-names>J</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>JK</given-names></name><name><surname>Choi</surname><given-names>W</given-names></name><name><surname>Chomienne</surname><given-names>C</given-names></name><name><surname>Chong</surname><given-names>Z</given-names></name><name><surname>Choo</surname><given-names>SP</given-names></name><name><surname>Chou</surname><given-names>A</given-names></name><name><surname>Christ</surname><given-names>AN</given-names></name><name><surname>Christie</surname><given-names>EL</given-names></name><name><surname>Chuah</surname><given-names>E</given-names></name><name><surname>Cibulskis</surname><given-names>C</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Cingarlini</surname><given-names>S</given-names></name><name><surname>Clapham</surname><given-names>P</given-names></name><name><surname>Claviez</surname><given-names>A</given-names></name><name><surname>Cleary</surname><given-names>S</given-names></name><name><surname>Cloonan</surname><given-names>N</given-names></name><name><surname>Cmero</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>CC</given-names></name><name><surname>Connor</surname><given-names>AA</given-names></name><name><surname>Cooke</surname><given-names>SL</given-names></name><name><surname>Cooper</surname><given-names>CS</given-names></name><name><surname>Cope</surname><given-names>L</given-names></name><name><surname>Corbo</surname><given-names>V</given-names></name><name><surname>Cordes</surname><given-names>MG</given-names></name><name><surname>Cordner</surname><given-names>SM</given-names></name><name><surname>Cortés-Ciriano</surname><given-names>I</given-names></name><name><surname>Covington</surname><given-names>K</given-names></name><name><surname>Cowin</surname><given-names>PA</given-names></name><name><surname>Craft</surname><given-names>B</given-names></name><name><surname>Craft</surname><given-names>D</given-names></name><name><surname>Creighton</surname><given-names>CJ</given-names></name><name><surname>Cun</surname><given-names>Y</given-names></name><name><surname>Curley</surname><given-names>E</given-names></name><name><surname>Cutcutache</surname><given-names>I</given-names></name><name><surname>Czajka</surname><given-names>K</given-names></name><name><surname>Czerniak</surname><given-names>B</given-names></name><name><surname>Dagg</surname><given-names>RA</given-names></name><name><surname>Danilova</surname><given-names>L</given-names></name><name><surname>Davi</surname><given-names>MV</given-names></name><name><surname>Davidson</surname><given-names>NR</given-names></name><name><surname>Davies</surname><given-names>H</given-names></name><name><surname>Davis</surname><given-names>IJ</given-names></name><name><surname>Davis-Dusenbery</surname><given-names>BN</given-names></name><name><surname>Dawson</surname><given-names>KJ</given-names></name><name><surname>De La Vega</surname><given-names>FM</given-names></name><name><surname>De Paoli-Iseppi</surname><given-names>R</given-names></name><name><surname>Defreitas</surname><given-names>T</given-names></name><name><surname>Tos</surname><given-names>APD</given-names></name><name><surname>Delaneau</surname><given-names>O</given-names></name><name><surname>Demchok</surname><given-names>JA</given-names></name><name><surname>Demeulemeester</surname><given-names>J</given-names></name><name><surname>Demidov</surname><given-names>GM</given-names></name><name><surname>Demircioğlu</surname><given-names>D</given-names></name><name><surname>Dennis</surname><given-names>NM</given-names></name><name><surname>Denroche</surname><given-names>RE</given-names></name><name><surname>Dentro</surname><given-names>SC</given-names></name><name><surname>Desai</surname><given-names>N</given-names></name><name><surname>Deshpande</surname><given-names>V</given-names></name><name><surname>Deshwar</surname><given-names>AG</given-names></name><name><surname>Desmedt</surname><given-names>C</given-names></name><name><surname>Deu-Pons</surname><given-names>J</given-names></name><name><surname>Dhalla</surname><given-names>N</given-names></name><name><surname>Dhani</surname><given-names>NC</given-names></name><name><surname>Dhingra</surname><given-names>P</given-names></name><name><surname>Dhir</surname><given-names>R</given-names></name><name><surname>DiBiase</surname><given-names>A</given-names></name><name><surname>Diamanti</surname><given-names>K</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Ding</surname><given-names>S</given-names></name><name><surname>Dinh</surname><given-names>HQ</given-names></name><name><surname>Dirix</surname><given-names>L</given-names></name><name><surname>Doddapaneni</surname><given-names>H</given-names></name><name><surname>Donmez</surname><given-names>N</given-names></name><name><surname>Dow</surname><given-names>MT</given-names></name><name><surname>Drapkin</surname><given-names>R</given-names></name><name><surname>Drechsel</surname><given-names>O</given-names></name><name><surname>Drews</surname><given-names>RM</given-names></name><name><surname>Serge</surname><given-names>S</given-names></name><name><surname>Dudderidge</surname><given-names>T</given-names></name><name><surname>Dueso-Barroso</surname><given-names>A</given-names></name><name><surname>Dunford</surname><given-names>AJ</given-names></name><name><surname>Dunn</surname><given-names>M</given-names></name><name><surname>Dursi</surname><given-names>LJ</given-names></name><name><surname>Duthie</surname><given-names>FR</given-names></name><name><surname>Dutton-Regester</surname><given-names>K</given-names></name><name><surname>Eagles</surname><given-names>J</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name><name><surname>Edmonds</surname><given-names>S</given-names></name><name><surname>Edwards</surname><given-names>PA</given-names></name><name><surname>Edwards</surname><given-names>SE</given-names></name><name><surname>Eeles</surname><given-names>RA</given-names></name><name><surname>Ehinger</surname><given-names>A</given-names></name><name><surname>Eils</surname><given-names>J</given-names></name><name><surname>Eils</surname><given-names>R</given-names></name><name><surname>El-Naggar</surname><given-names>A</given-names></name><name><surname>Eldridge</surname><given-names>M</given-names></name><name><surname>Ellrott</surname><given-names>K</given-names></name><name><surname>Erkek</surname><given-names>S</given-names></name><name><surname>Escaramis</surname><given-names>G</given-names></name><name><surname>Espiritu</surname><given-names>SMG</given-names></name><name><surname>Estivill</surname><given-names>X</given-names></name><name><surname>Etemadmoghadam</surname><given-names>D</given-names></name><name><surname>Eyfjord</surname><given-names>JE</given-names></name><name><surname>Faltas</surname><given-names>BM</given-names></name><name><surname>Fan</surname><given-names>D</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Faquin</surname><given-names>WC</given-names></name><name><surname>Farcas</surname><given-names>C</given-names></name><name><surname>Fassan</surname><given-names>M</given-names></name><name><surname>Fatima</surname><given-names>A</given-names></name><name><surname>Favero</surname><given-names>F</given-names></name><name><surname>Fayzullaev</surname><given-names>N</given-names></name><name><surname>Felau</surname><given-names>I</given-names></name><name><surname>Fereday</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>ML</given-names></name><name><surname>Ferretti</surname><given-names>V</given-names></name><name><surname>Feuerbach</surname><given-names>L</given-names></name><name><surname>Field</surname><given-names>MA</given-names></name><name><surname>Fink</surname><given-names>JL</given-names></name><name><surname>Finocchiaro</surname><given-names>G</given-names></name><name><surname>Fisher</surname><given-names>C</given-names></name><name><surname>Fittall</surname><given-names>MW</given-names></name><name><surname>Fitzgerald</surname><given-names>A</given-names></name><name><surname>Fitzgerald</surname><given-names>RC</given-names></name><name><surname>Flanagan</surname><given-names>AM</given-names></name><name><surname>Fleshner</surname><given-names>NE</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Foekens</surname><given-names>JA</given-names></name><name><surname>Fong</surname><given-names>KM</given-names></name><name><surname>Fonseca</surname><given-names>NA</given-names></name><name><surname>Foster</surname><given-names>CS</given-names></name><name><surname>Fox</surname><given-names>NS</given-names></name><name><surname>Fraser</surname><given-names>M</given-names></name><name><surname>Frazer</surname><given-names>S</given-names></name><name><surname>Frenkel-Morgenstern</surname><given-names>M</given-names></name><name><surname>Friedman</surname><given-names>W</given-names></name><name><surname>Frigola</surname><given-names>J</given-names></name><name><surname>Fronick</surname><given-names>CC</given-names></name><name><surname>Fujimoto</surname><given-names>A</given-names></name><name><surname>Fujita</surname><given-names>M</given-names></name><name><surname>Fukayama</surname><given-names>M</given-names></name><name><surname>Fulton</surname><given-names>LA</given-names></name><name><surname>Fulton</surname><given-names>RS</given-names></name><name><surname>Furuta</surname><given-names>M</given-names></name><name><surname>Futreal</surname><given-names>PA</given-names></name><name><surname>Füllgrabe</surname><given-names>A</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Gallinger</surname><given-names>S</given-names></name><name><surname>Gambacorti-Passerini</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Garraway</surname><given-names>L</given-names></name><name><surname>Garred</surname><given-names>Ø</given-names></name><name><surname>Garrison</surname><given-names>E</given-names></name><name><surname>Garsed</surname><given-names>DW</given-names></name><name><surname>Gehlenborg</surname><given-names>N</given-names></name><name><surname>Gelpi</surname><given-names>JLL</given-names></name><name><surname>George</surname><given-names>J</given-names></name><name><surname>Gerhard</surname><given-names>DS</given-names></name><name><surname>Gerhauser</surname><given-names>C</given-names></name><name><surname>Gershenwald</surname><given-names>JE</given-names></name><name><surname>Gerstein</surname><given-names>M</given-names></name><name><surname>Gerstung</surname><given-names>M</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Ghori</surname><given-names>M</given-names></name><name><surname>Ghossein</surname><given-names>R</given-names></name><name><surname>Giama</surname><given-names>NH</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Gibson</surname><given-names>B</given-names></name><name><surname>Gill</surname><given-names>AJ</given-names></name><name><surname>Gill</surname><given-names>P</given-names></name><name><surname>Giri</surname><given-names>DD</given-names></name><name><surname>Glodzik</surname><given-names>D</given-names></name><name><surname>Gnanapragasam</surname><given-names>VJ</given-names></name><name><surname>Goebler</surname><given-names>ME</given-names></name><name><surname>Goldman</surname><given-names>MJ</given-names></name><name><surname>Gomez</surname><given-names>C</given-names></name><name><surname>Gonzalez</surname><given-names>S</given-names></name><name><surname>Gonzalez-Perez</surname><given-names>A</given-names></name><name><surname>Gordenin</surname><given-names>DA</given-names></name><name><surname>Gossage</surname><given-names>J</given-names></name><name><surname>Gotoh</surname><given-names>K</given-names></name><name><surname>Govindan</surname><given-names>R</given-names></name><name><surname>Grabau</surname><given-names>D</given-names></name><name><surname>Graham</surname><given-names>JS</given-names></name><name><surname>Grant</surname><given-names>RC</given-names></name><name><surname>Green</surname><given-names>AR</given-names></name><name><surname>Green</surname><given-names>E</given-names></name><name><surname>Greger</surname><given-names>L</given-names></name><name><surname>Grehan</surname><given-names>N</given-names></name><name><surname>Grimaldi</surname><given-names>S</given-names></name><name><surname>Grimmond</surname><given-names>SM</given-names></name><name><surname>Grossman</surname><given-names>RL</given-names></name><name><surname>Grundhoff</surname><given-names>A</given-names></name><name><surname>Gundem</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Gupta</surname><given-names>M</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Gut</surname><given-names>IG</given-names></name><name><surname>Gut</surname><given-names>M</given-names></name><name><surname>Göke</surname><given-names>J</given-names></name><name><surname>Ha</surname><given-names>G</given-names></name><name><surname>Haake</surname><given-names>A</given-names></name><name><surname>Haan</surname><given-names>D</given-names></name><name><surname>Haas</surname><given-names>S</given-names></name><name><surname>Haase</surname><given-names>K</given-names></name><name><surname>Haber</surname><given-names>JE</given-names></name><name><surname>Habermann</surname><given-names>N</given-names></name><name><surname>Hach</surname><given-names>F</given-names></name><name><surname>Haider</surname><given-names>S</given-names></name><name><surname>Hama</surname><given-names>N</given-names></name><name><surname>Hamdy</surname><given-names>FC</given-names></name><name><surname>Hamilton</surname><given-names>A</given-names></name><name><surname>Hamilton</surname><given-names>MP</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Hanna</surname><given-names>GB</given-names></name><name><surname>Hansmann</surname><given-names>M</given-names></name><name><surname>Haradhvala</surname><given-names>NJ</given-names></name><name><surname>Harismendy</surname><given-names>O</given-names></name><name><surname>Harliwong</surname><given-names>I</given-names></name><name><surname>Harmanci</surname><given-names>AO</given-names></name><name><surname>Harrington</surname><given-names>E</given-names></name><name><surname>Hasegawa</surname><given-names>T</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Hawkins</surname><given-names>S</given-names></name><name><surname>Hayami</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>S</given-names></name><name><surname>Hayes</surname><given-names>DN</given-names></name><name><surname>Hayes</surname><given-names>SJ</given-names></name><name><surname>Hayward</surname><given-names>NK</given-names></name><name><surname>Hazell</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Heath</surname><given-names>AP</given-names></name><name><surname>Heath</surname><given-names>SC</given-names></name><name><surname>Hedley</surname><given-names>D</given-names></name><name><surname>Hegde</surname><given-names>AM</given-names></name><name><surname>Heiman</surname><given-names>DI</given-names></name><name><surname>Heinold</surname><given-names>MC</given-names></name><name><surname>Heins</surname><given-names>Z</given-names></name><name><surname>Heisler</surname><given-names>LE</given-names></name><name><surname>Hellstrom-Lindberg</surname><given-names>E</given-names></name><name><surname>Helmy</surname><given-names>M</given-names></name><name><surname>Heo</surname><given-names>SG</given-names></name><name><surname>Hepperla</surname><given-names>AJ</given-names></name><name><surname>Heredia-Genestar</surname><given-names>JM</given-names></name><name><surname>Herrmann</surname><given-names>C</given-names></name><name><surname>Hersey</surname><given-names>P</given-names></name><name><surname>Hess</surname><given-names>JM</given-names></name><name><surname>Hilmarsdottir</surname><given-names>H</given-names></name><name><surname>Hinton</surname><given-names>J</given-names></name><name><surname>Hirano</surname><given-names>S</given-names></name><name><surname>Hiraoka</surname><given-names>N</given-names></name><name><surname>Hoadley</surname><given-names>KA</given-names></name><name><surname>Hobolth</surname><given-names>A</given-names></name><name><surname>Hodzic</surname><given-names>E</given-names></name><name><surname>Hoell</surname><given-names>JI</given-names></name><name><surname>Hoffmann</surname><given-names>S</given-names></name><name><surname>Hofmann</surname><given-names>O</given-names></name><name><surname>Holbrook</surname><given-names>A</given-names></name><name><surname>Holik</surname><given-names>AZ</given-names></name><name><surname>Hollingsworth</surname><given-names>MA</given-names></name><name><surname>Holmes</surname><given-names>O</given-names></name><name><surname>Holt</surname><given-names>RA</given-names></name><name><surname>Hong</surname><given-names>C</given-names></name><name><surname>Hong</surname><given-names>EP</given-names></name><name><surname>Hong</surname><given-names>JH</given-names></name><name><surname>Hooijer</surname><given-names>GK</given-names></name><name><surname>Hornshøj</surname><given-names>H</given-names></name><name><surname>Hosoda</surname><given-names>F</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Hovestadt</surname><given-names>V</given-names></name><name><surname>Howat</surname><given-names>W</given-names></name><name><surname>Hoyle</surname><given-names>AP</given-names></name><name><surname>Hruban</surname><given-names>RH</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Hua</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>MN</given-names></name><name><surname>Huang</surname><given-names>V</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Hudson</surname><given-names>TJ</given-names></name><name><surname>Hummel</surname><given-names>M</given-names></name><name><surname>Hung</surname><given-names>JA</given-names></name><name><surname>Huntsman</surname><given-names>D</given-names></name><name><surname>Hupp</surname><given-names>TR</given-names></name><name><surname>Huse</surname><given-names>J</given-names></name><name><surname>Huska</surname><given-names>MR</given-names></name><name><surname>Hutter</surname><given-names>B</given-names></name><name><surname>Hutter</surname><given-names>CM</given-names></name><name><surname>Hübschmann</surname><given-names>D</given-names></name><name><surname>Iacobuzio-Donahue</surname><given-names>CA</given-names></name><name><surname>Imbusch</surname><given-names>CD</given-names></name><name><surname>Imielinski</surname><given-names>M</given-names></name><name><surname>Imoto</surname><given-names>S</given-names></name><name><surname>Isaacs</surname><given-names>WB</given-names></name><name><surname>Isaev</surname><given-names>K</given-names></name><name><surname>Ishikawa</surname><given-names>S</given-names></name><name><surname>Iskar</surname><given-names>M</given-names></name><name><surname>Islam</surname><given-names>SMA</given-names></name><name><surname>Ittmann</surname><given-names>M</given-names></name><name><surname>Ivkovic</surname><given-names>S</given-names></name><name><surname>Izarzugaza</surname><given-names>JMG</given-names></name><name><surname>Jacquemier</surname><given-names>J</given-names></name><name><surname>Jakrot</surname><given-names>V</given-names></name><name><surname>Jamieson</surname><given-names>NB</given-names></name><name><surname>Jang</surname><given-names>GH</given-names></name><name><surname>Jang</surname><given-names>SJ</given-names></name><name><surname>Jayaseelan</surname><given-names>JC</given-names></name><name><surname>Jayasinghe</surname><given-names>R</given-names></name><name><surname>Jefferys</surname><given-names>SR</given-names></name><name><surname>Jegalian</surname><given-names>K</given-names></name><name><surname>Jennings</surname><given-names>JL</given-names></name><name><surname>Jeon</surname><given-names>S-H</given-names></name><name><surname>Jerman</surname><given-names>L</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Jiao</surname><given-names>W</given-names></name><name><surname>Johansson</surname><given-names>PA</given-names></name><name><surname>Johns</surname><given-names>AL</given-names></name><name><surname>Johns</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>TA</given-names></name><name><surname>Jolly</surname><given-names>C</given-names></name><name><surname>Joly</surname><given-names>Y</given-names></name><name><surname>Jonasson</surname><given-names>JG</given-names></name><name><surname>Jones</surname><given-names>CD</given-names></name><name><surname>Jones</surname><given-names>DR</given-names></name><name><surname>Jones</surname><given-names>DTW</given-names></name><name><surname>Jones</surname><given-names>N</given-names></name><name><surname>Jones</surname><given-names>SJM</given-names></name><name><surname>Jonkers</surname><given-names>J</given-names></name><name><surname>Ju</surname><given-names>YS</given-names></name><name><surname>Juhl</surname><given-names>H</given-names></name><name><surname>Jung</surname><given-names>J</given-names></name><name><surname>Juul</surname><given-names>M</given-names></name><name><surname>Juul</surname><given-names>RI</given-names></name><name><surname>Juul</surname><given-names>S</given-names></name><name><surname>Jäger</surname><given-names>N</given-names></name><name><surname>Kabbe</surname><given-names>R</given-names></name><name><surname>Kahles</surname><given-names>A</given-names></name><name><surname>Kahraman</surname><given-names>A</given-names></name><name><surname>Kaiser</surname><given-names>VB</given-names></name><name><surname>Kakavand</surname><given-names>H</given-names></name><name><surname>Kalimuthu</surname><given-names>S</given-names></name><name><surname>von Kalle</surname><given-names>C</given-names></name><name><surname>Kang</surname><given-names>KJ</given-names></name><name><surname>Karaszi</surname><given-names>K</given-names></name><name><surname>Karlan</surname><given-names>B</given-names></name><name><surname>Karlić</surname><given-names>R</given-names></name><name><surname>Karsch</surname><given-names>D</given-names></name><name><surname>Kasaian</surname><given-names>K</given-names></name><name><surname>Kassahn</surname><given-names>KS</given-names></name><name><surname>Katai</surname><given-names>H</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Katoh</surname><given-names>H</given-names></name><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Kay</surname><given-names>JD</given-names></name><name><surname>Kazakoff</surname><given-names>SH</given-names></name><name><surname>Kazanov</surname><given-names>MD</given-names></name><name><surname>Keays</surname><given-names>M</given-names></name><name><surname>Kebebew</surname><given-names>E</given-names></name><name><surname>Kefford</surname><given-names>RF</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Kench</surname><given-names>JG</given-names></name><name><surname>Kennedy</surname><given-names>CJ</given-names></name><name><surname>Kerssemakers</surname><given-names>JNA</given-names></name><name><surname>Khoo</surname><given-names>D</given-names></name><name><surname>Khoo</surname><given-names>V</given-names></name><name><surname>Khuntikeo</surname><given-names>N</given-names></name><name><surname>Khurana</surname><given-names>E</given-names></name><name><surname>Kilpinen</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>H-L</given-names></name><name><surname>Kim</surname><given-names>H-Y</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>King</surname><given-names>TA</given-names></name><name><surname>Klapper</surname><given-names>W</given-names></name><name><surname>Kleinheinz</surname><given-names>K</given-names></name><name><surname>Klimczak</surname><given-names>LJ</given-names></name><name><surname>Knappskog</surname><given-names>S</given-names></name><name><surname>Kneba</surname><given-names>M</given-names></name><name><surname>Knoppers</surname><given-names>BM</given-names></name><name><surname>Koh</surname><given-names>Y</given-names></name><name><surname>Komorowski</surname><given-names>J</given-names></name><name><surname>Komura</surname><given-names>D</given-names></name><name><surname>Komura</surname><given-names>M</given-names></name><name><surname>Kong</surname><given-names>G</given-names></name><name><surname>Kool</surname><given-names>M</given-names></name><name><surname>Korbel</surname><given-names>JO</given-names></name><name><surname>Korchina</surname><given-names>V</given-names></name><name><surname>Korshunov</surname><given-names>A</given-names></name><name><surname>Koscher</surname><given-names>M</given-names></name><name><surname>Koster</surname><given-names>R</given-names></name><name><surname>Kote-Jarai</surname><given-names>Z</given-names></name><name><surname>Koures</surname><given-names>A</given-names></name><name><surname>Kovacevic</surname><given-names>M</given-names></name><name><surname>Kremeyer</surname><given-names>B</given-names></name><name><surname>Kretzmer</surname><given-names>H</given-names></name><name><surname>Kreuz</surname><given-names>M</given-names></name><name><surname>Krishnamurthy</surname><given-names>S</given-names></name><name><surname>Kube</surname><given-names>D</given-names></name><name><surname>Kumar</surname><given-names>K</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>Y</given-names></name><name><surname>Kundra</surname><given-names>R</given-names></name><name><surname>Kübler</surname><given-names>K</given-names></name><name><surname>Küppers</surname><given-names>R</given-names></name><name><surname>Lagergren</surname><given-names>J</given-names></name><name><surname>Lai</surname><given-names>PH</given-names></name><name><surname>Laird</surname><given-names>PW</given-names></name><name><surname>Lakhani</surname><given-names>SR</given-names></name><name><surname>Lalansingh</surname><given-names>CM</given-names></name><name><surname>Lalonde</surname><given-names>E</given-names></name><name><surname>Lamaze</surname><given-names>FC</given-names></name><name><surname>Lambert</surname><given-names>A</given-names></name><name><surname>Lander</surname><given-names>E</given-names></name><name><surname>Landgraf</surname><given-names>P</given-names></name><name><surname>Landoni</surname><given-names>L</given-names></name><name><surname>Langerød</surname><given-names>A</given-names></name><name><surname>Lanzós</surname><given-names>A</given-names></name><name><surname>Larsimont</surname><given-names>D</given-names></name><name><surname>Larsson</surname><given-names>E</given-names></name><name><surname>Lathrop</surname><given-names>M</given-names></name><name><surname>Lau</surname><given-names>LMS</given-names></name><name><surname>Lawerenz</surname><given-names>C</given-names></name><name><surname>Lawlor</surname><given-names>RT</given-names></name><name><surname>Lawrence</surname><given-names>MS</given-names></name><name><surname>Lazar</surname><given-names>AJ</given-names></name><name><surname>Lazic</surname><given-names>AM</given-names></name><name><surname>Le</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>EA</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>JJ-K</given-names></name><name><surname>Lee</surname><given-names>J-Y</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>MTM</given-names></name><name><surname>Lee-Six</surname><given-names>H</given-names></name><name><surname>Lehmann</surname><given-names>K-V</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Lenze</surname><given-names>D</given-names></name><name><surname>Leonard</surname><given-names>CR</given-names></name><name><surname>Leongamornlert</surname><given-names>DA</given-names></name><name><surname>Leshchiner</surname><given-names>I</given-names></name><name><surname>Letourneau</surname><given-names>L</given-names></name><name><surname>Letunic</surname><given-names>I</given-names></name><name><surname>Levine</surname><given-names>DA</given-names></name><name><surname>Lewis</surname><given-names>L</given-names></name><name><surname>Ley</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>CH</given-names></name><name><surname>Li</surname><given-names>HI</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Liang</surname><given-names>S-B</given-names></name><name><surname>Lichter</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Linehan</surname><given-names>WM</given-names></name><name><surname>Lingjærde</surname><given-names>OC</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>EM</given-names></name><name><surname>Liu</surname><given-names>F-FF</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Livingstone</surname><given-names>J</given-names></name><name><surname>Livitz</surname><given-names>D</given-names></name><name><surname>Livni</surname><given-names>N</given-names></name><name><surname>Lochovsky</surname><given-names>L</given-names></name><name><surname>Loeffler</surname><given-names>M</given-names></name><name><surname>Long</surname><given-names>GV</given-names></name><name><surname>Lopez-Guillermo</surname><given-names>A</given-names></name><name><surname>Lou</surname><given-names>S</given-names></name><name><surname>Louis</surname><given-names>DN</given-names></name><name><surname>Lovat</surname><given-names>LB</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Y-J</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Luchini</surname><given-names>C</given-names></name><name><surname>Lungu</surname><given-names>I</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Luxton</surname><given-names>HJ</given-names></name><name><surname>Lynch</surname><given-names>AG</given-names></name><name><surname>Lype</surname><given-names>L</given-names></name><name><surname>López</surname><given-names>C</given-names></name><name><surname>López-Otín</surname><given-names>C</given-names></name><name><surname>Ma</surname><given-names>EZ</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>MacGrogan</surname><given-names>G</given-names></name><name><surname>MacRae</surname><given-names>S</given-names></name><name><surname>Macintyre</surname><given-names>G</given-names></name><name><surname>Madsen</surname><given-names>T</given-names></name><name><surname>Maejima</surname><given-names>K</given-names></name><name><surname>Mafficini</surname><given-names>A</given-names></name><name><surname>Maglinte</surname><given-names>DT</given-names></name><name><surname>Maitra</surname><given-names>A</given-names></name><name><surname>Majumder</surname><given-names>PP</given-names></name><name><surname>Malcovati</surname><given-names>L</given-names></name><name><surname>Malikic</surname><given-names>S</given-names></name><name><surname>Malleo</surname><given-names>G</given-names></name><name><surname>Mann</surname><given-names>GJ</given-names></name><name><surname>Mantovani-Löffler</surname><given-names>L</given-names></name><name><surname>Marchal</surname><given-names>K</given-names></name><name><surname>Marchegiani</surname><given-names>G</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Margolin</surname><given-names>AA</given-names></name><name><surname>Marin</surname><given-names>MG</given-names></name><name><surname>Markowetz</surname><given-names>F</given-names></name><name><surname>Markowski</surname><given-names>J</given-names></name><name><surname>Marks</surname><given-names>J</given-names></name><name><surname>Marques-Bonet</surname><given-names>T</given-names></name><name><surname>Marra</surname><given-names>MA</given-names></name><name><surname>Marsden</surname><given-names>L</given-names></name><name><surname>Martens</surname><given-names>JWM</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Martin-Subero</surname><given-names>JI</given-names></name><name><surname>Martincorena</surname><given-names>I</given-names></name><name><surname>Martinez-Fundichely</surname><given-names>A</given-names></name><name><surname>Maruvka</surname><given-names>YE</given-names></name><name><surname>Mashl</surname><given-names>RJ</given-names></name><name><surname>Massie</surname><given-names>CE</given-names></name><name><surname>Matthew</surname><given-names>TJ</given-names></name><name><surname>Matthews</surname><given-names>L</given-names></name><name><surname>Mayer</surname><given-names>E</given-names></name><name><surname>Mayes</surname><given-names>S</given-names></name><name><surname>Mayo</surname><given-names>M</given-names></name><name><surname>Mbabaali</surname><given-names>F</given-names></name><name><surname>McCune</surname><given-names>K</given-names></name><name><surname>McDermott</surname><given-names>U</given-names></name><name><surname>McGillivray</surname><given-names>PD</given-names></name><name><surname>McLellan</surname><given-names>MD</given-names></name><name><surname>McPherson</surname><given-names>JD</given-names></name><name><surname>McPherson</surname><given-names>JR</given-names></name><name><surname>McPherson</surname><given-names>TA</given-names></name><name><surname>Meier</surname><given-names>SR</given-names></name><name><surname>Meng</surname><given-names>A</given-names></name><name><surname>Meng</surname><given-names>S</given-names></name><name><surname>Menzies</surname><given-names>A</given-names></name><name><surname>Merrett</surname><given-names>ND</given-names></name><name><surname>Merson</surname><given-names>S</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Meyerson</surname><given-names>W</given-names></name><name><surname>Mieczkowski</surname><given-names>PA</given-names></name><name><surname>Mihaiescu</surname><given-names>GL</given-names></name><name><surname>Mijalkovic</surname><given-names>S</given-names></name><name><surname>Mikkelsen</surname><given-names>T</given-names></name><name><surname>Milella</surname><given-names>M</given-names></name><name><surname>Mileshkin</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>CA</given-names></name><name><surname>Miller</surname><given-names>DK</given-names></name><name><surname>Miller</surname><given-names>JK</given-names></name><name><surname>Mills</surname><given-names>GB</given-names></name><name><surname>Milovanovic</surname><given-names>A</given-names></name><name><surname>Minner</surname><given-names>S</given-names></name><name><surname>Miotto</surname><given-names>M</given-names></name><name><surname>Arnau</surname><given-names>GM</given-names></name><name><surname>Mirabello</surname><given-names>L</given-names></name><name><surname>Mitchell</surname><given-names>C</given-names></name><name><surname>Mitchell</surname><given-names>TJ</given-names></name><name><surname>Miyano</surname><given-names>S</given-names></name><name><surname>Miyoshi</surname><given-names>N</given-names></name><name><surname>Mizuno</surname><given-names>S</given-names></name><name><surname>Molnár-Gábor</surname><given-names>F</given-names></name><name><surname>Moore</surname><given-names>MJ</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name><name><surname>Morganella</surname><given-names>S</given-names></name><name><surname>Morris</surname><given-names>QD</given-names></name><name><surname>Morrison</surname><given-names>C</given-names></name><name><surname>Mose</surname><given-names>LE</given-names></name><name><surname>Moser</surname><given-names>CD</given-names></name><name><surname>Muiños</surname><given-names>F</given-names></name><name><surname>Mularoni</surname><given-names>L</given-names></name><name><surname>Mungall</surname><given-names>AJ</given-names></name><name><surname>Mungall</surname><given-names>K</given-names></name><name><surname>Musgrove</surname><given-names>EA</given-names></name><name><surname>Mustonen</surname><given-names>V</given-names></name><name><surname>Mutch</surname><given-names>D</given-names></name><name><surname>Muyas</surname><given-names>F</given-names></name><name><surname>Muzny</surname><given-names>DM</given-names></name><name><surname>Muñoz</surname><given-names>A</given-names></name><name><surname>Myers</surname><given-names>J</given-names></name><name><surname>Myklebost</surname><given-names>O</given-names></name><name><surname>Möller</surname><given-names>P</given-names></name><name><surname>Nagae</surname><given-names>G</given-names></name><name><surname>Nagrial</surname><given-names>AM</given-names></name><name><surname>Nahal-Bose</surname><given-names>HK</given-names></name><name><surname>Nakagama</surname><given-names>H</given-names></name><name><surname>Nakagawa</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Nakano</surname><given-names>K</given-names></name><name><surname>Nandi</surname><given-names>T</given-names></name><name><surname>Nangalia</surname><given-names>J</given-names></name><name><surname>Nastic</surname><given-names>M</given-names></name><name><surname>Navarro</surname><given-names>A</given-names></name><name><surname>Navarro</surname><given-names>FCP</given-names></name><name><surname>Neal</surname><given-names>DE</given-names></name><name><surname>Nettekoven</surname><given-names>G</given-names></name><name><surname>Newell</surname><given-names>F</given-names></name><name><surname>Newhouse</surname><given-names>SJ</given-names></name><name><surname>Newton</surname><given-names>Y</given-names></name><name><surname>Ng</surname><given-names>AWT</given-names></name><name><surname>Ng</surname><given-names>A</given-names></name><name><surname>Nicholson</surname><given-names>J</given-names></name><name><surname>Nicol</surname><given-names>D</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Nielsen</surname><given-names>GP</given-names></name><name><surname>Nielsen</surname><given-names>MM</given-names></name><name><surname>Nik-Zainal</surname><given-names>S</given-names></name><name><surname>Noble</surname><given-names>MS</given-names></name><name><surname>Nones</surname><given-names>K</given-names></name><name><surname>Northcott</surname><given-names>PA</given-names></name><name><surname>Notta</surname><given-names>F</given-names></name><name><surname>O’Connor</surname><given-names>BD</given-names></name><name><surname>O’Donnell</surname><given-names>P</given-names></name><name><surname>O’Donovan</surname><given-names>M</given-names></name><name><surname>O’Meara</surname><given-names>S</given-names></name><name><surname>O’Neill</surname><given-names>BP</given-names></name><name><surname>O’Neill</surname><given-names>JR</given-names></name><name><surname>Ocana</surname><given-names>D</given-names></name><name><surname>Ochoa</surname><given-names>A</given-names></name><name><surname>Oesper</surname><given-names>L</given-names></name><name><surname>Ogden</surname><given-names>C</given-names></name><name><surname>Ohdan</surname><given-names>H</given-names></name><name><surname>Ohi</surname><given-names>K</given-names></name><name><surname>Ohno-Machado</surname><given-names>L</given-names></name><name><surname>Oien</surname><given-names>KA</given-names></name><name><surname>Ojesina</surname><given-names>AI</given-names></name><name><surname>Ojima</surname><given-names>H</given-names></name><name><surname>Okusaka</surname><given-names>T</given-names></name><name><surname>Omberg</surname><given-names>L</given-names></name><name><surname>Ong</surname><given-names>CK</given-names></name><name><surname>Ossowski</surname><given-names>S</given-names></name><name><surname>Ott</surname><given-names>G</given-names></name><name><surname>Ouellette</surname><given-names>BFF</given-names></name><name><surname>P’ng</surname><given-names>C</given-names></name><name><surname>Paczkowska</surname><given-names>M</given-names></name><name><surname>Paiella</surname><given-names>S</given-names></name><name><surname>Pairojkul</surname><given-names>C</given-names></name><name><surname>Pajic</surname><given-names>M</given-names></name><name><surname>Pan-Hammarström</surname><given-names>Q</given-names></name><name><surname>Papaemmanuil</surname><given-names>E</given-names></name><name><surname>Papatheodorou</surname><given-names>I</given-names></name><name><surname>Paramasivam</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Park</surname><given-names>J-W</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>PJ</given-names></name><name><surname>Parker</surname><given-names>JS</given-names></name><name><surname>Parsons</surname><given-names>SL</given-names></name><name><surname>Pass</surname><given-names>H</given-names></name><name><surname>Pasternack</surname><given-names>D</given-names></name><name><surname>Pastore</surname><given-names>A</given-names></name><name><surname>Patch</surname><given-names>AM</given-names></name><name><surname>Pauporté</surname><given-names>I</given-names></name><name><surname>Pea</surname><given-names>A</given-names></name><name><surname>Pearson</surname><given-names>JV</given-names></name><name><surname>Pedamallu</surname><given-names>CS</given-names></name><name><surname>Pedersen</surname><given-names>JS</given-names></name><name><surname>Pederzoli</surname><given-names>P</given-names></name><name><surname>Peifer</surname><given-names>M</given-names></name><name><surname>Pennell</surname><given-names>NA</given-names></name><name><surname>Perou</surname><given-names>CM</given-names></name><name><surname>Perry</surname><given-names>MD</given-names></name><name><surname>Petersen</surname><given-names>GM</given-names></name><name><surname>Peto</surname><given-names>M</given-names></name><name><surname>Petrelli</surname><given-names>N</given-names></name><name><surname>Petryszak</surname><given-names>R</given-names></name><name><surname>Pfister</surname><given-names>SM</given-names></name><name><surname>Phillips</surname><given-names>M</given-names></name><name><surname>Pich</surname><given-names>O</given-names></name><name><surname>Pickett</surname><given-names>HA</given-names></name><name><surname>Pihl</surname><given-names>TD</given-names></name><name><surname>Pillay</surname><given-names>N</given-names></name><name><surname>Pinder</surname><given-names>S</given-names></name><name><surname>Pinese</surname><given-names>M</given-names></name><name><surname>Pinho</surname><given-names>AV</given-names></name><name><surname>Pitkänen</surname><given-names>E</given-names></name><name><surname>Pivot</surname><given-names>X</given-names></name><name><surname>Piñeiro-Yáñez</surname><given-names>E</given-names></name><name><surname>Planko</surname><given-names>L</given-names></name><name><surname>Plass</surname><given-names>C</given-names></name><name><surname>Polak</surname><given-names>P</given-names></name><name><surname>Pons</surname><given-names>T</given-names></name><name><surname>Popescu</surname><given-names>I</given-names></name><name><surname>Potapova</surname><given-names>O</given-names></name><name><surname>Prasad</surname><given-names>A</given-names></name><name><surname>Preston</surname><given-names>SR</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Pritchard</surname><given-names>AL</given-names></name><name><surname>Prokopec</surname><given-names>SD</given-names></name><name><surname>Provenzano</surname><given-names>E</given-names></name><name><surname>Puente</surname><given-names>XS</given-names></name><name><surname>Puig</surname><given-names>S</given-names></name><name><surname>Puiggròs</surname><given-names>M</given-names></name><name><surname>Pulido-Tamayo</surname><given-names>S</given-names></name><name><surname>Pupo</surname><given-names>GM</given-names></name><name><surname>Purdie</surname><given-names>CA</given-names></name><name><surname>Quinn</surname><given-names>MC</given-names></name><name><surname>Rabionet</surname><given-names>R</given-names></name><name><surname>Rader</surname><given-names>JS</given-names></name><name><surname>Radlwimmer</surname><given-names>B</given-names></name><name><surname>Radovic</surname><given-names>P</given-names></name><name><surname>Raeder</surname><given-names>B</given-names></name><name><surname>Raine</surname><given-names>KM</given-names></name><name><surname>Ramakrishna</surname><given-names>M</given-names></name><name><surname>Ramakrishnan</surname><given-names>K</given-names></name><name><surname>Ramalingam</surname><given-names>S</given-names></name><name><surname>Raphael</surname><given-names>BJ</given-names></name><name><surname>Rathmell</surname><given-names>WK</given-names></name><name><surname>Rausch</surname><given-names>T</given-names></name><name><surname>Reifenberger</surname><given-names>G</given-names></name><name><surname>Reimand</surname><given-names>J</given-names></name><name><surname>Reis-Filho</surname><given-names>J</given-names></name><name><surname>Reuter</surname><given-names>V</given-names></name><name><surname>Reyes-Salazar</surname><given-names>I</given-names></name><name><surname>Reyna</surname><given-names>MA</given-names></name><name><surname>Reynolds</surname><given-names>SM</given-names></name><name><surname>Rheinbay</surname><given-names>E</given-names></name><name><surname>Riazalhosseini</surname><given-names>Y</given-names></name><name><surname>Richardson</surname><given-names>AL</given-names></name><name><surname>Richter</surname><given-names>J</given-names></name><name><surname>Ringel</surname><given-names>M</given-names></name><name><surname>Ringnér</surname><given-names>M</given-names></name><name><surname>Rino</surname><given-names>Y</given-names></name><name><surname>Rippe</surname><given-names>K</given-names></name><name><surname>Roach</surname><given-names>J</given-names></name><name><surname>Roberts</surname><given-names>LR</given-names></name><name><surname>Roberts</surname><given-names>ND</given-names></name><name><surname>Roberts</surname><given-names>SA</given-names></name><name><surname>Robertson</surname><given-names>AG</given-names></name><name><surname>Robertson</surname><given-names>AJ</given-names></name><name><surname>Rodriguez</surname><given-names>JB</given-names></name><name><surname>Rodriguez-Martin</surname><given-names>B</given-names></name><name><surname>Rodríguez-González</surname><given-names>FG</given-names></name><name><surname>Roehrl</surname><given-names>MHA</given-names></name><name><surname>Rohde</surname><given-names>M</given-names></name><name><surname>Rokutan</surname><given-names>H</given-names></name><name><surname>Romieu</surname><given-names>G</given-names></name><name><surname>Rooman</surname><given-names>I</given-names></name><name><surname>Roques</surname><given-names>T</given-names></name><name><surname>Rosebrock</surname><given-names>D</given-names></name><name><surname>Rosenberg</surname><given-names>M</given-names></name><name><surname>Rosenstiel</surname><given-names>PC</given-names></name><name><surname>Rosenwald</surname><given-names>A</given-names></name><name><surname>Rowe</surname><given-names>EW</given-names></name><name><surname>Royo</surname><given-names>R</given-names></name><name><surname>Rozen</surname><given-names>SG</given-names></name><name><surname>Rubanova</surname><given-names>Y</given-names></name><name><surname>Rubin</surname><given-names>MA</given-names></name><name><surname>Rubio-Perez</surname><given-names>C</given-names></name><name><surname>Rudneva</surname><given-names>VA</given-names></name><name><surname>Rusev</surname><given-names>BC</given-names></name><name><surname>Ruzzenente</surname><given-names>A</given-names></name><name><surname>Rätsch</surname><given-names>G</given-names></name><name><surname>Sabarinathan</surname><given-names>R</given-names></name><name><surname>Sabelnykova</surname><given-names>VY</given-names></name><name><surname>Sadeghi</surname><given-names>S</given-names></name><name><surname>Sahinalp</surname><given-names>SC</given-names></name><name><surname>Saini</surname><given-names>N</given-names></name><name><surname>Saito-Adachi</surname><given-names>M</given-names></name><name><surname>Saksena</surname><given-names>G</given-names></name><name><surname>Salcedo</surname><given-names>A</given-names></name><name><surname>Salgado</surname><given-names>R</given-names></name><name><surname>Salichos</surname><given-names>L</given-names></name><name><surname>Sallari</surname><given-names>R</given-names></name><name><surname>Saller</surname><given-names>C</given-names></name><name><surname>Salvia</surname><given-names>R</given-names></name><name><surname>Sam</surname><given-names>M</given-names></name><name><surname>Samra</surname><given-names>JS</given-names></name><name><surname>Sanchez-Vega</surname><given-names>F</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name><name><surname>Sanders</surname><given-names>G</given-names></name><name><surname>Sarin</surname><given-names>R</given-names></name><name><surname>Sarrafi</surname><given-names>I</given-names></name><name><surname>Sasaki-Oku</surname><given-names>A</given-names></name><name><surname>Sauer</surname><given-names>T</given-names></name><name><surname>Sauter</surname><given-names>G</given-names></name><name><surname>Saw</surname><given-names>RPM</given-names></name><name><surname>Scardoni</surname><given-names>M</given-names></name><name><surname>Scarlett</surname><given-names>CJ</given-names></name><name><surname>Scarpa</surname><given-names>A</given-names></name><name><surname>Scelo</surname><given-names>G</given-names></name><name><surname>Schadendorf</surname><given-names>D</given-names></name><name><surname>Schein</surname><given-names>JE</given-names></name><name><surname>Schilhabel</surname><given-names>MB</given-names></name><name><surname>Schlesner</surname><given-names>M</given-names></name><name><surname>Schlomm</surname><given-names>T</given-names></name><name><surname>Schmidt</surname><given-names>HK</given-names></name><name><surname>Schramm</surname><given-names>S-J</given-names></name><name><surname>Schreiber</surname><given-names>S</given-names></name><name><surname>Schultz</surname><given-names>N</given-names></name><name><surname>Schumacher</surname><given-names>SE</given-names></name><name><surname>Schwarz</surname><given-names>RF</given-names></name><name><surname>Scolyer</surname><given-names>RA</given-names></name><name><surname>Scott</surname><given-names>D</given-names></name><name><surname>Scully</surname><given-names>R</given-names></name><name><surname>Seethala</surname><given-names>R</given-names></name><name><surname>Segre</surname><given-names>AV</given-names></name><name><surname>Selander</surname><given-names>I</given-names></name><name><surname>Semple</surname><given-names>CA</given-names></name><name><surname>Senbabaoglu</surname><given-names>Y</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>Sereni</surname><given-names>E</given-names></name><name><surname>Serra</surname><given-names>S</given-names></name><name><surname>Sgroi</surname><given-names>DC</given-names></name><name><surname>Shackleton</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>NC</given-names></name><name><surname>Shahabi</surname><given-names>S</given-names></name><name><surname>Shang</surname><given-names>CA</given-names></name><name><surname>Shang</surname><given-names>P</given-names></name><name><surname>Shapira</surname><given-names>O</given-names></name><name><surname>Shelton</surname><given-names>T</given-names></name><name><surname>Shen</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Shepherd</surname><given-names>R</given-names></name><name><surname>Shi</surname><given-names>R</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Shiah</surname><given-names>Y-J</given-names></name><name><surname>Shibata</surname><given-names>T</given-names></name><name><surname>Shih</surname><given-names>J</given-names></name><name><surname>Shimizu</surname><given-names>E</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Shin</surname><given-names>SJ</given-names></name><name><surname>Shiraishi</surname><given-names>Y</given-names></name><name><surname>Shmaya</surname><given-names>T</given-names></name><name><surname>Shmulevich</surname><given-names>I</given-names></name><name><surname>Shorser</surname><given-names>SI</given-names></name><name><surname>Short</surname><given-names>C</given-names></name><name><surname>Shrestha</surname><given-names>R</given-names></name><name><surname>Shringarpure</surname><given-names>SS</given-names></name><name><surname>Shriver</surname><given-names>C</given-names></name><name><surname>Shuai</surname><given-names>S</given-names></name><name><surname>Sidiropoulos</surname><given-names>N</given-names></name><name><surname>Siebert</surname><given-names>R</given-names></name><name><surname>Sieuwerts</surname><given-names>AM</given-names></name><name><surname>Sieverling</surname><given-names>L</given-names></name><name><surname>Signoretti</surname><given-names>S</given-names></name><name><surname>Sikora</surname><given-names>KO</given-names></name><name><surname>Simbolo</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>R</given-names></name><name><surname>Simons</surname><given-names>JV</given-names></name><name><surname>Simpson</surname><given-names>JT</given-names></name><name><surname>Simpson</surname><given-names>PT</given-names></name><name><surname>Singer</surname><given-names>S</given-names></name><name><surname>Sinnott-Armstrong</surname><given-names>N</given-names></name><name><surname>Sipahimalani</surname><given-names>P</given-names></name><name><surname>Skelly</surname><given-names>TJ</given-names></name><name><surname>Smid</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Smith-McCune</surname><given-names>K</given-names></name><name><surname>Socci</surname><given-names>ND</given-names></name><name><surname>Sofia</surname><given-names>HJ</given-names></name><name><surname>Soloway</surname><given-names>MG</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name><name><surname>Sothi</surname><given-names>S</given-names></name><name><surname>Sotiriou</surname><given-names>C</given-names></name><name><surname>Soulette</surname><given-names>CM</given-names></name><name><surname>Span</surname><given-names>PN</given-names></name><name><surname>Spellman</surname><given-names>PT</given-names></name><name><surname>Sperandio</surname><given-names>N</given-names></name><name><surname>Spillane</surname><given-names>AJ</given-names></name><name><surname>Spiro</surname><given-names>O</given-names></name><name><surname>Spring</surname><given-names>J</given-names></name><name><surname>Staaf</surname><given-names>J</given-names></name><name><surname>Stadler</surname><given-names>PF</given-names></name><name><surname>Staib</surname><given-names>P</given-names></name><name><surname>Stark</surname><given-names>SG</given-names></name><name><surname>Stebbings</surname><given-names>L</given-names></name><name><surname>Stefánsson</surname><given-names>ÓA</given-names></name><name><surname>Stegle</surname><given-names>O</given-names></name><name><surname>Stein</surname><given-names>LD</given-names></name><name><surname>Stenhouse</surname><given-names>A</given-names></name><name><surname>Stewart</surname><given-names>C</given-names></name><name><surname>Stilgenbauer</surname><given-names>S</given-names></name><name><surname>Stobbe</surname><given-names>MD</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name><name><surname>Stretch</surname><given-names>JR</given-names></name><name><surname>Struck</surname><given-names>AJ</given-names></name><name><surname>Stuart</surname><given-names>JM</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>RX</given-names></name><name><surname>Sungalee</surname><given-names>S</given-names></name><name><surname>Susak</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Sweep</surname><given-names>F</given-names></name><name><surname>Szczepanowski</surname><given-names>M</given-names></name><name><surname>Sültmann</surname><given-names>H</given-names></name><name><surname>Yugawa</surname><given-names>T</given-names></name><name><surname>Tam</surname><given-names>A</given-names></name><name><surname>Tamborero</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>BKT</given-names></name><name><surname>Tan</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>P</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Taniguchi</surname><given-names>H</given-names></name><name><surname>Tanskanen</surname><given-names>TJ</given-names></name><name><surname>Tarabichi</surname><given-names>M</given-names></name><name><surname>Tarnuzzer</surname><given-names>R</given-names></name><name><surname>Tarpey</surname><given-names>P</given-names></name><name><surname>Taschuk</surname><given-names>ML</given-names></name><name><surname>Tatsuno</surname><given-names>K</given-names></name><name><surname>Tavaré</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>DF</given-names></name><name><surname>Taylor-Weiner</surname><given-names>A</given-names></name><name><surname>Teague</surname><given-names>JW</given-names></name><name><surname>Teh</surname><given-names>BT</given-names></name><name><surname>Tembe</surname><given-names>V</given-names></name><name><surname>Temes</surname><given-names>J</given-names></name><name><surname>Thai</surname><given-names>K</given-names></name><name><surname>Thayer</surname><given-names>SP</given-names></name><name><surname>Thiessen</surname><given-names>N</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>A</given-names></name><name><surname>Thompson</surname><given-names>AM</given-names></name><name><surname>Thompson</surname><given-names>JFF</given-names></name><name><surname>Thompson</surname><given-names>RH</given-names></name><name><surname>Thorne</surname><given-names>H</given-names></name><name><surname>Thorne</surname><given-names>LB</given-names></name><name><surname>Thorogood</surname><given-names>A</given-names></name><name><surname>Tiao</surname><given-names>G</given-names></name><name><surname>Tijanic</surname><given-names>N</given-names></name><name><surname>Timms</surname><given-names>LE</given-names></name><name><surname>Tirabosco</surname><given-names>R</given-names></name><name><surname>Tojo</surname><given-names>M</given-names></name><name><surname>Tommasi</surname><given-names>S</given-names></name><name><surname>Toon</surname><given-names>CW</given-names></name><name><surname>Toprak</surname><given-names>UH</given-names></name><name><surname>Torrents</surname><given-names>D</given-names></name><name><surname>Tortora</surname><given-names>G</given-names></name><name><surname>Tost</surname><given-names>J</given-names></name><name><surname>Totoki</surname><given-names>Y</given-names></name><name><surname>Townend</surname><given-names>D</given-names></name><name><surname>Traficante</surname><given-names>N</given-names></name><name><surname>Treilleux</surname><given-names>I</given-names></name><name><surname>Trotta</surname><given-names>J-R</given-names></name><name><surname>Trümper</surname><given-names>LHP</given-names></name><name><surname>Tsao</surname><given-names>M</given-names></name><name><surname>Tsunoda</surname><given-names>T</given-names></name><name><surname>Tubio</surname><given-names>JMC</given-names></name><name><surname>Tucker</surname><given-names>O</given-names></name><name><surname>Turkington</surname><given-names>R</given-names></name><name><surname>Turner</surname><given-names>DJ</given-names></name><name><surname>Tutt</surname><given-names>A</given-names></name><name><surname>Ueno</surname><given-names>M</given-names></name><name><surname>Ueno</surname><given-names>NT</given-names></name><name><surname>Umbricht</surname><given-names>C</given-names></name><name><surname>Umer</surname><given-names>HM</given-names></name><name><surname>Underwood</surname><given-names>TJ</given-names></name><name><surname>Urban</surname><given-names>L</given-names></name><name><surname>Urushidate</surname><given-names>T</given-names></name><name><surname>Ushiku</surname><given-names>T</given-names></name><name><surname>Uusküla-Reimand</surname><given-names>L</given-names></name><name><surname>Valencia</surname><given-names>A</given-names></name><name><surname>Van Den Berg</surname><given-names>DJ</given-names></name><name><surname>Van Laere</surname><given-names>S</given-names></name><name><surname>Van Loo</surname><given-names>P</given-names></name><name><surname>Van Meir</surname><given-names>EG</given-names></name><name><surname>Van den Eynden</surname><given-names>GG</given-names></name><name><surname>Van der Kwast</surname><given-names>T</given-names></name><name><surname>Vasudev</surname><given-names>N</given-names></name><name><surname>Vazquez</surname><given-names>M</given-names></name><name><surname>Vedururu</surname><given-names>R</given-names></name><name><surname>Veluvolu</surname><given-names>U</given-names></name><name><surname>Vembu</surname><given-names>S</given-names></name><name><surname>Verbeke</surname><given-names>LPC</given-names></name><name><surname>Vermeulen</surname><given-names>P</given-names></name><name><surname>Verrill</surname><given-names>C</given-names></name><name><surname>Viari</surname><given-names>A</given-names></name><name><surname>Vicente</surname><given-names>D</given-names></name><name><surname>Vicentini</surname><given-names>C</given-names></name><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><name><surname>Viksna</surname><given-names>J</given-names></name><name><surname>Vilain</surname><given-names>RE</given-names></name><name><surname>Villasante</surname><given-names>I</given-names></name><name><surname>Vincent-Salomon</surname><given-names>A</given-names></name><name><surname>Visakorpi</surname><given-names>T</given-names></name><name><surname>Voet</surname><given-names>D</given-names></name><name><surname>Vyas</surname><given-names>P</given-names></name><name><surname>Vázquez-García</surname><given-names>I</given-names></name><name><surname>Waddell</surname><given-names>NM</given-names></name><name><surname>Waddell</surname><given-names>N</given-names></name><name><surname>Wadelius</surname><given-names>C</given-names></name><name><surname>Wadi</surname><given-names>L</given-names></name><name><surname>Wagener</surname><given-names>R</given-names></name><name><surname>Wala</surname><given-names>JA</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Waring</surname><given-names>PM</given-names></name><name><surname>Warnatz</surname><given-names>H-J</given-names></name><name><surname>Warrell</surname><given-names>J</given-names></name><name><surname>Warren</surname><given-names>AY</given-names></name><name><surname>Waszak</surname><given-names>SM</given-names></name><name><surname>Wedge</surname><given-names>DC</given-names></name><name><surname>Weichenhan</surname><given-names>D</given-names></name><name><surname>Weinberger</surname><given-names>P</given-names></name><name><surname>Weinstein</surname><given-names>JN</given-names></name><name><surname>Weischenfeldt</surname><given-names>J</given-names></name><name><surname>Weisenberger</surname><given-names>DJ</given-names></name><name><surname>Welch</surname><given-names>I</given-names></name><name><surname>Wendl</surname><given-names>MC</given-names></name><name><surname>Werner</surname><given-names>J</given-names></name><name><surname>Whalley</surname><given-names>JP</given-names></name><name><surname>Wheeler</surname><given-names>DA</given-names></name><name><surname>Whitaker</surname><given-names>HC</given-names></name><name><surname>Wigle</surname><given-names>D</given-names></name><name><surname>Wilkerson</surname><given-names>MD</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Wilmott</surname><given-names>JS</given-names></name><name><surname>Wilson</surname><given-names>GW</given-names></name><name><surname>Wilson</surname><given-names>JM</given-names></name><name><surname>Wilson</surname><given-names>RK</given-names></name><name><surname>Winterhoff</surname><given-names>B</given-names></name><name><surname>Wintersinger</surname><given-names>JA</given-names></name><name><surname>Wiznerowicz</surname><given-names>M</given-names></name><name><surname>Wolf</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>BH</given-names></name><name><surname>Wong</surname><given-names>T</given-names></name><name><surname>Wong</surname><given-names>W</given-names></name><name><surname>Woo</surname><given-names>Y</given-names></name><name><surname>Wood</surname><given-names>S</given-names></name><name><surname>Wouters</surname><given-names>BG</given-names></name><name><surname>Wright</surname><given-names>AJ</given-names></name><name><surname>Wright</surname><given-names>DW</given-names></name><name><surname>Wright</surname><given-names>MH</given-names></name><name><surname>Wu</surname><given-names>C-L</given-names></name><name><surname>Wu</surname><given-names>D-Y</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Xi</surname><given-names>L</given-names></name><name><surname>Xia</surname><given-names>T</given-names></name><name><surname>Xiang</surname><given-names>Q</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Xing</surname><given-names>R</given-names></name><name><surname>Xiong</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Xue</surname><given-names>H</given-names></name><name><surname>Yachida</surname><given-names>S</given-names></name><name><surname>Yakneen</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>R</given-names></name><name><surname>Yamaguchi</surname><given-names>TN</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Yamaue</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>JY</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>T-P</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Yaspo</surname><given-names>M-L</given-names></name><name><surname>Yates</surname><given-names>L</given-names></name><name><surname>Yau</surname><given-names>C</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name><name><surname>Yellapantula</surname><given-names>VD</given-names></name><name><surname>Yoon</surname><given-names>CJ</given-names></name><name><surname>Yoon</surname><given-names>S-S</given-names></name><name><surname>Yousif</surname><given-names>F</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>K</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Yuen</surname><given-names>D</given-names></name><name><surname>Yung</surname><given-names>CK</given-names></name><name><surname>Zaikova</surname><given-names>O</given-names></name><name><surname>Zamora</surname><given-names>J</given-names></name><name><surname>Zapatka</surname><given-names>M</given-names></name><name><surname>Zenklusen</surname><given-names>JC</given-names></name><name><surname>Zenz</surname><given-names>T</given-names></name><name><surname>Zeps</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>C-Z</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Zou</surname><given-names>L</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>deFazio</surname><given-names>A</given-names></name><name><surname>van As</surname><given-names>N</given-names></name><name><surname>van Deurzen</surname><given-names>CHM</given-names></name><name><surname>van de Vijver</surname><given-names>MJ</given-names></name><name><surname>van’t Veer</surname><given-names>L</given-names></name><name><surname>von Mering</surname><given-names>C</given-names></name><collab>The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Pan-Cancer analysis of whole genomes</article-title><source>Nature</source><volume>578</volume><fpage>82</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-1969-6</pub-id><pub-id pub-id-type="pmid">32025007</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>AA</given-names></name><name><surname>Etemadmoghadam</surname><given-names>D</given-names></name><name><surname>Temple</surname><given-names>J</given-names></name><name><surname>Lynch</surname><given-names>AG</given-names></name><name><surname>Riad</surname><given-names>M</given-names></name><name><surname>Sharma</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>C</given-names></name><name><surname>Fereday</surname><given-names>S</given-names></name><name><surname>Caldas</surname><given-names>C</given-names></name><name><surname>Defazio</surname><given-names>A</given-names></name><name><surname>Bowtell</surname><given-names>D</given-names></name><name><surname>Brenton</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary</article-title><source>The Journal of Pathology</source><volume>221</volume><fpage>49</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1002/path.2696</pub-id><pub-id pub-id-type="pmid">20229506</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexandrov</surname><given-names>LB</given-names></name><name><surname>Nik-Zainal</surname><given-names>S</given-names></name><name><surname>Wedge</surname><given-names>DC</given-names></name><name><surname>Aparicio</surname><given-names>SAJR</given-names></name><name><surname>Behjati</surname><given-names>S</given-names></name><name><surname>Biankin</surname><given-names>AV</given-names></name><name><surname>Bignell</surname><given-names>GR</given-names></name><name><surname>Bolli</surname><given-names>N</given-names></name><name><surname>Borg</surname><given-names>A</given-names></name><name><surname>Børresen-Dale</surname><given-names>A-L</given-names></name><name><surname>Boyault</surname><given-names>S</given-names></name><name><surname>Burkhardt</surname><given-names>B</given-names></name><name><surname>Butler</surname><given-names>AP</given-names></name><name><surname>Caldas</surname><given-names>C</given-names></name><name><surname>Davies</surname><given-names>HR</given-names></name><name><surname>Desmedt</surname><given-names>C</given-names></name><name><surname>Eils</surname><given-names>R</given-names></name><name><surname>Eyfjörd</surname><given-names>JE</given-names></name><name><surname>Foekens</surname><given-names>JA</given-names></name><name><surname>Greaves</surname><given-names>M</given-names></name><name><surname>Hosoda</surname><given-names>F</given-names></name><name><surname>Hutter</surname><given-names>B</given-names></name><name><surname>Ilicic</surname><given-names>T</given-names></name><name><surname>Imbeaud</surname><given-names>S</given-names></name><name><surname>Imielinski</surname><given-names>M</given-names></name><name><surname>Jäger</surname><given-names>N</given-names></name><name><surname>Jones</surname><given-names>DTW</given-names></name><name><surname>Jones</surname><given-names>D</given-names></name><name><surname>Knappskog</surname><given-names>S</given-names></name><name><surname>Kool</surname><given-names>M</given-names></name><name><surname>Lakhani</surname><given-names>SR</given-names></name><name><surname>López-Otín</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Munshi</surname><given-names>NC</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Northcott</surname><given-names>PA</given-names></name><name><surname>Pajic</surname><given-names>M</given-names></name><name><surname>Papaemmanuil</surname><given-names>E</given-names></name><name><surname>Paradiso</surname><given-names>A</given-names></name><name><surname>Pearson</surname><given-names>JV</given-names></name><name><surname>Puente</surname><given-names>XS</given-names></name><name><surname>Raine</surname><given-names>K</given-names></name><name><surname>Ramakrishna</surname><given-names>M</given-names></name><name><surname>Richardson</surname><given-names>AL</given-names></name><name><surname>Richter</surname><given-names>J</given-names></name><name><surname>Rosenstiel</surname><given-names>P</given-names></name><name><surname>Schlesner</surname><given-names>M</given-names></name><name><surname>Schumacher</surname><given-names>TN</given-names></name><name><surname>Span</surname><given-names>PN</given-names></name><name><surname>Teague</surname><given-names>JW</given-names></name><name><surname>Totoki</surname><given-names>Y</given-names></name><name><surname>Tutt</surname><given-names>ANJ</given-names></name><name><surname>Valdés-Mas</surname><given-names>R</given-names></name><name><surname>van Buuren</surname><given-names>MM</given-names></name><name><surname>van ’t Veer</surname><given-names>L</given-names></name><name><surname>Vincent-Salomon</surname><given-names>A</given-names></name><name><surname>Waddell</surname><given-names>N</given-names></name><name><surname>Yates</surname><given-names>LR</given-names></name><name><surname>Zucman-Rossi</surname><given-names>J</given-names></name><name><surname>Futreal</surname><given-names>PA</given-names></name><name><surname>McDermott</surname><given-names>U</given-names></name><name><surname>Lichter</surname><given-names>P</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Grimmond</surname><given-names>SM</given-names></name><name><surname>Siebert</surname><given-names>R</given-names></name><name><surname>Campo</surname><given-names>E</given-names></name><name><surname>Shibata</surname><given-names>T</given-names></name><name><surname>Pfister</surname><given-names>SM</given-names></name><name><surname>Campbell</surname><given-names>PJ</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name><collab>Australian Pancreatic Cancer Genome Initiative</collab><collab>ICGC Breast Cancer Consortium</collab><collab>ICGC MMML-Seq Consortium</collab><collab>ICGC PedBrain</collab></person-group><year iso-8601-date="2013">2013</year><article-title>Signatures of mutational processes in human cancer</article-title><source>Nature</source><volume>500</volume><fpage>415</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1038/nature12477</pub-id><pub-id pub-id-type="pmid">23945592</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakhoum</surname><given-names>SF</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The multifaceted role of chromosomal instability in cancer and its microenvironment</article-title><source>Cell</source><volume>174</volume><fpage>1347</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.08.027</pub-id><pub-id pub-id-type="pmid">30193109</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakhoum</surname><given-names>SF</given-names></name><name><surname>Ngo</surname><given-names>B</given-names></name><name><surname>Laughney</surname><given-names>AM</given-names></name><name><surname>Cavallo</surname><given-names>J-A</given-names></name><name><surname>Murphy</surname><given-names>CJ</given-names></name><name><surname>Ly</surname><given-names>P</given-names></name><name><surname>Shah</surname><given-names>P</given-names></name><name><surname>Sriram</surname><given-names>RK</given-names></name><name><surname>Watkins</surname><given-names>TBK</given-names></name><name><surname>Taunk</surname><given-names>NK</given-names></name><name><surname>Duran</surname><given-names>M</given-names></name><name><surname>Pauli</surname><given-names>C</given-names></name><name><surname>Shaw</surname><given-names>C</given-names></name><name><surname>Chadalavada</surname><given-names>K</given-names></name><name><surname>Rajasekhar</surname><given-names>VK</given-names></name><name><surname>Genovese</surname><given-names>G</given-names></name><name><surname>Venkatesan</surname><given-names>S</given-names></name><name><surname>Birkbak</surname><given-names>NJ</given-names></name><name><surname>McGranahan</surname><given-names>N</given-names></name><name><surname>Lundquist</surname><given-names>M</given-names></name><name><surname>LaPlant</surname><given-names>Q</given-names></name><name><surname>Healey</surname><given-names>JH</given-names></name><name><surname>Elemento</surname><given-names>O</given-names></name><name><surname>Chung</surname><given-names>CH</given-names></name><name><surname>Lee</surname><given-names>NY</given-names></name><name><surname>Imielenski</surname><given-names>M</given-names></name><name><surname>Nanjangud</surname><given-names>G</given-names></name><name><surname>Pe’er</surname><given-names>D</given-names></name><name><surname>Cleveland</surname><given-names>DW</given-names></name><name><surname>Powell</surname><given-names>SN</given-names></name><name><surname>Lammerding</surname><given-names>J</given-names></name><name><surname>Swanton</surname><given-names>C</given-names></name><name><surname>Cantley</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Chromosomal instability drives metastasis through a cytosolic DNA response</article-title><source>Nature</source><volume>553</volume><fpage>467</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1038/nature25432</pub-id><pub-id pub-id-type="pmid">29342134</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bester</surname><given-names>AC</given-names></name><name><surname>Roniger</surname><given-names>M</given-names></name><name><surname>Oren</surname><given-names>YS</given-names></name><name><surname>Im</surname><given-names>MM</given-names></name><name><surname>Sarni</surname><given-names>D</given-names></name><name><surname>Chaoat</surname><given-names>M</given-names></name><name><surname>Bensimon</surname><given-names>A</given-names></name><name><surname>Zamir</surname><given-names>G</given-names></name><name><surname>Shewach</surname><given-names>DS</given-names></name><name><surname>Kerem</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Nucleotide deficiency promotes genomic instability in early stages of cancer development</article-title><source>Cell</source><volume>145</volume><fpage>435</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.03.044</pub-id><pub-id pub-id-type="pmid">21529715</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>A</given-names></name><name><surname>Bense</surname><given-names>RD</given-names></name><name><surname>Urzúa-Traslaviña</surname><given-names>CG</given-names></name><name><surname>de Vries</surname><given-names>EGE</given-names></name><name><surname>van Vugt</surname><given-names>MATM</given-names></name><name><surname>Fehrmann</surname><given-names>RSN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Transcriptional effects of copy number alterations in a large set of human cancers</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>715</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-14605-5</pub-id><pub-id pub-id-type="pmid">32024838</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broutier</surname><given-names>L</given-names></name><name><surname>Mastrogiovanni</surname><given-names>G</given-names></name><name><surname>Verstegen</surname><given-names>MM</given-names></name><name><surname>Francies</surname><given-names>HE</given-names></name><name><surname>Gavarró</surname><given-names>LM</given-names></name><name><surname>Bradshaw</surname><given-names>CR</given-names></name><name><surname>Allen</surname><given-names>GE</given-names></name><name><surname>Arnes-Benito</surname><given-names>R</given-names></name><name><surname>Sidorova</surname><given-names>O</given-names></name><name><surname>Gaspersz</surname><given-names>MP</given-names></name><name><surname>Georgakopoulos</surname><given-names>N</given-names></name><name><surname>Koo</surname><given-names>BK</given-names></name><name><surname>Dietmann</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>SE</given-names></name><name><surname>Praseedom</surname><given-names>RK</given-names></name><name><surname>Lieshout</surname><given-names>R</given-names></name><name><surname>IJzermans</surname><given-names>JNM</given-names></name><name><surname>Wigmore</surname><given-names>SJ</given-names></name><name><surname>Saeb-Parsy</surname><given-names>K</given-names></name><name><surname>Garnett</surname><given-names>MJ</given-names></name><name><surname>van der Laan</surname><given-names>LJ</given-names></name><name><surname>Huch</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human primary liver cancer-derived organoid cultures for disease modeling and drug screening</article-title><source>Nature Medicine</source><volume>23</volume><fpage>1424</fpage><lpage>1435</lpage><pub-id pub-id-type="doi">10.1038/nm.4438</pub-id><pub-id pub-id-type="pmid">29131160</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burrell</surname><given-names>RA</given-names></name><name><surname>McClelland</surname><given-names>SE</given-names></name><name><surname>Endesfelder</surname><given-names>D</given-names></name><name><surname>Groth</surname><given-names>P</given-names></name><name><surname>Weller</surname><given-names>M-C</given-names></name><name><surname>Shaikh</surname><given-names>N</given-names></name><name><surname>Domingo</surname><given-names>E</given-names></name><name><surname>Kanu</surname><given-names>N</given-names></name><name><surname>Dewhurst</surname><given-names>SM</given-names></name><name><surname>Gronroos</surname><given-names>E</given-names></name><name><surname>Chew</surname><given-names>SK</given-names></name><name><surname>Rowan</surname><given-names>AJ</given-names></name><name><surname>Schenk</surname><given-names>A</given-names></name><name><surname>Sheffer</surname><given-names>M</given-names></name><name><surname>Howell</surname><given-names>M</given-names></name><name><surname>Kschischo</surname><given-names>M</given-names></name><name><surname>Behrens</surname><given-names>A</given-names></name><name><surname>Helleday</surname><given-names>T</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name><name><surname>Tomlinson</surname><given-names>IP</given-names></name><name><surname>Swanton</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Replication stress links structural and numerical cancer chromosomal instability</article-title><source>Nature</source><volume>494</volume><fpage>492</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1038/nature11935</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Cancer Genome Atlas Research Network</collab></person-group><year iso-8601-date="2011">2011</year><article-title>Integrated genomic analyses of ovarian carcinoma</article-title><source>Nature</source><volume>474</volume><fpage>609</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1038/nature10166</pub-id><pub-id pub-id-type="pmid">21720365</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Cast</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Consensustme: Tumour Microenvironment cell estimation</data-title><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/cansysbio/ConsensusTME">https://github.com/cansysbio/ConsensusTME</ext-link></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Z</given-names></name><name><surname>Mirza</surname><given-names>H</given-names></name><name><surname>Ennis</surname><given-names>DP</given-names></name><name><surname>Smith</surname><given-names>P</given-names></name><name><surname>Morrill Gavarró</surname><given-names>L</given-names></name><name><surname>Sokota</surname><given-names>C</given-names></name><name><surname>Giannone</surname><given-names>G</given-names></name><name><surname>Goranova</surname><given-names>T</given-names></name><name><surname>Bradley</surname><given-names>T</given-names></name><name><surname>Piskorz</surname><given-names>A</given-names></name><name><surname>Lockley</surname><given-names>M</given-names></name><collab>BriTROC-1 Investigators</collab><name><surname>Kaur</surname><given-names>B</given-names></name><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Tookman</surname><given-names>LA</given-names></name><name><surname>Krell</surname><given-names>J</given-names></name><name><surname>McDermott</surname><given-names>J</given-names></name><name><surname>Macintyre</surname><given-names>G</given-names></name><name><surname>Markowetz</surname><given-names>F</given-names></name><name><surname>Brenton</surname><given-names>JD</given-names></name><name><surname>McNeish</surname><given-names>IA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The genomic landscape of early-stage ovarian high-grade serous carcinoma</article-title><source>Clinical Cancer Research</source><volume>28</volume><fpage>2911</fpage><lpage>2922</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-21-1643</pub-id><pub-id pub-id-type="pmid">35398881</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortés-Ciriano</surname><given-names>I</given-names></name><name><surname>Lee</surname><given-names>JJK</given-names></name><name><surname>Xi</surname><given-names>R</given-names></name><name><surname>Jain</surname><given-names>D</given-names></name><name><surname>Jung</surname><given-names>YL</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Gordenin</surname><given-names>D</given-names></name><name><surname>Klimczak</surname><given-names>LJ</given-names></name><name><surname>Zhang</surname><given-names>CZ</given-names></name><name><surname>Pellman</surname><given-names>DS</given-names></name><name><surname>Park</surname><given-names>PJ</given-names></name><collab>PCAWG Structural Variation Working Group</collab><collab>PCAWG Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Comprehensive analysis of Chromothripsis in 2,658 human cancers using whole-genome sequencing</article-title><source>Nature Genetics</source><volume>52</volume><fpage>331</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0576-7</pub-id><pub-id pub-id-type="pmid">32404988</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>H</given-names></name><name><surname>Glodzik</surname><given-names>D</given-names></name><name><surname>Morganella</surname><given-names>S</given-names></name><name><surname>Yates</surname><given-names>LR</given-names></name><name><surname>Staaf</surname><given-names>J</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>Ramakrishna</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Boyault</surname><given-names>S</given-names></name><name><surname>Sieuwerts</surname><given-names>AM</given-names></name><name><surname>Simpson</surname><given-names>PT</given-names></name><name><surname>King</surname><given-names>TA</given-names></name><name><surname>Raine</surname><given-names>K</given-names></name><name><surname>Eyfjord</surname><given-names>JE</given-names></name><name><surname>Kong</surname><given-names>G</given-names></name><name><surname>Borg</surname><given-names>Å</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>van de Vijver</surname><given-names>MJ</given-names></name><name><surname>Børresen-Dale</surname><given-names>A-L</given-names></name><name><surname>Martens</surname><given-names>JWM</given-names></name><name><surname>Span</surname><given-names>PN</given-names></name><name><surname>Lakhani</surname><given-names>SR</given-names></name><name><surname>Vincent-Salomon</surname><given-names>A</given-names></name><name><surname>Sotiriou</surname><given-names>C</given-names></name><name><surname>Tutt</surname><given-names>A</given-names></name><name><surname>Thompson</surname><given-names>AM</given-names></name><name><surname>Van Laere</surname><given-names>S</given-names></name><name><surname>Richardson</surname><given-names>AL</given-names></name><name><surname>Viari</surname><given-names>A</given-names></name><name><surname>Campbell</surname><given-names>PJ</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name><name><surname>Nik-Zainal</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>HRDetect is a Predictor of BRCA1 and BRCA2 deficiency based on mutational signatures</article-title><source>Nature Medicine</source><volume>23</volume><fpage>517</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1038/nm.4292</pub-id><pub-id pub-id-type="pmid">28288110</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drews</surname><given-names>RM</given-names></name><name><surname>Hernando</surname><given-names>B</given-names></name><name><surname>Tarabichi</surname><given-names>M</given-names></name><name><surname>Haase</surname><given-names>K</given-names></name><name><surname>Lesluyes</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>PS</given-names></name><name><surname>Morrill Gavarró</surname><given-names>L</given-names></name><name><surname>Couturier</surname><given-names>DL</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Schneider</surname><given-names>M</given-names></name><name><surname>Brenton</surname><given-names>JD</given-names></name><name><surname>Van Loo</surname><given-names>P</given-names></name><name><surname>Macintyre</surname><given-names>G</given-names></name><name><surname>Markowetz</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A pan-cancer compendium of chromosomal instability</article-title><source>Nature</source><volume>606</volume><fpage>976</fpage><lpage>983</lpage><pub-id pub-id-type="doi">10.1038/s41586-022-04789-9</pub-id><pub-id pub-id-type="pmid">35705807</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Etemadmoghadam</surname><given-names>D</given-names></name><name><surname>deFazio</surname><given-names>A</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Mermel</surname><given-names>C</given-names></name><name><surname>George</surname><given-names>J</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Tothill</surname><given-names>R</given-names></name><name><surname>Okamoto</surname><given-names>A</given-names></name><name><surname>Raeder</surname><given-names>MB</given-names></name><name><surname>Harnett</surname><given-names>P</given-names></name><name><surname>Lade</surname><given-names>S</given-names></name><name><surname>Akslen</surname><given-names>LA</given-names></name><name><surname>Tinker</surname><given-names>AV</given-names></name><name><surname>Locandro</surname><given-names>B</given-names></name><name><surname>Alsop</surname><given-names>K</given-names></name><name><surname>Chiew</surname><given-names>Y-E</given-names></name><name><surname>Traficante</surname><given-names>N</given-names></name><name><surname>Fereday</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>D</given-names></name><name><surname>Fox</surname><given-names>S</given-names></name><name><surname>Sellers</surname><given-names>W</given-names></name><name><surname>Urashima</surname><given-names>M</given-names></name><name><surname>Salvesen</surname><given-names>HB</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Bowtell</surname><given-names>D</given-names></name><collab>AOCS Study Group</collab></person-group><year iso-8601-date="2009">2009</year><article-title>Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas</article-title><source>Clinical Cancer Research</source><volume>15</volume><fpage>1417</fpage><lpage>1427</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-08-1564</pub-id><pub-id pub-id-type="pmid">19193619</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehrmann</surname><given-names>RSN</given-names></name><name><surname>Karjalainen</surname><given-names>JM</given-names></name><name><surname>Krajewska</surname><given-names>M</given-names></name><name><surname>Westra</surname><given-names>HJ</given-names></name><name><surname>Maloney</surname><given-names>D</given-names></name><name><surname>Simeonov</surname><given-names>A</given-names></name><name><surname>Pers</surname><given-names>TH</given-names></name><name><surname>Hirschhorn</surname><given-names>JN</given-names></name><name><surname>Jansen</surname><given-names>RC</given-names></name><name><surname>Schultes</surname><given-names>EA</given-names></name><name><surname>van Haagen</surname><given-names>H</given-names></name><name><surname>de Vries</surname><given-names>EGE</given-names></name><name><surname>te Meerman</surname><given-names>GJ</given-names></name><name><surname>Wijmenga</surname><given-names>C</given-names></name><name><surname>van Vugt</surname><given-names>M</given-names></name><name><surname>Franke</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gene expression analysis identifies global gene dosage sensitivity in cancer</article-title><source>Nature Genetics</source><volume>47</volume><fpage>115</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1038/ng.3173</pub-id><pub-id pub-id-type="pmid">25581432</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleury</surname><given-names>H</given-names></name><name><surname>Communal</surname><given-names>L</given-names></name><name><surname>Carmona</surname><given-names>E</given-names></name><name><surname>Portelance</surname><given-names>L</given-names></name><name><surname>Arcand</surname><given-names>SL</given-names></name><name><surname>Rahimi</surname><given-names>K</given-names></name><name><surname>Tonin</surname><given-names>PN</given-names></name><name><surname>Provencher</surname><given-names>D</given-names></name><name><surname>Mes-Masson</surname><given-names>A-M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Novel high-grade serous epithelial ovarian cancer cell lines that reflect the molecular diversity of both the sporadic and hereditary disease</article-title><source>Genes &amp; Cancer</source><volume>6</volume><fpage>378</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.18632/genesandcancer.76</pub-id><pub-id pub-id-type="pmid">26622941</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forshew</surname><given-names>T</given-names></name><name><surname>Murtaza</surname><given-names>M</given-names></name><name><surname>Parkinson</surname><given-names>C</given-names></name><name><surname>Gale</surname><given-names>D</given-names></name><name><surname>Tsui</surname><given-names>DWY</given-names></name><name><surname>Kaper</surname><given-names>F</given-names></name><name><surname>Dawson</surname><given-names>S-J</given-names></name><name><surname>Piskorz</surname><given-names>AM</given-names></name><name><surname>Jimenez-Linan</surname><given-names>M</given-names></name><name><surname>Bentley</surname><given-names>D</given-names></name><name><surname>Hadfield</surname><given-names>J</given-names></name><name><surname>May</surname><given-names>AP</given-names></name><name><surname>Caldas</surname><given-names>C</given-names></name><name><surname>Brenton</surname><given-names>JD</given-names></name><name><surname>Rosenfeld</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA</article-title><source>Science Translational Medicine</source><volume>4</volume><elocation-id>136ra68</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3003726</pub-id><pub-id pub-id-type="pmid">22649089</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francies</surname><given-names>HE</given-names></name><name><surname>Barthorpe</surname><given-names>A</given-names></name><name><surname>McLaren-Douglas</surname><given-names>A</given-names></name><name><surname>Barendt</surname><given-names>WJ</given-names></name><name><surname>Garnett</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Drug sensitivity assays of human cancer organoid cultures</article-title><source>Methods in Molecular Biology</source><volume>1</volume><elocation-id>e1</elocation-id><pub-id pub-id-type="doi">10.1007/978-1-4939-7617-1</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>D</given-names></name><name><surname>Vela</surname><given-names>I</given-names></name><name><surname>Sboner</surname><given-names>A</given-names></name><name><surname>Iaquinta</surname><given-names>PJ</given-names></name><name><surname>Karthaus</surname><given-names>WR</given-names></name><name><surname>Gopalan</surname><given-names>A</given-names></name><name><surname>Dowling</surname><given-names>C</given-names></name><name><surname>Wanjala</surname><given-names>JN</given-names></name><name><surname>Undvall</surname><given-names>EA</given-names></name><name><surname>Arora</surname><given-names>VK</given-names></name><name><surname>Wongvipat</surname><given-names>J</given-names></name><name><surname>Kossai</surname><given-names>M</given-names></name><name><surname>Ramazanoglu</surname><given-names>S</given-names></name><name><surname>Barboza</surname><given-names>LP</given-names></name><name><surname>Di</surname><given-names>W</given-names></name><name><surname>Cao</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>QF</given-names></name><name><surname>Sirota</surname><given-names>I</given-names></name><name><surname>Ran</surname><given-names>L</given-names></name><name><surname>MacDonald</surname><given-names>TY</given-names></name><name><surname>Beltran</surname><given-names>H</given-names></name><name><surname>Mosquera</surname><given-names>J-M</given-names></name><name><surname>Touijer</surname><given-names>KA</given-names></name><name><surname>Scardino</surname><given-names>PT</given-names></name><name><surname>Laudone</surname><given-names>VP</given-names></name><name><surname>Curtis</surname><given-names>KR</given-names></name><name><surname>Rathkopf</surname><given-names>DE</given-names></name><name><surname>Morris</surname><given-names>MJ</given-names></name><name><surname>Danila</surname><given-names>DC</given-names></name><name><surname>Slovin</surname><given-names>SF</given-names></name><name><surname>Solomon</surname><given-names>SB</given-names></name><name><surname>Eastham</surname><given-names>JA</given-names></name><name><surname>Chi</surname><given-names>P</given-names></name><name><surname>Carver</surname><given-names>B</given-names></name><name><surname>Rubin</surname><given-names>MA</given-names></name><name><surname>Scher</surname><given-names>HI</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Sawyers</surname><given-names>CL</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Organoid cultures derived from patients with advanced prostate cancer</article-title><source>Cell</source><volume>159</volume><fpage>176</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.08.016</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gelmon</surname><given-names>KA</given-names></name><name><surname>Tischkowitz</surname><given-names>M</given-names></name><name><surname>Mackay</surname><given-names>H</given-names></name><name><surname>Swenerton</surname><given-names>K</given-names></name><name><surname>Robidoux</surname><given-names>A</given-names></name><name><surname>Tonkin</surname><given-names>K</given-names></name><name><surname>Hirte</surname><given-names>H</given-names></name><name><surname>Huntsman</surname><given-names>D</given-names></name><name><surname>Clemons</surname><given-names>M</given-names></name><name><surname>Gilks</surname><given-names>B</given-names></name><name><surname>Yerushalmi</surname><given-names>R</given-names></name><name><surname>Macpherson</surname><given-names>E</given-names></name><name><surname>Carmichael</surname><given-names>J</given-names></name><name><surname>Oza</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: A phase 2, multicentre, open-label, non-randomised study</article-title><source>The Lancet Oncology</source><volume>12</volume><fpage>852</fpage><lpage>861</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(11)70214-5</pub-id><pub-id pub-id-type="pmid">21862407</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerstung</surname><given-names>M</given-names></name><name><surname>Jolly</surname><given-names>C</given-names></name><name><surname>Leshchiner</surname><given-names>I</given-names></name><name><surname>Dentro</surname><given-names>SC</given-names></name><name><surname>Gonzalez</surname><given-names>S</given-names></name><name><surname>Rosebrock</surname><given-names>D</given-names></name><name><surname>Mitchell</surname><given-names>TJ</given-names></name><name><surname>Rubanova</surname><given-names>Y</given-names></name><name><surname>Anur</surname><given-names>P</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Tarabichi</surname><given-names>M</given-names></name><name><surname>Deshwar</surname><given-names>A</given-names></name><name><surname>Wintersinger</surname><given-names>J</given-names></name><name><surname>Kleinheinz</surname><given-names>K</given-names></name><name><surname>Vázquez-García</surname><given-names>I</given-names></name><name><surname>Haase</surname><given-names>K</given-names></name><name><surname>Jerman</surname><given-names>L</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>Macintyre</surname><given-names>G</given-names></name><name><surname>Malikic</surname><given-names>S</given-names></name><name><surname>Donmez</surname><given-names>N</given-names></name><name><surname>Livitz</surname><given-names>DG</given-names></name><name><surname>Cmero</surname><given-names>M</given-names></name><name><surname>Demeulemeester</surname><given-names>J</given-names></name><name><surname>Schumacher</surname><given-names>S</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Schlesner</surname><given-names>M</given-names></name><name><surname>Boutros</surname><given-names>PC</given-names></name><name><surname>Bowtell</surname><given-names>DD</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Imielinski</surname><given-names>M</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Sahinalp</surname><given-names>SC</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Peifer</surname><given-names>M</given-names></name><name><surname>Markowetz</surname><given-names>F</given-names></name><name><surname>Mustonen</surname><given-names>V</given-names></name><name><surname>Yuan</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Morris</surname><given-names>QD</given-names></name><collab>PCAWG Evolution &amp; Heterogeneity Working Group</collab><name><surname>Spellman</surname><given-names>PT</given-names></name><name><surname>Wedge</surname><given-names>DC</given-names></name><name><surname>Van Loo</surname><given-names>P</given-names></name><collab>PCAWG Consortium</collab></person-group><year iso-8601-date="2020">2020</year><article-title>The evolutionary history of 2,658 cancers</article-title><source>Nature</source><volume>578</volume><fpage>122</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1907-7</pub-id><pub-id pub-id-type="pmid">32025013</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gisselsson</surname><given-names>D</given-names></name><name><surname>Pettersson</surname><given-names>L</given-names></name><name><surname>Höglund</surname><given-names>M</given-names></name><name><surname>Heidenblad</surname><given-names>M</given-names></name><name><surname>Gorunova</surname><given-names>L</given-names></name><name><surname>Wiegant</surname><given-names>J</given-names></name><name><surname>Mertens</surname><given-names>F</given-names></name><name><surname>Dal Cin</surname><given-names>P</given-names></name><name><surname>Mitelman</surname><given-names>F</given-names></name><name><surname>Mandahl</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity</article-title><source>PNAS</source><volume>97</volume><fpage>5357</fpage><lpage>5362</lpage><pub-id pub-id-type="doi">10.1073/pnas.090013497</pub-id><pub-id pub-id-type="pmid">10805796</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafner</surname><given-names>M</given-names></name><name><surname>Niepel</surname><given-names>M</given-names></name><name><surname>Chung</surname><given-names>M</given-names></name><name><surname>Sorger</surname><given-names>PK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs</article-title><source>Nature Methods</source><volume>13</volume><fpage>521</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3853</pub-id><pub-id pub-id-type="pmid">27135972</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hänzelmann</surname><given-names>S</given-names></name><name><surname>Castelo</surname><given-names>R</given-names></name><name><surname>Guinney</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>GSVA: Gene set variation analysis for microarray and RNA-Seq data</article-title><source>BMC Bioinformatics</source><volume>14</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/1471-2105-14-7</pub-id><pub-id pub-id-type="pmid">23323831</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>SJ</given-names></name><name><surname>Decker</surname><given-names>B</given-names></name><name><surname>Roberts</surname><given-names>EA</given-names></name><name><surname>Horowitz</surname><given-names>NS</given-names></name><name><surname>Muto</surname><given-names>MG</given-names></name><name><surname>Worley</surname><given-names>MJ</given-names></name><name><surname>Feltmate</surname><given-names>CM</given-names></name><name><surname>Nucci</surname><given-names>MR</given-names></name><name><surname>Swisher</surname><given-names>EM</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Morizane</surname><given-names>R</given-names></name><name><surname>Kochupurakkal</surname><given-names>BS</given-names></name><name><surname>Do</surname><given-names>KT</given-names></name><name><surname>Konstantinopoulos</surname><given-names>PA</given-names></name><name><surname>Liu</surname><given-names>JF</given-names></name><name><surname>Bonventre</surname><given-names>JV</given-names></name><name><surname>Matulonis</surname><given-names>UA</given-names></name><name><surname>Shapiro</surname><given-names>GI</given-names></name><name><surname>Berkowitz</surname><given-names>RS</given-names></name><name><surname>Crum</surname><given-names>CP</given-names></name><name><surname>D’Andrea</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Prediction of DNA repair inhibitor response in short-term patient-derived ovarian cancer organoids</article-title><source>Cancer Discovery</source><volume>8</volume><fpage>1404</fpage><lpage>1421</lpage><pub-id pub-id-type="doi">10.1158/2159-8290.CD-18-0474</pub-id><pub-id pub-id-type="pmid">30213835</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>K</given-names></name><name><surname>Berger</surname><given-names>H</given-names></name><name><surname>Kulbe</surname><given-names>H</given-names></name><name><surname>Thillainadarasan</surname><given-names>S</given-names></name><name><surname>Mollenkopf</surname><given-names>H-J</given-names></name><name><surname>Zemojtel</surname><given-names>T</given-names></name><name><surname>Taube</surname><given-names>E</given-names></name><name><surname>Darb-Esfahani</surname><given-names>S</given-names></name><name><surname>Mangler</surname><given-names>M</given-names></name><name><surname>Sehouli</surname><given-names>J</given-names></name><name><surname>Chekerov</surname><given-names>R</given-names></name><name><surname>Braicu</surname><given-names>EI</given-names></name><name><surname>Meyer</surname><given-names>TF</given-names></name><name><surname>Kessler</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Stable expansion of high-grade serous ovarian cancer organoids requires a low-WNT environment</article-title><source>The EMBO Journal</source><volume>39</volume><elocation-id>e104013</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2019104013</pub-id><pub-id pub-id-type="pmid">32009247</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ippolito</surname><given-names>MR</given-names></name><name><surname>Martis</surname><given-names>V</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Tijhuis</surname><given-names>AE</given-names></name><name><surname>Hong</surname><given-names>C</given-names></name><name><surname>Wardenaar</surname><given-names>R</given-names></name><name><surname>Dumont</surname><given-names>M</given-names></name><name><surname>Zerbib</surname><given-names>J</given-names></name><name><surname>Spierings</surname><given-names>DCJ</given-names></name><name><surname>Fachinetti</surname><given-names>D</given-names></name><name><surname>Ben-David</surname><given-names>U</given-names></name><name><surname>Foijer</surname><given-names>F</given-names></name><name><surname>Santaguida</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Gene copy-number changes and chromosomal instability induced by aneuploidy confer resistance to chemotherapy</article-title><source>Developmental Cell</source><volume>56</volume><fpage>2440</fpage><lpage>2454</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.07.006</pub-id><pub-id pub-id-type="pmid">34352223</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiménez-Sánchez</surname><given-names>A</given-names></name><name><surname>Cast</surname><given-names>O</given-names></name><name><surname>Miller</surname><given-names>ML</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive benchmarking and integration of tumor microenvironment cell estimation methods</article-title><source>Cancer Research</source><volume>79</volume><fpage>6238</fpage><lpage>6246</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-18-3560</pub-id><pub-id pub-id-type="pmid">31641033</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessler</surname><given-names>M</given-names></name><name><surname>Hoffmann</surname><given-names>K</given-names></name><name><surname>Brinkmann</surname><given-names>V</given-names></name><name><surname>Thieck</surname><given-names>O</given-names></name><name><surname>Jackisch</surname><given-names>S</given-names></name><name><surname>Toelle</surname><given-names>B</given-names></name><name><surname>Berger</surname><given-names>H</given-names></name><name><surname>Mollenkopf</surname><given-names>H-J</given-names></name><name><surname>Mangler</surname><given-names>M</given-names></name><name><surname>Sehouli</surname><given-names>J</given-names></name><name><surname>Fotopoulou</surname><given-names>C</given-names></name><name><surname>Meyer</surname><given-names>TF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Notch and WNT pathways regulate stemness and differentiation in human fallopian tube organoids</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>8989</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms9989</pub-id><pub-id pub-id-type="pmid">26643275</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopper</surname><given-names>O</given-names></name><name><surname>de Witte</surname><given-names>CJ</given-names></name><name><surname>Lõhmussaar</surname><given-names>K</given-names></name><name><surname>Valle-Inclan</surname><given-names>JE</given-names></name><name><surname>Hami</surname><given-names>N</given-names></name><name><surname>Kester</surname><given-names>L</given-names></name><name><surname>Balgobind</surname><given-names>AV</given-names></name><name><surname>Korving</surname><given-names>J</given-names></name><name><surname>Proost</surname><given-names>N</given-names></name><name><surname>Begthel</surname><given-names>H</given-names></name><name><surname>van Wijk</surname><given-names>LM</given-names></name><name><surname>Revilla</surname><given-names>SA</given-names></name><name><surname>Theeuwsen</surname><given-names>R</given-names></name><name><surname>van de Ven</surname><given-names>M</given-names></name><name><surname>van Roosmalen</surname><given-names>MJ</given-names></name><name><surname>Ponsioen</surname><given-names>B</given-names></name><name><surname>Ho</surname><given-names>VWH</given-names></name><name><surname>Neel</surname><given-names>BG</given-names></name><name><surname>Bosse</surname><given-names>T</given-names></name><name><surname>Gaarenstroom</surname><given-names>KN</given-names></name><name><surname>Vrieling</surname><given-names>H</given-names></name><name><surname>Vreeswijk</surname><given-names>MPG</given-names></name><name><surname>van Diest</surname><given-names>PJ</given-names></name><name><surname>Witteveen</surname><given-names>PO</given-names></name><name><surname>Jonges</surname><given-names>T</given-names></name><name><surname>Bos</surname><given-names>JL</given-names></name><name><surname>van Oudenaarden</surname><given-names>A</given-names></name><name><surname>Zweemer</surname><given-names>RP</given-names></name><name><surname>Snippert</surname><given-names>HJG</given-names></name><name><surname>Kloosterman</surname><given-names>WP</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity</article-title><source>Nature Medicine</source><volume>25</volume><fpage>838</fpage><lpage>849</lpage><pub-id pub-id-type="doi">10.1038/s41591-019-0422-6</pub-id><pub-id pub-id-type="pmid">31011202</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Korotkevich</surname><given-names>G</given-names></name><name><surname>Vladimir</surname><given-names>S</given-names></name><name><surname>Nikolay</surname><given-names>B</given-names></name><name><surname>Boris</surname><given-names>S</given-names></name><name><surname>Maxim</surname><given-names>NA</given-names></name><name><surname>Alexey</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Fast gene set enrichment analysis</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/060012</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labidi-Galy</surname><given-names>SI</given-names></name><name><surname>Papp</surname><given-names>E</given-names></name><name><surname>Hallberg</surname><given-names>D</given-names></name><name><surname>Niknafs</surname><given-names>N</given-names></name><name><surname>Adleff</surname><given-names>V</given-names></name><name><surname>Noe</surname><given-names>M</given-names></name><name><surname>Bhattacharya</surname><given-names>R</given-names></name><name><surname>Novak</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>S</given-names></name><name><surname>Phallen</surname><given-names>J</given-names></name><name><surname>Hruban</surname><given-names>CA</given-names></name><name><surname>Hirsch</surname><given-names>MS</given-names></name><name><surname>Lin</surname><given-names>DI</given-names></name><name><surname>Schwartz</surname><given-names>L</given-names></name><name><surname>Maire</surname><given-names>CL</given-names></name><name><surname>Tille</surname><given-names>J-C</given-names></name><name><surname>Bowden</surname><given-names>M</given-names></name><name><surname>Ayhan</surname><given-names>A</given-names></name><name><surname>Wood</surname><given-names>LD</given-names></name><name><surname>Scharpf</surname><given-names>RB</given-names></name><name><surname>Kurman</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>T-L</given-names></name><name><surname>Shih</surname><given-names>I-M</given-names></name><name><surname>Karchin</surname><given-names>R</given-names></name><name><surname>Drapkin</surname><given-names>R</given-names></name><name><surname>Velculescu</surname><given-names>VE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>High grade serous ovarian carcinomas originate in the fallopian tube</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>1093</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-017-00962-1</pub-id><pub-id pub-id-type="pmid">29061967</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawrence</surname><given-names>M</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Pagès</surname><given-names>H</given-names></name><name><surname>Aboyoun</surname><given-names>P</given-names></name><name><surname>Carlson</surname><given-names>M</given-names></name><name><surname>Gentleman</surname><given-names>R</given-names></name><name><surname>Morgan</surname><given-names>MT</given-names></name><name><surname>Carey</surname><given-names>VJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Software for computing and annotating genomic ranges</article-title><source>PLOS Computational Biology</source><volume>9</volume><elocation-id>e1003118</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1003118</pub-id><pub-id pub-id-type="pmid">23950696</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Hu</surname><given-names>W</given-names></name><name><surname>Matulay</surname><given-names>JT</given-names></name><name><surname>Silva</surname><given-names>MV</given-names></name><name><surname>Owczarek</surname><given-names>TB</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Chua</surname><given-names>CW</given-names></name><name><surname>Barlow</surname><given-names>LJ</given-names></name><name><surname>Kandoth</surname><given-names>C</given-names></name><name><surname>Williams</surname><given-names>AB</given-names></name><name><surname>Bergren</surname><given-names>SK</given-names></name><name><surname>Pietzak</surname><given-names>EJ</given-names></name><name><surname>Anderson</surname><given-names>CB</given-names></name><name><surname>Benson</surname><given-names>MC</given-names></name><name><surname>Coleman</surname><given-names>JA</given-names></name><name><surname>Taylor</surname><given-names>BS</given-names></name><name><surname>Abate-Shen</surname><given-names>C</given-names></name><name><surname>McKiernan</surname><given-names>JM</given-names></name><name><surname>Al-Ahmadie</surname><given-names>H</given-names></name><name><surname>Solit</surname><given-names>DB</given-names></name><name><surname>Shen</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Tumor evolution and drug response in patient-derived organoid models of bladder cancer</article-title><source>Cell</source><volume>173</volume><fpage>515</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.017</pub-id><pub-id pub-id-type="pmid">29625057</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Létourneau</surname><given-names>IJ</given-names></name><name><surname>Quinn</surname><given-names>MCJ</given-names></name><name><surname>Wang</surname><given-names>L-L</given-names></name><name><surname>Portelance</surname><given-names>L</given-names></name><name><surname>Caceres</surname><given-names>KY</given-names></name><name><surname>Cyr</surname><given-names>L</given-names></name><name><surname>Delvoye</surname><given-names>N</given-names></name><name><surname>Meunier</surname><given-names>L</given-names></name><name><surname>de Ladurantaye</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>Z</given-names></name><name><surname>Arcand</surname><given-names>SL</given-names></name><name><surname>Tonin</surname><given-names>PN</given-names></name><name><surname>Provencher</surname><given-names>DM</given-names></name><name><surname>Mes-Masson</surname><given-names>A-M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer</article-title><source>BMC Cancer</source><volume>12</volume><elocation-id>379</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2407-12-379</pub-id><pub-id pub-id-type="pmid">22931248</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Heyer</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Homologous recombination in DNA repair and DNA damage tolerance</article-title><source>Cell Research</source><volume>18</volume><fpage>99</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1038/cr.2008.1</pub-id><pub-id pub-id-type="pmid">18166982</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Francies</surname><given-names>HE</given-names></name><name><surname>Secrier</surname><given-names>M</given-names></name><name><surname>Perner</surname><given-names>J</given-names></name><name><surname>Miremadi</surname><given-names>A</given-names></name><name><surname>Galeano-Dalmau</surname><given-names>N</given-names></name><name><surname>Barendt</surname><given-names>WJ</given-names></name><name><surname>Letchford</surname><given-names>L</given-names></name><name><surname>Leyden</surname><given-names>GM</given-names></name><name><surname>Goffin</surname><given-names>EK</given-names></name><name><surname>Barthorpe</surname><given-names>A</given-names></name><name><surname>Lightfoot</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>E</given-names></name><name><surname>Gilbert</surname><given-names>J</given-names></name><name><surname>Noorani</surname><given-names>A</given-names></name><name><surname>Devonshire</surname><given-names>G</given-names></name><name><surname>Bower</surname><given-names>L</given-names></name><name><surname>Grantham</surname><given-names>A</given-names></name><name><surname>MacRae</surname><given-names>S</given-names></name><name><surname>Grehan</surname><given-names>N</given-names></name><name><surname>Wedge</surname><given-names>DC</given-names></name><name><surname>Fitzgerald</surname><given-names>RC</given-names></name><name><surname>Garnett</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>2983</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-05190-9</pub-id><pub-id pub-id-type="pmid">30061675</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Roberts</surname><given-names>ND</given-names></name><name><surname>Wala</surname><given-names>JA</given-names></name><name><surname>Shapira</surname><given-names>O</given-names></name><name><surname>Schumacher</surname><given-names>SE</given-names></name><name><surname>Kumar</surname><given-names>K</given-names></name><name><surname>Khurana</surname><given-names>E</given-names></name><name><surname>Waszak</surname><given-names>S</given-names></name><name><surname>Korbel</surname><given-names>JO</given-names></name><name><surname>Haber</surname><given-names>JE</given-names></name><name><surname>Imielinski</surname><given-names>M</given-names></name><collab>PCAWG Structural Variation Working Group</collab><name><surname>Akdemir</surname><given-names>KC</given-names></name><name><surname>Alvarez</surname><given-names>EG</given-names></name><name><surname>Baez-Ortega</surname><given-names>A</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Boutros</surname><given-names>PC</given-names></name><name><surname>Bowtell</surname><given-names>DDL</given-names></name><name><surname>Brors</surname><given-names>B</given-names></name><name><surname>Burns</surname><given-names>KH</given-names></name><name><surname>Campbell</surname><given-names>PJ</given-names></name><name><surname>Chan</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Cortés-Ciriano</surname><given-names>I</given-names></name><name><surname>Dueso-Barroso</surname><given-names>A</given-names></name><name><surname>Dunford</surname><given-names>AJ</given-names></name><name><surname>Edwards</surname><given-names>PA</given-names></name><name><surname>Estivill</surname><given-names>X</given-names></name><name><surname>Etemadmoghadam</surname><given-names>D</given-names></name><name><surname>Feuerbach</surname><given-names>L</given-names></name><name><surname>Fink</surname><given-names>JL</given-names></name><name><surname>Frenkel-Morgenstern</surname><given-names>M</given-names></name><name><surname>Garsed</surname><given-names>DW</given-names></name><name><surname>Gerstein</surname><given-names>M</given-names></name><name><surname>Gordenin</surname><given-names>DA</given-names></name><name><surname>Haan</surname><given-names>D</given-names></name><name><surname>Haber</surname><given-names>JE</given-names></name><name><surname>Hess</surname><given-names>JM</given-names></name><name><surname>Hutter</surname><given-names>B</given-names></name><name><surname>Imielinski</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>DTW</given-names></name><name><surname>Ju</surname><given-names>YS</given-names></name><name><surname>Kazanov</surname><given-names>MD</given-names></name><name><surname>Klimczak</surname><given-names>LJ</given-names></name><name><surname>Koh</surname><given-names>Y</given-names></name><name><surname>Korbel</surname><given-names>JO</given-names></name><name><surname>Kumar</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>EA</given-names></name><name><surname>Lee</surname><given-names>JJ-K</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lynch</surname><given-names>AG</given-names></name><name><surname>Macintyre</surname><given-names>G</given-names></name><name><surname>Markowetz</surname><given-names>F</given-names></name><name><surname>Martincorena</surname><given-names>I</given-names></name><name><surname>Martinez-Fundichely</surname><given-names>A</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Miyano</surname><given-names>S</given-names></name><name><surname>Nakagawa</surname><given-names>H</given-names></name><name><surname>Navarro</surname><given-names>FCP</given-names></name><name><surname>Ossowski</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>PJ</given-names></name><name><surname>Pearson</surname><given-names>JV</given-names></name><name><surname>Puiggròs</surname><given-names>M</given-names></name><name><surname>Rippe</surname><given-names>K</given-names></name><name><surname>Roberts</surname><given-names>ND</given-names></name><name><surname>Roberts</surname><given-names>SA</given-names></name><name><surname>Rodriguez-Martin</surname><given-names>B</given-names></name><name><surname>Schumacher</surname><given-names>SE</given-names></name><name><surname>Scully</surname><given-names>R</given-names></name><name><surname>Shackleton</surname><given-names>M</given-names></name><name><surname>Sidiropoulos</surname><given-names>N</given-names></name><name><surname>Sieverling</surname><given-names>L</given-names></name><name><surname>Stewart</surname><given-names>C</given-names></name><name><surname>Torrents</surname><given-names>D</given-names></name><name><surname>Tubio</surname><given-names>JMC</given-names></name><name><surname>Villasante</surname><given-names>I</given-names></name><name><surname>Waddell</surname><given-names>N</given-names></name><name><surname>Wala</surname><given-names>JA</given-names></name><name><surname>Weischenfeldt</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Yoon</surname><given-names>S-S</given-names></name><name><surname>Zamora</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>C-Z</given-names></name><name><surname>Weischenfeldt</surname><given-names>J</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Campbell</surname><given-names>PJ</given-names></name><collab>PCAWG Consortium</collab><name><surname>Aaltonen</surname><given-names>LA</given-names></name><name><surname>Abascal</surname><given-names>F</given-names></name><name><surname>Abeshouse</surname><given-names>A</given-names></name><name><surname>Aburatani</surname><given-names>H</given-names></name><name><surname>Adams</surname><given-names>DJ</given-names></name><name><surname>Agrawal</surname><given-names>N</given-names></name><name><surname>Ahn</surname><given-names>KS</given-names></name><name><surname>Ahn</surname><given-names>S-M</given-names></name><name><surname>Aikata</surname><given-names>H</given-names></name><name><surname>Akbani</surname><given-names>R</given-names></name><name><surname>Akdemir</surname><given-names>KC</given-names></name><name><surname>Al-Ahmadie</surname><given-names>H</given-names></name><name><surname>Al-Sedairy</surname><given-names>ST</given-names></name><name><surname>Al-Shahrour</surname><given-names>F</given-names></name><name><surname>Alawi</surname><given-names>M</given-names></name><name><surname>Albert</surname><given-names>M</given-names></name><name><surname>Aldape</surname><given-names>K</given-names></name><name><surname>Alexandrov</surname><given-names>LB</given-names></name><name><surname>Ally</surname><given-names>A</given-names></name><name><surname>Alsop</surname><given-names>K</given-names></name><name><surname>Alvarez</surname><given-names>EG</given-names></name><name><surname>Amary</surname><given-names>F</given-names></name><name><surname>Amin</surname><given-names>SB</given-names></name><name><surname>Aminou</surname><given-names>B</given-names></name><name><surname>Ammerpohl</surname><given-names>O</given-names></name><name><surname>Anderson</surname><given-names>MJ</given-names></name><name><surname>Ang</surname><given-names>Y</given-names></name><name><surname>Antonello</surname><given-names>D</given-names></name><name><surname>Anur</surname><given-names>P</given-names></name><name><surname>Aparicio</surname><given-names>S</given-names></name><name><surname>Appelbaum</surname><given-names>EL</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><name><surname>Aretz</surname><given-names>A</given-names></name><name><surname>Arihiro</surname><given-names>K</given-names></name><name><surname>Ariizumi</surname><given-names>S</given-names></name><name><surname>Armenia</surname><given-names>J</given-names></name><name><surname>Arnould</surname><given-names>L</given-names></name><name><surname>Asa</surname><given-names>S</given-names></name><name><surname>Assenov</surname><given-names>Y</given-names></name><name><surname>Atwal</surname><given-names>G</given-names></name><name><surname>Aukema</surname><given-names>S</given-names></name><name><surname>Auman</surname><given-names>JT</given-names></name><name><surname>Aure</surname><given-names>MRR</given-names></name><name><surname>Awadalla</surname><given-names>P</given-names></name><name><surname>Aymerich</surname><given-names>M</given-names></name><name><surname>Bader</surname><given-names>GD</given-names></name><name><surname>Baez-Ortega</surname><given-names>A</given-names></name><name><surname>Bailey</surname><given-names>MH</given-names></name><name><surname>Bailey</surname><given-names>PJ</given-names></name><name><surname>Balasundaram</surname><given-names>M</given-names></name><name><surname>Balu</surname><given-names>S</given-names></name><name><surname>Bandopadhayay</surname><given-names>P</given-names></name><name><surname>Banks</surname><given-names>RE</given-names></name><name><surname>Barbi</surname><given-names>S</given-names></name><name><surname>Barbour</surname><given-names>AP</given-names></name><name><surname>Barenboim</surname><given-names>J</given-names></name><name><surname>Barnholtz-Sloan</surname><given-names>J</given-names></name><name><surname>Barr</surname><given-names>H</given-names></name><name><surname>Barrera</surname><given-names>E</given-names></name><name><surname>Bartlett</surname><given-names>J</given-names></name><name><surname>Bartolome</surname><given-names>J</given-names></name><name><surname>Bassi</surname><given-names>C</given-names></name><name><surname>Bathe</surname><given-names>OF</given-names></name><name><surname>Baumhoer</surname><given-names>D</given-names></name><name><surname>Bavi</surname><given-names>P</given-names></name><name><surname>Baylin</surname><given-names>SB</given-names></name><name><surname>Bazant</surname><given-names>W</given-names></name><name><surname>Beardsmore</surname><given-names>D</given-names></name><name><surname>Beck</surname><given-names>TA</given-names></name><name><surname>Behjati</surname><given-names>S</given-names></name><name><surname>Behren</surname><given-names>A</given-names></name><name><surname>Niu</surname><given-names>B</given-names></name><name><surname>Bell</surname><given-names>C</given-names></name><name><surname>Beltran</surname><given-names>S</given-names></name><name><surname>Benz</surname><given-names>C</given-names></name><name><surname>Berchuck</surname><given-names>A</given-names></name><name><surname>Bergmann</surname><given-names>AK</given-names></name><name><surname>Bergstrom</surname><given-names>EN</given-names></name><name><surname>Berman</surname><given-names>BP</given-names></name><name><surname>Berney</surname><given-names>DM</given-names></name><name><surname>Bernhart</surname><given-names>SH</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name><name><surname>Berrios</surname><given-names>M</given-names></name><name><surname>Bersani</surname><given-names>S</given-names></name><name><surname>Bertl</surname><given-names>J</given-names></name><name><surname>Betancourt</surname><given-names>M</given-names></name><name><surname>Bhandari</surname><given-names>V</given-names></name><name><surname>Bhosle</surname><given-names>SG</given-names></name><name><surname>Biankin</surname><given-names>AV</given-names></name><name><surname>Bieg</surname><given-names>M</given-names></name><name><surname>Bigner</surname><given-names>D</given-names></name><name><surname>Binder</surname><given-names>H</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Birrer</surname><given-names>M</given-names></name><name><surname>Biswas</surname><given-names>NK</given-names></name><name><surname>Bjerkehagen</surname><given-names>B</given-names></name><name><surname>Bodenheimer</surname><given-names>T</given-names></name><name><surname>Boice</surname><given-names>L</given-names></name><name><surname>Bonizzato</surname><given-names>G</given-names></name><name><surname>De Bono</surname><given-names>JS</given-names></name><name><surname>Boot</surname><given-names>A</given-names></name><name><surname>Bootwalla</surname><given-names>MS</given-names></name><name><surname>Borg</surname><given-names>A</given-names></name><name><surname>Borkhardt</surname><given-names>A</given-names></name><name><surname>Boroevich</surname><given-names>KA</given-names></name><name><surname>Borozan</surname><given-names>I</given-names></name><name><surname>Borst</surname><given-names>C</given-names></name><name><surname>Bosenberg</surname><given-names>M</given-names></name><name><surname>Bosio</surname><given-names>M</given-names></name><name><surname>Boultwood</surname><given-names>J</given-names></name><name><surname>Bourque</surname><given-names>G</given-names></name><name><surname>Boutros</surname><given-names>PC</given-names></name><name><surname>Bova</surname><given-names>GS</given-names></name><name><surname>Bowen</surname><given-names>DT</given-names></name><name><surname>Bowlby</surname><given-names>R</given-names></name><name><surname>Bowtell</surname><given-names>DDL</given-names></name><name><surname>Boyault</surname><given-names>S</given-names></name><name><surname>Boyce</surname><given-names>R</given-names></name><name><surname>Boyd</surname><given-names>J</given-names></name><name><surname>Brazma</surname><given-names>A</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><name><surname>Brewer</surname><given-names>DS</given-names></name><name><surname>Brinkman</surname><given-names>AB</given-names></name><name><surname>Bristow</surname><given-names>RG</given-names></name><name><surname>Broaddus</surname><given-names>RR</given-names></name><name><surname>Brock</surname><given-names>JE</given-names></name><name><surname>Brock</surname><given-names>M</given-names></name><name><surname>Broeks</surname><given-names>A</given-names></name><name><surname>Brooks</surname><given-names>AN</given-names></name><name><surname>Brooks</surname><given-names>D</given-names></name><name><surname>Brors</surname><given-names>B</given-names></name><name><surname>Brunak</surname><given-names>S</given-names></name><name><surname>Bruxner</surname><given-names>TJC</given-names></name><name><surname>Bruzos</surname><given-names>AL</given-names></name><name><surname>Buchanan</surname><given-names>A</given-names></name><name><surname>Buchhalter</surname><given-names>I</given-names></name><name><surname>Buchholz</surname><given-names>C</given-names></name><name><surname>Bullman</surname><given-names>S</given-names></name><name><surname>Burke</surname><given-names>H</given-names></name><name><surname>Burkhardt</surname><given-names>B</given-names></name><name><surname>Burns</surname><given-names>KH</given-names></name><name><surname>Busanovich</surname><given-names>J</given-names></name><name><surname>Bustamante</surname><given-names>CD</given-names></name><name><surname>Butler</surname><given-names>AP</given-names></name><name><surname>Butte</surname><given-names>AJ</given-names></name><name><surname>Byrne</surname><given-names>NJ</given-names></name><name><surname>Børresen-Dale</surname><given-names>A-L</given-names></name><name><surname>Caesar-Johnson</surname><given-names>SJ</given-names></name><name><surname>Cafferkey</surname><given-names>A</given-names></name><name><surname>Cahill</surname><given-names>D</given-names></name><name><surname>Calabrese</surname><given-names>C</given-names></name><name><surname>Caldas</surname><given-names>C</given-names></name><name><surname>Calvo</surname><given-names>F</given-names></name><name><surname>Camacho</surname><given-names>N</given-names></name><name><surname>Campbell</surname><given-names>PJ</given-names></name><name><surname>Campo</surname><given-names>E</given-names></name><name><surname>Cantù</surname><given-names>C</given-names></name><name><surname>Cao</surname><given-names>S</given-names></name><name><surname>Carey</surname><given-names>TE</given-names></name><name><surname>Carlevaro-Fita</surname><given-names>J</given-names></name><name><surname>Carlsen</surname><given-names>R</given-names></name><name><surname>Cataldo</surname><given-names>I</given-names></name><name><surname>Cazzola</surname><given-names>M</given-names></name><name><surname>Cebon</surname><given-names>J</given-names></name><name><surname>Cerfolio</surname><given-names>R</given-names></name><name><surname>Chadwick</surname><given-names>DE</given-names></name><name><surname>Chakravarty</surname><given-names>D</given-names></name><name><surname>Chalmers</surname><given-names>D</given-names></name><name><surname>Chan</surname><given-names>CWY</given-names></name><name><surname>Chan</surname><given-names>K</given-names></name><name><surname>Chan-Seng-Yue</surname><given-names>M</given-names></name><name><surname>Chandan</surname><given-names>VS</given-names></name><name><surname>Chang</surname><given-names>DK</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><name><surname>Chantrill</surname><given-names>LA</given-names></name><name><surname>Chateigner</surname><given-names>A</given-names></name><name><surname>Chatterjee</surname><given-names>N</given-names></name><name><surname>Chayama</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>H-W</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Cherniack</surname><given-names>AD</given-names></name><name><surname>Chien</surname><given-names>J</given-names></name><name><surname>Chiew</surname><given-names>Y-E</given-names></name><name><surname>Chin</surname><given-names>S-F</given-names></name><name><surname>Cho</surname><given-names>J</given-names></name><name><surname>Cho</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>JK</given-names></name><name><surname>Choi</surname><given-names>W</given-names></name><name><surname>Chomienne</surname><given-names>C</given-names></name><name><surname>Chong</surname><given-names>Z</given-names></name><name><surname>Choo</surname><given-names>SP</given-names></name><name><surname>Chou</surname><given-names>A</given-names></name><name><surname>Christ</surname><given-names>AN</given-names></name><name><surname>Christie</surname><given-names>EL</given-names></name><name><surname>Chuah</surname><given-names>E</given-names></name><name><surname>Cibulskis</surname><given-names>C</given-names></name><name><surname>Cibulskis</surname><given-names>K</given-names></name><name><surname>Cingarlini</surname><given-names>S</given-names></name><name><surname>Clapham</surname><given-names>P</given-names></name><name><surname>Claviez</surname><given-names>A</given-names></name><name><surname>Cleary</surname><given-names>S</given-names></name><name><surname>Cloonan</surname><given-names>N</given-names></name><name><surname>Cmero</surname><given-names>M</given-names></name><name><surname>Collins</surname><given-names>CC</given-names></name><name><surname>Connor</surname><given-names>AA</given-names></name><name><surname>Cooke</surname><given-names>SL</given-names></name><name><surname>Cooper</surname><given-names>CS</given-names></name><name><surname>Cope</surname><given-names>L</given-names></name><name><surname>Corbo</surname><given-names>V</given-names></name><name><surname>Cordes</surname><given-names>MG</given-names></name><name><surname>Cordner</surname><given-names>SM</given-names></name><name><surname>Cortés-Ciriano</surname><given-names>I</given-names></name><name><surname>Covington</surname><given-names>K</given-names></name><name><surname>Cowin</surname><given-names>PA</given-names></name><name><surname>Craft</surname><given-names>B</given-names></name><name><surname>Craft</surname><given-names>D</given-names></name><name><surname>Creighton</surname><given-names>CJ</given-names></name><name><surname>Cun</surname><given-names>Y</given-names></name><name><surname>Curley</surname><given-names>E</given-names></name><name><surname>Cutcutache</surname><given-names>I</given-names></name><name><surname>Czajka</surname><given-names>K</given-names></name><name><surname>Czerniak</surname><given-names>B</given-names></name><name><surname>Dagg</surname><given-names>RA</given-names></name><name><surname>Danilova</surname><given-names>L</given-names></name><name><surname>Davi</surname><given-names>MV</given-names></name><name><surname>Davidson</surname><given-names>NR</given-names></name><name><surname>Davies</surname><given-names>H</given-names></name><name><surname>Davis</surname><given-names>IJ</given-names></name><name><surname>Davis-Dusenbery</surname><given-names>BN</given-names></name><name><surname>Dawson</surname><given-names>KJ</given-names></name><name><surname>De La Vega</surname><given-names>FM</given-names></name><name><surname>De Paoli-Iseppi</surname><given-names>R</given-names></name><name><surname>Defreitas</surname><given-names>T</given-names></name><name><surname>Tos</surname><given-names>APD</given-names></name><name><surname>Delaneau</surname><given-names>O</given-names></name><name><surname>Demchok</surname><given-names>JA</given-names></name><name><surname>Demeulemeester</surname><given-names>J</given-names></name><name><surname>Demidov</surname><given-names>GM</given-names></name><name><surname>Demircioğlu</surname><given-names>D</given-names></name><name><surname>Dennis</surname><given-names>NM</given-names></name><name><surname>Denroche</surname><given-names>RE</given-names></name><name><surname>Dentro</surname><given-names>SC</given-names></name><name><surname>Desai</surname><given-names>N</given-names></name><name><surname>Deshpande</surname><given-names>V</given-names></name><name><surname>Deshwar</surname><given-names>AG</given-names></name><name><surname>Desmedt</surname><given-names>C</given-names></name><name><surname>Deu-Pons</surname><given-names>J</given-names></name><name><surname>Dhalla</surname><given-names>N</given-names></name><name><surname>Dhani</surname><given-names>NC</given-names></name><name><surname>Dhingra</surname><given-names>P</given-names></name><name><surname>Dhir</surname><given-names>R</given-names></name><name><surname>DiBiase</surname><given-names>A</given-names></name><name><surname>Diamanti</surname><given-names>K</given-names></name><name><surname>Ding</surname><given-names>L</given-names></name><name><surname>Ding</surname><given-names>S</given-names></name><name><surname>Dinh</surname><given-names>HQ</given-names></name><name><surname>Dirix</surname><given-names>L</given-names></name><name><surname>Doddapaneni</surname><given-names>H</given-names></name><name><surname>Donmez</surname><given-names>N</given-names></name><name><surname>Dow</surname><given-names>MT</given-names></name><name><surname>Drapkin</surname><given-names>R</given-names></name><name><surname>Drechsel</surname><given-names>O</given-names></name><name><surname>Drews</surname><given-names>RM</given-names></name><name><surname>Serge</surname><given-names>S</given-names></name><name><surname>Dudderidge</surname><given-names>T</given-names></name><name><surname>Dueso-Barroso</surname><given-names>A</given-names></name><name><surname>Dunford</surname><given-names>AJ</given-names></name><name><surname>Dunn</surname><given-names>M</given-names></name><name><surname>Dursi</surname><given-names>LJ</given-names></name><name><surname>Duthie</surname><given-names>FR</given-names></name><name><surname>Dutton-Regester</surname><given-names>K</given-names></name><name><surname>Eagles</surname><given-names>J</given-names></name><name><surname>Easton</surname><given-names>DF</given-names></name><name><surname>Edmonds</surname><given-names>S</given-names></name><name><surname>Edwards</surname><given-names>PA</given-names></name><name><surname>Edwards</surname><given-names>SE</given-names></name><name><surname>Eeles</surname><given-names>RA</given-names></name><name><surname>Ehinger</surname><given-names>A</given-names></name><name><surname>Eils</surname><given-names>J</given-names></name><name><surname>Eils</surname><given-names>R</given-names></name><name><surname>El-Naggar</surname><given-names>A</given-names></name><name><surname>Eldridge</surname><given-names>M</given-names></name><name><surname>Ellrott</surname><given-names>K</given-names></name><name><surname>Erkek</surname><given-names>S</given-names></name><name><surname>Escaramis</surname><given-names>G</given-names></name><name><surname>Espiritu</surname><given-names>SMG</given-names></name><name><surname>Estivill</surname><given-names>X</given-names></name><name><surname>Etemadmoghadam</surname><given-names>D</given-names></name><name><surname>Eyfjord</surname><given-names>JE</given-names></name><name><surname>Faltas</surname><given-names>BM</given-names></name><name><surname>Fan</surname><given-names>D</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Faquin</surname><given-names>WC</given-names></name><name><surname>Farcas</surname><given-names>C</given-names></name><name><surname>Fassan</surname><given-names>M</given-names></name><name><surname>Fatima</surname><given-names>A</given-names></name><name><surname>Favero</surname><given-names>F</given-names></name><name><surname>Fayzullaev</surname><given-names>N</given-names></name><name><surname>Felau</surname><given-names>I</given-names></name><name><surname>Fereday</surname><given-names>S</given-names></name><name><surname>Ferguson</surname><given-names>ML</given-names></name><name><surname>Ferretti</surname><given-names>V</given-names></name><name><surname>Feuerbach</surname><given-names>L</given-names></name><name><surname>Field</surname><given-names>MA</given-names></name><name><surname>Fink</surname><given-names>JL</given-names></name><name><surname>Finocchiaro</surname><given-names>G</given-names></name><name><surname>Fisher</surname><given-names>C</given-names></name><name><surname>Fittall</surname><given-names>MW</given-names></name><name><surname>Fitzgerald</surname><given-names>A</given-names></name><name><surname>Fitzgerald</surname><given-names>RC</given-names></name><name><surname>Flanagan</surname><given-names>AM</given-names></name><name><surname>Fleshner</surname><given-names>NE</given-names></name><name><surname>Flicek</surname><given-names>P</given-names></name><name><surname>Foekens</surname><given-names>JA</given-names></name><name><surname>Fong</surname><given-names>KM</given-names></name><name><surname>Fonseca</surname><given-names>NA</given-names></name><name><surname>Foster</surname><given-names>CS</given-names></name><name><surname>Fox</surname><given-names>NS</given-names></name><name><surname>Fraser</surname><given-names>M</given-names></name><name><surname>Frazer</surname><given-names>S</given-names></name><name><surname>Frenkel-Morgenstern</surname><given-names>M</given-names></name><name><surname>Friedman</surname><given-names>W</given-names></name><name><surname>Frigola</surname><given-names>J</given-names></name><name><surname>Fronick</surname><given-names>CC</given-names></name><name><surname>Fujimoto</surname><given-names>A</given-names></name><name><surname>Fujita</surname><given-names>M</given-names></name><name><surname>Fukayama</surname><given-names>M</given-names></name><name><surname>Fulton</surname><given-names>LA</given-names></name><name><surname>Fulton</surname><given-names>RS</given-names></name><name><surname>Furuta</surname><given-names>M</given-names></name><name><surname>Futreal</surname><given-names>PA</given-names></name><name><surname>Füllgrabe</surname><given-names>A</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Gallinger</surname><given-names>S</given-names></name><name><surname>Gambacorti-Passerini</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Garraway</surname><given-names>L</given-names></name><name><surname>Garred</surname><given-names>Ø</given-names></name><name><surname>Garrison</surname><given-names>E</given-names></name><name><surname>Garsed</surname><given-names>DW</given-names></name><name><surname>Gehlenborg</surname><given-names>N</given-names></name><name><surname>Gelpi</surname><given-names>JLL</given-names></name><name><surname>George</surname><given-names>J</given-names></name><name><surname>Gerhard</surname><given-names>DS</given-names></name><name><surname>Gerhauser</surname><given-names>C</given-names></name><name><surname>Gershenwald</surname><given-names>JE</given-names></name><name><surname>Gerstein</surname><given-names>M</given-names></name><name><surname>Gerstung</surname><given-names>M</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Ghori</surname><given-names>M</given-names></name><name><surname>Ghossein</surname><given-names>R</given-names></name><name><surname>Giama</surname><given-names>NH</given-names></name><name><surname>Gibbs</surname><given-names>RA</given-names></name><name><surname>Gibson</surname><given-names>B</given-names></name><name><surname>Gill</surname><given-names>AJ</given-names></name><name><surname>Gill</surname><given-names>P</given-names></name><name><surname>Giri</surname><given-names>DD</given-names></name><name><surname>Glodzik</surname><given-names>D</given-names></name><name><surname>Gnanapragasam</surname><given-names>VJ</given-names></name><name><surname>Goebler</surname><given-names>ME</given-names></name><name><surname>Goldman</surname><given-names>MJ</given-names></name><name><surname>Gomez</surname><given-names>C</given-names></name><name><surname>Gonzalez</surname><given-names>S</given-names></name><name><surname>Gonzalez-Perez</surname><given-names>A</given-names></name><name><surname>Gordenin</surname><given-names>DA</given-names></name><name><surname>Gossage</surname><given-names>J</given-names></name><name><surname>Gotoh</surname><given-names>K</given-names></name><name><surname>Govindan</surname><given-names>R</given-names></name><name><surname>Grabau</surname><given-names>D</given-names></name><name><surname>Graham</surname><given-names>JS</given-names></name><name><surname>Grant</surname><given-names>RC</given-names></name><name><surname>Green</surname><given-names>AR</given-names></name><name><surname>Green</surname><given-names>E</given-names></name><name><surname>Greger</surname><given-names>L</given-names></name><name><surname>Grehan</surname><given-names>N</given-names></name><name><surname>Grimaldi</surname><given-names>S</given-names></name><name><surname>Grimmond</surname><given-names>SM</given-names></name><name><surname>Grossman</surname><given-names>RL</given-names></name><name><surname>Grundhoff</surname><given-names>A</given-names></name><name><surname>Gundem</surname><given-names>G</given-names></name><name><surname>Guo</surname><given-names>Q</given-names></name><name><surname>Gupta</surname><given-names>M</given-names></name><name><surname>Gupta</surname><given-names>S</given-names></name><name><surname>Gut</surname><given-names>IG</given-names></name><name><surname>Gut</surname><given-names>M</given-names></name><name><surname>Göke</surname><given-names>J</given-names></name><name><surname>Ha</surname><given-names>G</given-names></name><name><surname>Haake</surname><given-names>A</given-names></name><name><surname>Haan</surname><given-names>D</given-names></name><name><surname>Haas</surname><given-names>S</given-names></name><name><surname>Haase</surname><given-names>K</given-names></name><name><surname>Haber</surname><given-names>JE</given-names></name><name><surname>Habermann</surname><given-names>N</given-names></name><name><surname>Hach</surname><given-names>F</given-names></name><name><surname>Haider</surname><given-names>S</given-names></name><name><surname>Hama</surname><given-names>N</given-names></name><name><surname>Hamdy</surname><given-names>FC</given-names></name><name><surname>Hamilton</surname><given-names>A</given-names></name><name><surname>Hamilton</surname><given-names>MP</given-names></name><name><surname>Han</surname><given-names>L</given-names></name><name><surname>Hanna</surname><given-names>GB</given-names></name><name><surname>Hansmann</surname><given-names>M</given-names></name><name><surname>Haradhvala</surname><given-names>NJ</given-names></name><name><surname>Harismendy</surname><given-names>O</given-names></name><name><surname>Harliwong</surname><given-names>I</given-names></name><name><surname>Harmanci</surname><given-names>AO</given-names></name><name><surname>Harrington</surname><given-names>E</given-names></name><name><surname>Hasegawa</surname><given-names>T</given-names></name><name><surname>Haussler</surname><given-names>D</given-names></name><name><surname>Hawkins</surname><given-names>S</given-names></name><name><surname>Hayami</surname><given-names>S</given-names></name><name><surname>Hayashi</surname><given-names>S</given-names></name><name><surname>Hayes</surname><given-names>DN</given-names></name><name><surname>Hayes</surname><given-names>SJ</given-names></name><name><surname>Hayward</surname><given-names>NK</given-names></name><name><surname>Hazell</surname><given-names>S</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Heath</surname><given-names>AP</given-names></name><name><surname>Heath</surname><given-names>SC</given-names></name><name><surname>Hedley</surname><given-names>D</given-names></name><name><surname>Hegde</surname><given-names>AM</given-names></name><name><surname>Heiman</surname><given-names>DI</given-names></name><name><surname>Heinold</surname><given-names>MC</given-names></name><name><surname>Heins</surname><given-names>Z</given-names></name><name><surname>Heisler</surname><given-names>LE</given-names></name><name><surname>Hellstrom-Lindberg</surname><given-names>E</given-names></name><name><surname>Helmy</surname><given-names>M</given-names></name><name><surname>Heo</surname><given-names>SG</given-names></name><name><surname>Hepperla</surname><given-names>AJ</given-names></name><name><surname>Heredia-Genestar</surname><given-names>JM</given-names></name><name><surname>Herrmann</surname><given-names>C</given-names></name><name><surname>Hersey</surname><given-names>P</given-names></name><name><surname>Hess</surname><given-names>JM</given-names></name><name><surname>Hilmarsdottir</surname><given-names>H</given-names></name><name><surname>Hinton</surname><given-names>J</given-names></name><name><surname>Hirano</surname><given-names>S</given-names></name><name><surname>Hiraoka</surname><given-names>N</given-names></name><name><surname>Hoadley</surname><given-names>KA</given-names></name><name><surname>Hobolth</surname><given-names>A</given-names></name><name><surname>Hodzic</surname><given-names>E</given-names></name><name><surname>Hoell</surname><given-names>JI</given-names></name><name><surname>Hoffmann</surname><given-names>S</given-names></name><name><surname>Hofmann</surname><given-names>O</given-names></name><name><surname>Holbrook</surname><given-names>A</given-names></name><name><surname>Holik</surname><given-names>AZ</given-names></name><name><surname>Hollingsworth</surname><given-names>MA</given-names></name><name><surname>Holmes</surname><given-names>O</given-names></name><name><surname>Holt</surname><given-names>RA</given-names></name><name><surname>Hong</surname><given-names>C</given-names></name><name><surname>Hong</surname><given-names>EP</given-names></name><name><surname>Hong</surname><given-names>JH</given-names></name><name><surname>Hooijer</surname><given-names>GK</given-names></name><name><surname>Hornshøj</surname><given-names>H</given-names></name><name><surname>Hosoda</surname><given-names>F</given-names></name><name><surname>Hou</surname><given-names>Y</given-names></name><name><surname>Hovestadt</surname><given-names>V</given-names></name><name><surname>Howat</surname><given-names>W</given-names></name><name><surname>Hoyle</surname><given-names>AP</given-names></name><name><surname>Hruban</surname><given-names>RH</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Hua</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>MN</given-names></name><name><surname>Huang</surname><given-names>V</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Hudson</surname><given-names>TJ</given-names></name><name><surname>Hummel</surname><given-names>M</given-names></name><name><surname>Hung</surname><given-names>JA</given-names></name><name><surname>Huntsman</surname><given-names>D</given-names></name><name><surname>Hupp</surname><given-names>TR</given-names></name><name><surname>Huse</surname><given-names>J</given-names></name><name><surname>Huska</surname><given-names>MR</given-names></name><name><surname>Hutter</surname><given-names>B</given-names></name><name><surname>Hutter</surname><given-names>CM</given-names></name><name><surname>Hübschmann</surname><given-names>D</given-names></name><name><surname>Iacobuzio-Donahue</surname><given-names>CA</given-names></name><name><surname>Imbusch</surname><given-names>CD</given-names></name><name><surname>Imielinski</surname><given-names>M</given-names></name><name><surname>Imoto</surname><given-names>S</given-names></name><name><surname>Isaacs</surname><given-names>WB</given-names></name><name><surname>Isaev</surname><given-names>K</given-names></name><name><surname>Ishikawa</surname><given-names>S</given-names></name><name><surname>Iskar</surname><given-names>M</given-names></name><name><surname>Islam</surname><given-names>SMA</given-names></name><name><surname>Ittmann</surname><given-names>M</given-names></name><name><surname>Ivkovic</surname><given-names>S</given-names></name><name><surname>Izarzugaza</surname><given-names>JMG</given-names></name><name><surname>Jacquemier</surname><given-names>J</given-names></name><name><surname>Jakrot</surname><given-names>V</given-names></name><name><surname>Jamieson</surname><given-names>NB</given-names></name><name><surname>Jang</surname><given-names>GH</given-names></name><name><surname>Jang</surname><given-names>SJ</given-names></name><name><surname>Jayaseelan</surname><given-names>JC</given-names></name><name><surname>Jayasinghe</surname><given-names>R</given-names></name><name><surname>Jefferys</surname><given-names>SR</given-names></name><name><surname>Jegalian</surname><given-names>K</given-names></name><name><surname>Jennings</surname><given-names>JL</given-names></name><name><surname>Jeon</surname><given-names>S-H</given-names></name><name><surname>Jerman</surname><given-names>L</given-names></name><name><surname>Ji</surname><given-names>Y</given-names></name><name><surname>Jiao</surname><given-names>W</given-names></name><name><surname>Johansson</surname><given-names>PA</given-names></name><name><surname>Johns</surname><given-names>AL</given-names></name><name><surname>Johns</surname><given-names>J</given-names></name><name><surname>Johnson</surname><given-names>R</given-names></name><name><surname>Johnson</surname><given-names>TA</given-names></name><name><surname>Jolly</surname><given-names>C</given-names></name><name><surname>Joly</surname><given-names>Y</given-names></name><name><surname>Jonasson</surname><given-names>JG</given-names></name><name><surname>Jones</surname><given-names>CD</given-names></name><name><surname>Jones</surname><given-names>DR</given-names></name><name><surname>Jones</surname><given-names>DTW</given-names></name><name><surname>Jones</surname><given-names>N</given-names></name><name><surname>Jones</surname><given-names>SJM</given-names></name><name><surname>Jonkers</surname><given-names>J</given-names></name><name><surname>Ju</surname><given-names>YS</given-names></name><name><surname>Juhl</surname><given-names>H</given-names></name><name><surname>Jung</surname><given-names>J</given-names></name><name><surname>Juul</surname><given-names>M</given-names></name><name><surname>Juul</surname><given-names>RI</given-names></name><name><surname>Juul</surname><given-names>S</given-names></name><name><surname>Jäger</surname><given-names>N</given-names></name><name><surname>Kabbe</surname><given-names>R</given-names></name><name><surname>Kahles</surname><given-names>A</given-names></name><name><surname>Kahraman</surname><given-names>A</given-names></name><name><surname>Kaiser</surname><given-names>VB</given-names></name><name><surname>Kakavand</surname><given-names>H</given-names></name><name><surname>Kalimuthu</surname><given-names>S</given-names></name><name><surname>von Kalle</surname><given-names>C</given-names></name><name><surname>Kang</surname><given-names>KJ</given-names></name><name><surname>Karaszi</surname><given-names>K</given-names></name><name><surname>Karlan</surname><given-names>B</given-names></name><name><surname>Karlić</surname><given-names>R</given-names></name><name><surname>Karsch</surname><given-names>D</given-names></name><name><surname>Kasaian</surname><given-names>K</given-names></name><name><surname>Kassahn</surname><given-names>KS</given-names></name><name><surname>Katai</surname><given-names>H</given-names></name><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Katoh</surname><given-names>H</given-names></name><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Kay</surname><given-names>JD</given-names></name><name><surname>Kazakoff</surname><given-names>SH</given-names></name><name><surname>Kazanov</surname><given-names>MD</given-names></name><name><surname>Keays</surname><given-names>M</given-names></name><name><surname>Kebebew</surname><given-names>E</given-names></name><name><surname>Kefford</surname><given-names>RF</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Kench</surname><given-names>JG</given-names></name><name><surname>Kennedy</surname><given-names>CJ</given-names></name><name><surname>Kerssemakers</surname><given-names>JNA</given-names></name><name><surname>Khoo</surname><given-names>D</given-names></name><name><surname>Khoo</surname><given-names>V</given-names></name><name><surname>Khuntikeo</surname><given-names>N</given-names></name><name><surname>Khurana</surname><given-names>E</given-names></name><name><surname>Kilpinen</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Kim</surname><given-names>H-L</given-names></name><name><surname>Kim</surname><given-names>H-Y</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>King</surname><given-names>TA</given-names></name><name><surname>Klapper</surname><given-names>W</given-names></name><name><surname>Kleinheinz</surname><given-names>K</given-names></name><name><surname>Klimczak</surname><given-names>LJ</given-names></name><name><surname>Knappskog</surname><given-names>S</given-names></name><name><surname>Kneba</surname><given-names>M</given-names></name><name><surname>Knoppers</surname><given-names>BM</given-names></name><name><surname>Koh</surname><given-names>Y</given-names></name><name><surname>Komorowski</surname><given-names>J</given-names></name><name><surname>Komura</surname><given-names>D</given-names></name><name><surname>Komura</surname><given-names>M</given-names></name><name><surname>Kong</surname><given-names>G</given-names></name><name><surname>Kool</surname><given-names>M</given-names></name><name><surname>Korbel</surname><given-names>JO</given-names></name><name><surname>Korchina</surname><given-names>V</given-names></name><name><surname>Korshunov</surname><given-names>A</given-names></name><name><surname>Koscher</surname><given-names>M</given-names></name><name><surname>Koster</surname><given-names>R</given-names></name><name><surname>Kote-Jarai</surname><given-names>Z</given-names></name><name><surname>Koures</surname><given-names>A</given-names></name><name><surname>Kovacevic</surname><given-names>M</given-names></name><name><surname>Kremeyer</surname><given-names>B</given-names></name><name><surname>Kretzmer</surname><given-names>H</given-names></name><name><surname>Kreuz</surname><given-names>M</given-names></name><name><surname>Krishnamurthy</surname><given-names>S</given-names></name><name><surname>Kube</surname><given-names>D</given-names></name><name><surname>Kumar</surname><given-names>K</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Kumar</surname><given-names>Y</given-names></name><name><surname>Kundra</surname><given-names>R</given-names></name><name><surname>Kübler</surname><given-names>K</given-names></name><name><surname>Küppers</surname><given-names>R</given-names></name><name><surname>Lagergren</surname><given-names>J</given-names></name><name><surname>Lai</surname><given-names>PH</given-names></name><name><surname>Laird</surname><given-names>PW</given-names></name><name><surname>Lakhani</surname><given-names>SR</given-names></name><name><surname>Lalansingh</surname><given-names>CM</given-names></name><name><surname>Lalonde</surname><given-names>E</given-names></name><name><surname>Lamaze</surname><given-names>FC</given-names></name><name><surname>Lambert</surname><given-names>A</given-names></name><name><surname>Lander</surname><given-names>E</given-names></name><name><surname>Landgraf</surname><given-names>P</given-names></name><name><surname>Landoni</surname><given-names>L</given-names></name><name><surname>Langerød</surname><given-names>A</given-names></name><name><surname>Lanzós</surname><given-names>A</given-names></name><name><surname>Larsimont</surname><given-names>D</given-names></name><name><surname>Larsson</surname><given-names>E</given-names></name><name><surname>Lathrop</surname><given-names>M</given-names></name><name><surname>Lau</surname><given-names>LMS</given-names></name><name><surname>Lawerenz</surname><given-names>C</given-names></name><name><surname>Lawlor</surname><given-names>RT</given-names></name><name><surname>Lawrence</surname><given-names>MS</given-names></name><name><surname>Lazar</surname><given-names>AJ</given-names></name><name><surname>Lazic</surname><given-names>AM</given-names></name><name><surname>Le</surname><given-names>X</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>EA</given-names></name><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>JJ-K</given-names></name><name><surname>Lee</surname><given-names>J-Y</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>MTM</given-names></name><name><surname>Lee-Six</surname><given-names>H</given-names></name><name><surname>Lehmann</surname><given-names>K-V</given-names></name><name><surname>Lehrach</surname><given-names>H</given-names></name><name><surname>Lenze</surname><given-names>D</given-names></name><name><surname>Leonard</surname><given-names>CR</given-names></name><name><surname>Leongamornlert</surname><given-names>DA</given-names></name><name><surname>Leshchiner</surname><given-names>I</given-names></name><name><surname>Letourneau</surname><given-names>L</given-names></name><name><surname>Letunic</surname><given-names>I</given-names></name><name><surname>Levine</surname><given-names>DA</given-names></name><name><surname>Lewis</surname><given-names>L</given-names></name><name><surname>Ley</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>CH</given-names></name><name><surname>Li</surname><given-names>HI</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Liang</surname><given-names>S-B</given-names></name><name><surname>Lichter</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>P</given-names></name><name><surname>Lin</surname><given-names>Z</given-names></name><name><surname>Linehan</surname><given-names>WM</given-names></name><name><surname>Lingjærde</surname><given-names>OC</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>EM</given-names></name><name><surname>Liu</surname><given-names>F-FF</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Livingstone</surname><given-names>J</given-names></name><name><surname>Livitz</surname><given-names>D</given-names></name><name><surname>Livni</surname><given-names>N</given-names></name><name><surname>Lochovsky</surname><given-names>L</given-names></name><name><surname>Loeffler</surname><given-names>M</given-names></name><name><surname>Long</surname><given-names>GV</given-names></name><name><surname>Lopez-Guillermo</surname><given-names>A</given-names></name><name><surname>Lou</surname><given-names>S</given-names></name><name><surname>Louis</surname><given-names>DN</given-names></name><name><surname>Lovat</surname><given-names>LB</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Y-J</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Luchini</surname><given-names>C</given-names></name><name><surname>Lungu</surname><given-names>I</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name><name><surname>Luxton</surname><given-names>HJ</given-names></name><name><surname>Lynch</surname><given-names>AG</given-names></name><name><surname>Lype</surname><given-names>L</given-names></name><name><surname>López</surname><given-names>C</given-names></name><name><surname>López-Otín</surname><given-names>C</given-names></name><name><surname>Ma</surname><given-names>EZ</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>MacGrogan</surname><given-names>G</given-names></name><name><surname>MacRae</surname><given-names>S</given-names></name><name><surname>Macintyre</surname><given-names>G</given-names></name><name><surname>Madsen</surname><given-names>T</given-names></name><name><surname>Maejima</surname><given-names>K</given-names></name><name><surname>Mafficini</surname><given-names>A</given-names></name><name><surname>Maglinte</surname><given-names>DT</given-names></name><name><surname>Maitra</surname><given-names>A</given-names></name><name><surname>Majumder</surname><given-names>PP</given-names></name><name><surname>Malcovati</surname><given-names>L</given-names></name><name><surname>Malikic</surname><given-names>S</given-names></name><name><surname>Malleo</surname><given-names>G</given-names></name><name><surname>Mann</surname><given-names>GJ</given-names></name><name><surname>Mantovani-Löffler</surname><given-names>L</given-names></name><name><surname>Marchal</surname><given-names>K</given-names></name><name><surname>Marchegiani</surname><given-names>G</given-names></name><name><surname>Mardis</surname><given-names>ER</given-names></name><name><surname>Margolin</surname><given-names>AA</given-names></name><name><surname>Marin</surname><given-names>MG</given-names></name><name><surname>Markowetz</surname><given-names>F</given-names></name><name><surname>Markowski</surname><given-names>J</given-names></name><name><surname>Marks</surname><given-names>J</given-names></name><name><surname>Marques-Bonet</surname><given-names>T</given-names></name><name><surname>Marra</surname><given-names>MA</given-names></name><name><surname>Marsden</surname><given-names>L</given-names></name><name><surname>Martens</surname><given-names>JWM</given-names></name><name><surname>Martin</surname><given-names>S</given-names></name><name><surname>Martin-Subero</surname><given-names>JI</given-names></name><name><surname>Martincorena</surname><given-names>I</given-names></name><name><surname>Martinez-Fundichely</surname><given-names>A</given-names></name><name><surname>Maruvka</surname><given-names>YE</given-names></name><name><surname>Mashl</surname><given-names>RJ</given-names></name><name><surname>Massie</surname><given-names>CE</given-names></name><name><surname>Matthew</surname><given-names>TJ</given-names></name><name><surname>Matthews</surname><given-names>L</given-names></name><name><surname>Mayer</surname><given-names>E</given-names></name><name><surname>Mayes</surname><given-names>S</given-names></name><name><surname>Mayo</surname><given-names>M</given-names></name><name><surname>Mbabaali</surname><given-names>F</given-names></name><name><surname>McCune</surname><given-names>K</given-names></name><name><surname>McDermott</surname><given-names>U</given-names></name><name><surname>McGillivray</surname><given-names>PD</given-names></name><name><surname>McLellan</surname><given-names>MD</given-names></name><name><surname>McPherson</surname><given-names>JD</given-names></name><name><surname>McPherson</surname><given-names>JR</given-names></name><name><surname>McPherson</surname><given-names>TA</given-names></name><name><surname>Meier</surname><given-names>SR</given-names></name><name><surname>Meng</surname><given-names>A</given-names></name><name><surname>Meng</surname><given-names>S</given-names></name><name><surname>Menzies</surname><given-names>A</given-names></name><name><surname>Merrett</surname><given-names>ND</given-names></name><name><surname>Merson</surname><given-names>S</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Meyerson</surname><given-names>W</given-names></name><name><surname>Mieczkowski</surname><given-names>PA</given-names></name><name><surname>Mihaiescu</surname><given-names>GL</given-names></name><name><surname>Mijalkovic</surname><given-names>S</given-names></name><name><surname>Mikkelsen</surname><given-names>T</given-names></name><name><surname>Milella</surname><given-names>M</given-names></name><name><surname>Mileshkin</surname><given-names>L</given-names></name><name><surname>Miller</surname><given-names>CA</given-names></name><name><surname>Miller</surname><given-names>DK</given-names></name><name><surname>Miller</surname><given-names>JK</given-names></name><name><surname>Mills</surname><given-names>GB</given-names></name><name><surname>Milovanovic</surname><given-names>A</given-names></name><name><surname>Minner</surname><given-names>S</given-names></name><name><surname>Miotto</surname><given-names>M</given-names></name><name><surname>Arnau</surname><given-names>GM</given-names></name><name><surname>Mirabello</surname><given-names>L</given-names></name><name><surname>Mitchell</surname><given-names>C</given-names></name><name><surname>Mitchell</surname><given-names>TJ</given-names></name><name><surname>Miyano</surname><given-names>S</given-names></name><name><surname>Miyoshi</surname><given-names>N</given-names></name><name><surname>Mizuno</surname><given-names>S</given-names></name><name><surname>Molnár-Gábor</surname><given-names>F</given-names></name><name><surname>Moore</surname><given-names>MJ</given-names></name><name><surname>Moore</surname><given-names>RA</given-names></name><name><surname>Morganella</surname><given-names>S</given-names></name><name><surname>Morris</surname><given-names>QD</given-names></name><name><surname>Morrison</surname><given-names>C</given-names></name><name><surname>Mose</surname><given-names>LE</given-names></name><name><surname>Moser</surname><given-names>CD</given-names></name><name><surname>Muiños</surname><given-names>F</given-names></name><name><surname>Mularoni</surname><given-names>L</given-names></name><name><surname>Mungall</surname><given-names>AJ</given-names></name><name><surname>Mungall</surname><given-names>K</given-names></name><name><surname>Musgrove</surname><given-names>EA</given-names></name><name><surname>Mustonen</surname><given-names>V</given-names></name><name><surname>Mutch</surname><given-names>D</given-names></name><name><surname>Muyas</surname><given-names>F</given-names></name><name><surname>Muzny</surname><given-names>DM</given-names></name><name><surname>Muñoz</surname><given-names>A</given-names></name><name><surname>Myers</surname><given-names>J</given-names></name><name><surname>Myklebost</surname><given-names>O</given-names></name><name><surname>Möller</surname><given-names>P</given-names></name><name><surname>Nagae</surname><given-names>G</given-names></name><name><surname>Nagrial</surname><given-names>AM</given-names></name><name><surname>Nahal-Bose</surname><given-names>HK</given-names></name><name><surname>Nakagama</surname><given-names>H</given-names></name><name><surname>Nakagawa</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>H</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Nakano</surname><given-names>K</given-names></name><name><surname>Nandi</surname><given-names>T</given-names></name><name><surname>Nangalia</surname><given-names>J</given-names></name><name><surname>Nastic</surname><given-names>M</given-names></name><name><surname>Navarro</surname><given-names>A</given-names></name><name><surname>Navarro</surname><given-names>FCP</given-names></name><name><surname>Neal</surname><given-names>DE</given-names></name><name><surname>Nettekoven</surname><given-names>G</given-names></name><name><surname>Newell</surname><given-names>F</given-names></name><name><surname>Newhouse</surname><given-names>SJ</given-names></name><name><surname>Newton</surname><given-names>Y</given-names></name><name><surname>Ng</surname><given-names>AWT</given-names></name><name><surname>Ng</surname><given-names>A</given-names></name><name><surname>Nicholson</surname><given-names>J</given-names></name><name><surname>Nicol</surname><given-names>D</given-names></name><name><surname>Nie</surname><given-names>Y</given-names></name><name><surname>Nielsen</surname><given-names>GP</given-names></name><name><surname>Nielsen</surname><given-names>MM</given-names></name><name><surname>Nik-Zainal</surname><given-names>S</given-names></name><name><surname>Noble</surname><given-names>MS</given-names></name><name><surname>Nones</surname><given-names>K</given-names></name><name><surname>Northcott</surname><given-names>PA</given-names></name><name><surname>Notta</surname><given-names>F</given-names></name><name><surname>O’Connor</surname><given-names>BD</given-names></name><name><surname>O’Donnell</surname><given-names>P</given-names></name><name><surname>O’Donovan</surname><given-names>M</given-names></name><name><surname>O’Meara</surname><given-names>S</given-names></name><name><surname>O’Neill</surname><given-names>BP</given-names></name><name><surname>O’Neill</surname><given-names>JR</given-names></name><name><surname>Ocana</surname><given-names>D</given-names></name><name><surname>Ochoa</surname><given-names>A</given-names></name><name><surname>Oesper</surname><given-names>L</given-names></name><name><surname>Ogden</surname><given-names>C</given-names></name><name><surname>Ohdan</surname><given-names>H</given-names></name><name><surname>Ohi</surname><given-names>K</given-names></name><name><surname>Ohno-Machado</surname><given-names>L</given-names></name><name><surname>Oien</surname><given-names>KA</given-names></name><name><surname>Ojesina</surname><given-names>AI</given-names></name><name><surname>Ojima</surname><given-names>H</given-names></name><name><surname>Okusaka</surname><given-names>T</given-names></name><name><surname>Omberg</surname><given-names>L</given-names></name><name><surname>Ong</surname><given-names>CK</given-names></name><name><surname>Ossowski</surname><given-names>S</given-names></name><name><surname>Ott</surname><given-names>G</given-names></name><name><surname>Ouellette</surname><given-names>BFF</given-names></name><name><surname>P’ng</surname><given-names>C</given-names></name><name><surname>Paczkowska</surname><given-names>M</given-names></name><name><surname>Paiella</surname><given-names>S</given-names></name><name><surname>Pairojkul</surname><given-names>C</given-names></name><name><surname>Pajic</surname><given-names>M</given-names></name><name><surname>Pan-Hammarström</surname><given-names>Q</given-names></name><name><surname>Papaemmanuil</surname><given-names>E</given-names></name><name><surname>Papatheodorou</surname><given-names>I</given-names></name><name><surname>Paramasivam</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Park</surname><given-names>J-W</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>PJ</given-names></name><name><surname>Parker</surname><given-names>JS</given-names></name><name><surname>Parsons</surname><given-names>SL</given-names></name><name><surname>Pass</surname><given-names>H</given-names></name><name><surname>Pasternack</surname><given-names>D</given-names></name><name><surname>Pastore</surname><given-names>A</given-names></name><name><surname>Patch</surname><given-names>A-M</given-names></name><name><surname>Pauporté</surname><given-names>I</given-names></name><name><surname>Pea</surname><given-names>A</given-names></name><name><surname>Pearson</surname><given-names>JV</given-names></name><name><surname>Pedamallu</surname><given-names>CS</given-names></name><name><surname>Pedersen</surname><given-names>JS</given-names></name><name><surname>Pederzoli</surname><given-names>P</given-names></name><name><surname>Peifer</surname><given-names>M</given-names></name><name><surname>Pennell</surname><given-names>NA</given-names></name><name><surname>Perou</surname><given-names>CM</given-names></name><name><surname>Perry</surname><given-names>MD</given-names></name><name><surname>Petersen</surname><given-names>GM</given-names></name><name><surname>Peto</surname><given-names>M</given-names></name><name><surname>Petrelli</surname><given-names>N</given-names></name><name><surname>Petryszak</surname><given-names>R</given-names></name><name><surname>Pfister</surname><given-names>SM</given-names></name><name><surname>Phillips</surname><given-names>M</given-names></name><name><surname>Pich</surname><given-names>O</given-names></name><name><surname>Pickett</surname><given-names>HA</given-names></name><name><surname>Pihl</surname><given-names>TD</given-names></name><name><surname>Pillay</surname><given-names>N</given-names></name><name><surname>Pinder</surname><given-names>S</given-names></name><name><surname>Pinese</surname><given-names>M</given-names></name><name><surname>Pinho</surname><given-names>AV</given-names></name><name><surname>Pitkänen</surname><given-names>E</given-names></name><name><surname>Pivot</surname><given-names>X</given-names></name><name><surname>Piñeiro-Yáñez</surname><given-names>E</given-names></name><name><surname>Planko</surname><given-names>L</given-names></name><name><surname>Plass</surname><given-names>C</given-names></name><name><surname>Polak</surname><given-names>P</given-names></name><name><surname>Pons</surname><given-names>T</given-names></name><name><surname>Popescu</surname><given-names>I</given-names></name><name><surname>Potapova</surname><given-names>O</given-names></name><name><surname>Prasad</surname><given-names>A</given-names></name><name><surname>Preston</surname><given-names>SR</given-names></name><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Pritchard</surname><given-names>AL</given-names></name><name><surname>Prokopec</surname><given-names>SD</given-names></name><name><surname>Provenzano</surname><given-names>E</given-names></name><name><surname>Puente</surname><given-names>XS</given-names></name><name><surname>Puig</surname><given-names>S</given-names></name><name><surname>Puiggròs</surname><given-names>M</given-names></name><name><surname>Pulido-Tamayo</surname><given-names>S</given-names></name><name><surname>Pupo</surname><given-names>GM</given-names></name><name><surname>Purdie</surname><given-names>CA</given-names></name><name><surname>Quinn</surname><given-names>MC</given-names></name><name><surname>Rabionet</surname><given-names>R</given-names></name><name><surname>Rader</surname><given-names>JS</given-names></name><name><surname>Radlwimmer</surname><given-names>B</given-names></name><name><surname>Radovic</surname><given-names>P</given-names></name><name><surname>Raeder</surname><given-names>B</given-names></name><name><surname>Raine</surname><given-names>KM</given-names></name><name><surname>Ramakrishna</surname><given-names>M</given-names></name><name><surname>Ramakrishnan</surname><given-names>K</given-names></name><name><surname>Ramalingam</surname><given-names>S</given-names></name><name><surname>Raphael</surname><given-names>BJ</given-names></name><name><surname>Rathmell</surname><given-names>WK</given-names></name><name><surname>Rausch</surname><given-names>T</given-names></name><name><surname>Reifenberger</surname><given-names>G</given-names></name><name><surname>Reimand</surname><given-names>J</given-names></name><name><surname>Reis-Filho</surname><given-names>J</given-names></name><name><surname>Reuter</surname><given-names>V</given-names></name><name><surname>Reyes-Salazar</surname><given-names>I</given-names></name><name><surname>Reyna</surname><given-names>MA</given-names></name><name><surname>Reynolds</surname><given-names>SM</given-names></name><name><surname>Rheinbay</surname><given-names>E</given-names></name><name><surname>Riazalhosseini</surname><given-names>Y</given-names></name><name><surname>Richardson</surname><given-names>AL</given-names></name><name><surname>Richter</surname><given-names>J</given-names></name><name><surname>Ringel</surname><given-names>M</given-names></name><name><surname>Ringnér</surname><given-names>M</given-names></name><name><surname>Rino</surname><given-names>Y</given-names></name><name><surname>Rippe</surname><given-names>K</given-names></name><name><surname>Roach</surname><given-names>J</given-names></name><name><surname>Roberts</surname><given-names>LR</given-names></name><name><surname>Roberts</surname><given-names>ND</given-names></name><name><surname>Roberts</surname><given-names>SA</given-names></name><name><surname>Robertson</surname><given-names>AG</given-names></name><name><surname>Robertson</surname><given-names>AJ</given-names></name><name><surname>Rodriguez</surname><given-names>JB</given-names></name><name><surname>Rodriguez-Martin</surname><given-names>B</given-names></name><name><surname>Rodríguez-González</surname><given-names>FG</given-names></name><name><surname>Roehrl</surname><given-names>MHA</given-names></name><name><surname>Rohde</surname><given-names>M</given-names></name><name><surname>Rokutan</surname><given-names>H</given-names></name><name><surname>Romieu</surname><given-names>G</given-names></name><name><surname>Rooman</surname><given-names>I</given-names></name><name><surname>Roques</surname><given-names>T</given-names></name><name><surname>Rosebrock</surname><given-names>D</given-names></name><name><surname>Rosenberg</surname><given-names>M</given-names></name><name><surname>Rosenstiel</surname><given-names>PC</given-names></name><name><surname>Rosenwald</surname><given-names>A</given-names></name><name><surname>Rowe</surname><given-names>EW</given-names></name><name><surname>Royo</surname><given-names>R</given-names></name><name><surname>Rozen</surname><given-names>SG</given-names></name><name><surname>Rubanova</surname><given-names>Y</given-names></name><name><surname>Rubin</surname><given-names>MA</given-names></name><name><surname>Rubio-Perez</surname><given-names>C</given-names></name><name><surname>Rudneva</surname><given-names>VA</given-names></name><name><surname>Rusev</surname><given-names>BC</given-names></name><name><surname>Ruzzenente</surname><given-names>A</given-names></name><name><surname>Rätsch</surname><given-names>G</given-names></name><name><surname>Sabarinathan</surname><given-names>R</given-names></name><name><surname>Sabelnykova</surname><given-names>VY</given-names></name><name><surname>Sadeghi</surname><given-names>S</given-names></name><name><surname>Sahinalp</surname><given-names>SC</given-names></name><name><surname>Saini</surname><given-names>N</given-names></name><name><surname>Saito-Adachi</surname><given-names>M</given-names></name><name><surname>Saksena</surname><given-names>G</given-names></name><name><surname>Salcedo</surname><given-names>A</given-names></name><name><surname>Salgado</surname><given-names>R</given-names></name><name><surname>Salichos</surname><given-names>L</given-names></name><name><surname>Sallari</surname><given-names>R</given-names></name><name><surname>Saller</surname><given-names>C</given-names></name><name><surname>Salvia</surname><given-names>R</given-names></name><name><surname>Sam</surname><given-names>M</given-names></name><name><surname>Samra</surname><given-names>JS</given-names></name><name><surname>Sanchez-Vega</surname><given-names>F</given-names></name><name><surname>Sander</surname><given-names>C</given-names></name><name><surname>Sanders</surname><given-names>G</given-names></name><name><surname>Sarin</surname><given-names>R</given-names></name><name><surname>Sarrafi</surname><given-names>I</given-names></name><name><surname>Sasaki-Oku</surname><given-names>A</given-names></name><name><surname>Sauer</surname><given-names>T</given-names></name><name><surname>Sauter</surname><given-names>G</given-names></name><name><surname>Saw</surname><given-names>RPM</given-names></name><name><surname>Scardoni</surname><given-names>M</given-names></name><name><surname>Scarlett</surname><given-names>CJ</given-names></name><name><surname>Scarpa</surname><given-names>A</given-names></name><name><surname>Scelo</surname><given-names>G</given-names></name><name><surname>Schadendorf</surname><given-names>D</given-names></name><name><surname>Schein</surname><given-names>JE</given-names></name><name><surname>Schilhabel</surname><given-names>MB</given-names></name><name><surname>Schlesner</surname><given-names>M</given-names></name><name><surname>Schlomm</surname><given-names>T</given-names></name><name><surname>Schmidt</surname><given-names>HK</given-names></name><name><surname>Schramm</surname><given-names>S-J</given-names></name><name><surname>Schreiber</surname><given-names>S</given-names></name><name><surname>Schultz</surname><given-names>N</given-names></name><name><surname>Schumacher</surname><given-names>SE</given-names></name><name><surname>Schwarz</surname><given-names>RF</given-names></name><name><surname>Scolyer</surname><given-names>RA</given-names></name><name><surname>Scott</surname><given-names>D</given-names></name><name><surname>Scully</surname><given-names>R</given-names></name><name><surname>Seethala</surname><given-names>R</given-names></name><name><surname>Segre</surname><given-names>AV</given-names></name><name><surname>Selander</surname><given-names>I</given-names></name><name><surname>Semple</surname><given-names>CA</given-names></name><name><surname>Senbabaoglu</surname><given-names>Y</given-names></name><name><surname>Sengupta</surname><given-names>S</given-names></name><name><surname>Sereni</surname><given-names>E</given-names></name><name><surname>Serra</surname><given-names>S</given-names></name><name><surname>Sgroi</surname><given-names>DC</given-names></name><name><surname>Shackleton</surname><given-names>M</given-names></name><name><surname>Shah</surname><given-names>NC</given-names></name><name><surname>Shahabi</surname><given-names>S</given-names></name><name><surname>Shang</surname><given-names>CA</given-names></name><name><surname>Shang</surname><given-names>P</given-names></name><name><surname>Shapira</surname><given-names>O</given-names></name><name><surname>Shelton</surname><given-names>T</given-names></name><name><surname>Shen</surname><given-names>C</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Shepherd</surname><given-names>R</given-names></name><name><surname>Shi</surname><given-names>R</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Shiah</surname><given-names>Y-J</given-names></name><name><surname>Shibata</surname><given-names>T</given-names></name><name><surname>Shih</surname><given-names>J</given-names></name><name><surname>Shimizu</surname><given-names>E</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Shin</surname><given-names>SJ</given-names></name><name><surname>Shiraishi</surname><given-names>Y</given-names></name><name><surname>Shmaya</surname><given-names>T</given-names></name><name><surname>Shmulevich</surname><given-names>I</given-names></name><name><surname>Shorser</surname><given-names>SI</given-names></name><name><surname>Short</surname><given-names>C</given-names></name><name><surname>Shrestha</surname><given-names>R</given-names></name><name><surname>Shringarpure</surname><given-names>SS</given-names></name><name><surname>Shriver</surname><given-names>C</given-names></name><name><surname>Shuai</surname><given-names>S</given-names></name><name><surname>Sidiropoulos</surname><given-names>N</given-names></name><name><surname>Siebert</surname><given-names>R</given-names></name><name><surname>Sieuwerts</surname><given-names>AM</given-names></name><name><surname>Sieverling</surname><given-names>L</given-names></name><name><surname>Signoretti</surname><given-names>S</given-names></name><name><surname>Sikora</surname><given-names>KO</given-names></name><name><surname>Simbolo</surname><given-names>M</given-names></name><name><surname>Simon</surname><given-names>R</given-names></name><name><surname>Simons</surname><given-names>JV</given-names></name><name><surname>Simpson</surname><given-names>JT</given-names></name><name><surname>Simpson</surname><given-names>PT</given-names></name><name><surname>Singer</surname><given-names>S</given-names></name><name><surname>Sinnott-Armstrong</surname><given-names>N</given-names></name><name><surname>Sipahimalani</surname><given-names>P</given-names></name><name><surname>Skelly</surname><given-names>TJ</given-names></name><name><surname>Smid</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>J</given-names></name><name><surname>Smith-McCune</surname><given-names>K</given-names></name><name><surname>Socci</surname><given-names>ND</given-names></name><name><surname>Sofia</surname><given-names>HJ</given-names></name><name><surname>Soloway</surname><given-names>MG</given-names></name><name><surname>Song</surname><given-names>L</given-names></name><name><surname>Sood</surname><given-names>AK</given-names></name><name><surname>Sothi</surname><given-names>S</given-names></name><name><surname>Sotiriou</surname><given-names>C</given-names></name><name><surname>Soulette</surname><given-names>CM</given-names></name><name><surname>Span</surname><given-names>PN</given-names></name><name><surname>Spellman</surname><given-names>PT</given-names></name><name><surname>Sperandio</surname><given-names>N</given-names></name><name><surname>Spillane</surname><given-names>AJ</given-names></name><name><surname>Spiro</surname><given-names>O</given-names></name><name><surname>Spring</surname><given-names>J</given-names></name><name><surname>Staaf</surname><given-names>J</given-names></name><name><surname>Stadler</surname><given-names>PF</given-names></name><name><surname>Staib</surname><given-names>P</given-names></name><name><surname>Stark</surname><given-names>SG</given-names></name><name><surname>Stebbings</surname><given-names>L</given-names></name><name><surname>Stefánsson</surname><given-names>ÓA</given-names></name><name><surname>Stegle</surname><given-names>O</given-names></name><name><surname>Stein</surname><given-names>LD</given-names></name><name><surname>Stenhouse</surname><given-names>A</given-names></name><name><surname>Stewart</surname><given-names>C</given-names></name><name><surname>Stilgenbauer</surname><given-names>S</given-names></name><name><surname>Stobbe</surname><given-names>MD</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name><name><surname>Stretch</surname><given-names>JR</given-names></name><name><surname>Struck</surname><given-names>AJ</given-names></name><name><surname>Stuart</surname><given-names>JM</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Su</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>RX</given-names></name><name><surname>Sungalee</surname><given-names>S</given-names></name><name><surname>Susak</surname><given-names>H</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Sweep</surname><given-names>F</given-names></name><name><surname>Szczepanowski</surname><given-names>M</given-names></name><name><surname>Sültmann</surname><given-names>H</given-names></name><name><surname>Yugawa</surname><given-names>T</given-names></name><name><surname>Tam</surname><given-names>A</given-names></name><name><surname>Tamborero</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>BKT</given-names></name><name><surname>Tan</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>P</given-names></name><name><surname>Tanaka</surname><given-names>H</given-names></name><name><surname>Taniguchi</surname><given-names>H</given-names></name><name><surname>Tanskanen</surname><given-names>TJ</given-names></name><name><surname>Tarabichi</surname><given-names>M</given-names></name><name><surname>Tarnuzzer</surname><given-names>R</given-names></name><name><surname>Tarpey</surname><given-names>P</given-names></name><name><surname>Taschuk</surname><given-names>ML</given-names></name><name><surname>Tatsuno</surname><given-names>K</given-names></name><name><surname>Tavaré</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>DF</given-names></name><name><surname>Taylor-Weiner</surname><given-names>A</given-names></name><name><surname>Teague</surname><given-names>JW</given-names></name><name><surname>Teh</surname><given-names>BT</given-names></name><name><surname>Tembe</surname><given-names>V</given-names></name><name><surname>Temes</surname><given-names>J</given-names></name><name><surname>Thai</surname><given-names>K</given-names></name><name><surname>Thayer</surname><given-names>SP</given-names></name><name><surname>Thiessen</surname><given-names>N</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Thomas</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>A</given-names></name><name><surname>Thompson</surname><given-names>AM</given-names></name><name><surname>Thompson</surname><given-names>JFF</given-names></name><name><surname>Thompson</surname><given-names>RH</given-names></name><name><surname>Thorne</surname><given-names>H</given-names></name><name><surname>Thorne</surname><given-names>LB</given-names></name><name><surname>Thorogood</surname><given-names>A</given-names></name><name><surname>Tiao</surname><given-names>G</given-names></name><name><surname>Tijanic</surname><given-names>N</given-names></name><name><surname>Timms</surname><given-names>LE</given-names></name><name><surname>Tirabosco</surname><given-names>R</given-names></name><name><surname>Tojo</surname><given-names>M</given-names></name><name><surname>Tommasi</surname><given-names>S</given-names></name><name><surname>Toon</surname><given-names>CW</given-names></name><name><surname>Toprak</surname><given-names>UH</given-names></name><name><surname>Torrents</surname><given-names>D</given-names></name><name><surname>Tortora</surname><given-names>G</given-names></name><name><surname>Tost</surname><given-names>J</given-names></name><name><surname>Totoki</surname><given-names>Y</given-names></name><name><surname>Townend</surname><given-names>D</given-names></name><name><surname>Traficante</surname><given-names>N</given-names></name><name><surname>Treilleux</surname><given-names>I</given-names></name><name><surname>Trotta</surname><given-names>J-R</given-names></name><name><surname>Trümper</surname><given-names>LHP</given-names></name><name><surname>Tsao</surname><given-names>M</given-names></name><name><surname>Tsunoda</surname><given-names>T</given-names></name><name><surname>Tubio</surname><given-names>JMC</given-names></name><name><surname>Tucker</surname><given-names>O</given-names></name><name><surname>Turkington</surname><given-names>R</given-names></name><name><surname>Turner</surname><given-names>DJ</given-names></name><name><surname>Tutt</surname><given-names>A</given-names></name><name><surname>Ueno</surname><given-names>M</given-names></name><name><surname>Ueno</surname><given-names>NT</given-names></name><name><surname>Umbricht</surname><given-names>C</given-names></name><name><surname>Umer</surname><given-names>HM</given-names></name><name><surname>Underwood</surname><given-names>TJ</given-names></name><name><surname>Urban</surname><given-names>L</given-names></name><name><surname>Urushidate</surname><given-names>T</given-names></name><name><surname>Ushiku</surname><given-names>T</given-names></name><name><surname>Uusküla-Reimand</surname><given-names>L</given-names></name><name><surname>Valencia</surname><given-names>A</given-names></name><name><surname>Van Den Berg</surname><given-names>DJ</given-names></name><name><surname>Van Laere</surname><given-names>S</given-names></name><name><surname>Van Loo</surname><given-names>P</given-names></name><name><surname>Van Meir</surname><given-names>EG</given-names></name><name><surname>Van den Eynden</surname><given-names>GG</given-names></name><name><surname>Van der Kwast</surname><given-names>T</given-names></name><name><surname>Vasudev</surname><given-names>N</given-names></name><name><surname>Vazquez</surname><given-names>M</given-names></name><name><surname>Vedururu</surname><given-names>R</given-names></name><name><surname>Veluvolu</surname><given-names>U</given-names></name><name><surname>Vembu</surname><given-names>S</given-names></name><name><surname>Verbeke</surname><given-names>LPC</given-names></name><name><surname>Vermeulen</surname><given-names>P</given-names></name><name><surname>Verrill</surname><given-names>C</given-names></name><name><surname>Viari</surname><given-names>A</given-names></name><name><surname>Vicente</surname><given-names>D</given-names></name><name><surname>Vicentini</surname><given-names>C</given-names></name><name><surname>VijayRaghavan</surname><given-names>K</given-names></name><name><surname>Viksna</surname><given-names>J</given-names></name><name><surname>Vilain</surname><given-names>RE</given-names></name><name><surname>Villasante</surname><given-names>I</given-names></name><name><surname>Vincent-Salomon</surname><given-names>A</given-names></name><name><surname>Visakorpi</surname><given-names>T</given-names></name><name><surname>Voet</surname><given-names>D</given-names></name><name><surname>Vyas</surname><given-names>P</given-names></name><name><surname>Vázquez-García</surname><given-names>I</given-names></name><name><surname>Waddell</surname><given-names>NM</given-names></name><name><surname>Waddell</surname><given-names>N</given-names></name><name><surname>Wadelius</surname><given-names>C</given-names></name><name><surname>Wadi</surname><given-names>L</given-names></name><name><surname>Wagener</surname><given-names>R</given-names></name><name><surname>Wala</surname><given-names>JA</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Waring</surname><given-names>PM</given-names></name><name><surname>Warnatz</surname><given-names>H-J</given-names></name><name><surname>Warrell</surname><given-names>J</given-names></name><name><surname>Warren</surname><given-names>AY</given-names></name><name><surname>Waszak</surname><given-names>SM</given-names></name><name><surname>Wedge</surname><given-names>DC</given-names></name><name><surname>Weichenhan</surname><given-names>D</given-names></name><name><surname>Weinberger</surname><given-names>P</given-names></name><name><surname>Weinstein</surname><given-names>JN</given-names></name><name><surname>Weischenfeldt</surname><given-names>J</given-names></name><name><surname>Weisenberger</surname><given-names>DJ</given-names></name><name><surname>Welch</surname><given-names>I</given-names></name><name><surname>Wendl</surname><given-names>MC</given-names></name><name><surname>Werner</surname><given-names>J</given-names></name><name><surname>Whalley</surname><given-names>JP</given-names></name><name><surname>Wheeler</surname><given-names>DA</given-names></name><name><surname>Whitaker</surname><given-names>HC</given-names></name><name><surname>Wigle</surname><given-names>D</given-names></name><name><surname>Wilkerson</surname><given-names>MD</given-names></name><name><surname>Williams</surname><given-names>A</given-names></name><name><surname>Wilmott</surname><given-names>JS</given-names></name><name><surname>Wilson</surname><given-names>GW</given-names></name><name><surname>Wilson</surname><given-names>JM</given-names></name><name><surname>Wilson</surname><given-names>RK</given-names></name><name><surname>Winterhoff</surname><given-names>B</given-names></name><name><surname>Wintersinger</surname><given-names>JA</given-names></name><name><surname>Wiznerowicz</surname><given-names>M</given-names></name><name><surname>Wolf</surname><given-names>S</given-names></name><name><surname>Wong</surname><given-names>BH</given-names></name><name><surname>Wong</surname><given-names>T</given-names></name><name><surname>Wong</surname><given-names>W</given-names></name><name><surname>Woo</surname><given-names>Y</given-names></name><name><surname>Wood</surname><given-names>S</given-names></name><name><surname>Wouters</surname><given-names>BG</given-names></name><name><surname>Wright</surname><given-names>AJ</given-names></name><name><surname>Wright</surname><given-names>DW</given-names></name><name><surname>Wright</surname><given-names>MH</given-names></name><name><surname>Wu</surname><given-names>C-L</given-names></name><name><surname>Wu</surname><given-names>D-Y</given-names></name><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Xi</surname><given-names>L</given-names></name><name><surname>Xia</surname><given-names>T</given-names></name><name><surname>Xiang</surname><given-names>Q</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Xing</surname><given-names>R</given-names></name><name><surname>Xiong</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Xue</surname><given-names>H</given-names></name><name><surname>Yachida</surname><given-names>S</given-names></name><name><surname>Yakneen</surname><given-names>S</given-names></name><name><surname>Yamaguchi</surname><given-names>R</given-names></name><name><surname>Yamaguchi</surname><given-names>TN</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Yamamoto</surname><given-names>S</given-names></name><name><surname>Yamaue</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>JY</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>T-P</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Yaspo</surname><given-names>M-L</given-names></name><name><surname>Yates</surname><given-names>L</given-names></name><name><surname>Yau</surname><given-names>C</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Ye</surname><given-names>K</given-names></name><name><surname>Yellapantula</surname><given-names>VD</given-names></name><name><surname>Yoon</surname><given-names>CJ</given-names></name><name><surname>Yoon</surname><given-names>S-S</given-names></name><name><surname>Yousif</surname><given-names>F</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Yu</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>K</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Yuen</surname><given-names>D</given-names></name><name><surname>Yung</surname><given-names>CK</given-names></name><name><surname>Zaikova</surname><given-names>O</given-names></name><name><surname>Zamora</surname><given-names>J</given-names></name><name><surname>Zapatka</surname><given-names>M</given-names></name><name><surname>Zenklusen</surname><given-names>JC</given-names></name><name><surname>Zenz</surname><given-names>T</given-names></name><name><surname>Zeps</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>C-Z</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>S</given-names></name><name><surname>Zou</surname><given-names>L</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>deFazio</surname><given-names>A</given-names></name><name><surname>van As</surname><given-names>N</given-names></name><name><surname>van Deurzen</surname><given-names>CHM</given-names></name><name><surname>van de Vijver</surname><given-names>MJ</given-names></name><name><surname>van’t Veer</surname><given-names>L</given-names></name><name><surname>von Mering</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Patterns of somatic structural variation in human cancer Genomes</article-title><source>Nature</source><volume>578</volume><fpage>112</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1913-9</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname><given-names>MI</given-names></name><name><surname>Huber</surname><given-names>W</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loveday</surname><given-names>C</given-names></name><name><surname>Litchfield</surname><given-names>K</given-names></name><name><surname>Proszek</surname><given-names>PZ</given-names></name><name><surname>Cornish</surname><given-names>AJ</given-names></name><name><surname>Santo</surname><given-names>F</given-names></name><name><surname>Levy</surname><given-names>M</given-names></name><name><surname>Macintyre</surname><given-names>G</given-names></name><name><surname>Holryod</surname><given-names>A</given-names></name><name><surname>Broderick</surname><given-names>P</given-names></name><name><surname>Dudakia</surname><given-names>D</given-names></name><name><surname>Benton</surname><given-names>B</given-names></name><name><surname>Bakir</surname><given-names>MA</given-names></name><name><surname>Hiley</surname><given-names>C</given-names></name><name><surname>Grist</surname><given-names>E</given-names></name><name><surname>Swanton</surname><given-names>C</given-names></name><name><surname>Huddart</surname><given-names>R</given-names></name><name><surname>Powles</surname><given-names>T</given-names></name><name><surname>Chowdhury</surname><given-names>S</given-names></name><name><surname>Shipley</surname><given-names>J</given-names></name><name><surname>O’Connor</surname><given-names>S</given-names></name><name><surname>Brenton</surname><given-names>JD</given-names></name><name><surname>Reid</surname><given-names>A</given-names></name><name><surname>de Castro</surname><given-names>DG</given-names></name><name><surname>Houlston</surname><given-names>RS</given-names></name><name><surname>Turnbull</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Genomic landscape of platinum resistant and sensitive testicular cancers</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>2189</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-15768-x</pub-id><pub-id pub-id-type="pmid">32366847</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lukow</surname><given-names>DA</given-names></name><name><surname>Sausville</surname><given-names>EL</given-names></name><name><surname>Suri</surname><given-names>P</given-names></name><name><surname>Chunduri</surname><given-names>NK</given-names></name><name><surname>Wieland</surname><given-names>A</given-names></name><name><surname>Leu</surname><given-names>J</given-names></name><name><surname>Smith</surname><given-names>JC</given-names></name><name><surname>Girish</surname><given-names>V</given-names></name><name><surname>Kumar</surname><given-names>AA</given-names></name><name><surname>Kendall</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Storchova</surname><given-names>Z</given-names></name><name><surname>Sheltzer</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies</article-title><source>Developmental Cell</source><volume>56</volume><fpage>2427</fpage><lpage>2439</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2021.07.009</pub-id><pub-id pub-id-type="pmid">34352222</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maciejowski</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Bosco</surname><given-names>N</given-names></name><name><surname>Campbell</surname><given-names>PJ</given-names></name><name><surname>de Lange</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Chromothripsis and lataegis induced by telomere crisis</article-title><source>Cell</source><volume>163</volume><fpage>1641</fpage><lpage>1654</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.11.054</pub-id><pub-id pub-id-type="pmid">26687355</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maciejowski</surname><given-names>J</given-names></name><name><surname>Chatzipli</surname><given-names>A</given-names></name><name><surname>Dananberg</surname><given-names>A</given-names></name><name><surname>Chu</surname><given-names>K</given-names></name><name><surname>Toufektchan</surname><given-names>E</given-names></name><name><surname>Klimczak</surname><given-names>LJ</given-names></name><name><surname>Gordenin</surname><given-names>DA</given-names></name><name><surname>Campbell</surname><given-names>PJ</given-names></name><name><surname>de Lange</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>APOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis</article-title><source>Nature Genetics</source><volume>52</volume><fpage>884</fpage><lpage>890</lpage><pub-id pub-id-type="doi">10.1038/s41588-020-0667-5</pub-id><pub-id pub-id-type="pmid">32719516</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macintyre</surname><given-names>G</given-names></name><name><surname>Goranova</surname><given-names>TE</given-names></name><name><surname>De Silva</surname><given-names>D</given-names></name><name><surname>Ennis</surname><given-names>D</given-names></name><name><surname>Piskorz</surname><given-names>AM</given-names></name><name><surname>Eldridge</surname><given-names>M</given-names></name><name><surname>Sie</surname><given-names>D</given-names></name><name><surname>Lewsley</surname><given-names>L-A</given-names></name><name><surname>Hanif</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Dowson</surname><given-names>S</given-names></name><name><surname>Glasspool</surname><given-names>RM</given-names></name><name><surname>Lockley</surname><given-names>M</given-names></name><name><surname>Brockbank</surname><given-names>E</given-names></name><name><surname>Montes</surname><given-names>A</given-names></name><name><surname>Walther</surname><given-names>A</given-names></name><name><surname>Sundar</surname><given-names>S</given-names></name><name><surname>Edmondson</surname><given-names>R</given-names></name><name><surname>Hall</surname><given-names>GD</given-names></name><name><surname>Clamp</surname><given-names>A</given-names></name><name><surname>Gourley</surname><given-names>C</given-names></name><name><surname>Hall</surname><given-names>M</given-names></name><name><surname>Fotopoulou</surname><given-names>C</given-names></name><name><surname>Gabra</surname><given-names>H</given-names></name><name><surname>Paul</surname><given-names>J</given-names></name><name><surname>Supernat</surname><given-names>A</given-names></name><name><surname>Millan</surname><given-names>D</given-names></name><name><surname>Hoyle</surname><given-names>A</given-names></name><name><surname>Bryson</surname><given-names>G</given-names></name><name><surname>Nourse</surname><given-names>C</given-names></name><name><surname>Mincarelli</surname><given-names>L</given-names></name><name><surname>Sanchez</surname><given-names>LN</given-names></name><name><surname>Ylstra</surname><given-names>B</given-names></name><name><surname>Jimenez-Linan</surname><given-names>M</given-names></name><name><surname>Moore</surname><given-names>L</given-names></name><name><surname>Hofmann</surname><given-names>O</given-names></name><name><surname>Markowetz</surname><given-names>F</given-names></name><name><surname>McNeish</surname><given-names>IA</given-names></name><name><surname>Brenton</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Copy number signatures and mutational processes in ovarian carcinoma</article-title><source>Nature Genetics</source><volume>50</volume><fpage>1262</fpage><lpage>1270</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0179-8</pub-id><pub-id pub-id-type="pmid">30104763</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maclachlan</surname><given-names>KH</given-names></name><name><surname>Rustad</surname><given-names>EH</given-names></name><name><surname>Derkach</surname><given-names>A</given-names></name><name><surname>Zheng-Lin</surname><given-names>B</given-names></name><name><surname>Yellapantula</surname><given-names>V</given-names></name><name><surname>Diamond</surname><given-names>B</given-names></name><name><surname>Hultcrantz</surname><given-names>M</given-names></name><name><surname>Ziccheddu</surname><given-names>B</given-names></name><name><surname>Boyle</surname><given-names>EM</given-names></name><name><surname>Blaney</surname><given-names>P</given-names></name><name><surname>Bolli</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Dogan</surname><given-names>A</given-names></name><name><surname>Lesokhin</surname><given-names>AM</given-names></name><name><surname>Morgan</surname><given-names>GJ</given-names></name><name><surname>Landgren</surname><given-names>O</given-names></name><name><surname>Maura</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>5172</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-25469-8</pub-id><pub-id pub-id-type="pmid">34453055</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Maechler</surname><given-names>M</given-names></name><name><surname>Rousseeuw</surname><given-names>P</given-names></name><name><surname>Croux</surname><given-names>C</given-names></name><name><surname>Todorov</surname><given-names>V</given-names></name><name><surname>Ruckstuhl</surname><given-names>A</given-names></name><name><surname>Salibian-Barrera</surname><given-names>M</given-names></name><name><surname>Verbeke</surname><given-names>T</given-names></name><name><surname>Koller</surname><given-names>M</given-names></name><name><surname>Conceicao</surname><given-names>EL</given-names></name><name><surname>Anna di Palma</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Robustbase: basic robust statistics</data-title><version designator="0.95-1">0.95-1</version><source>R package</source><ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/robustbase/index.html">https://cran.r-project.org/web/packages/robustbase/index.html</ext-link></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maenhoudt</surname><given-names>N</given-names></name><name><surname>Defraye</surname><given-names>C</given-names></name><name><surname>Boretto</surname><given-names>M</given-names></name><name><surname>Jan</surname><given-names>Z</given-names></name><name><surname>Heremans</surname><given-names>R</given-names></name><name><surname>Boeckx</surname><given-names>B</given-names></name><name><surname>Hermans</surname><given-names>F</given-names></name><name><surname>Arijs</surname><given-names>I</given-names></name><name><surname>Cox</surname><given-names>B</given-names></name><name><surname>Van Nieuwenhuysen</surname><given-names>E</given-names></name><name><surname>Vergote</surname><given-names>I</given-names></name><name><surname>Van Rompuy</surname><given-names>A-S</given-names></name><name><surname>Lambrechts</surname><given-names>D</given-names></name><name><surname>Timmerman</surname><given-names>D</given-names></name><name><surname>Vankelecom</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Developing organoids from ovarian cancer as experimental and preclinical models</article-title><source>Stem Cell Reports</source><volume>14</volume><fpage>717</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1016/j.stemcr.2020.03.004</pub-id><pub-id pub-id-type="pmid">32243841</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>FC</given-names></name><name><surname>Couturier</surname><given-names>DL</given-names></name><name><surname>de Santiago</surname><given-names>I</given-names></name><name><surname>Sauer</surname><given-names>CM</given-names></name><name><surname>Vias</surname><given-names>M</given-names></name><name><surname>Angelova</surname><given-names>M</given-names></name><name><surname>Sanders</surname><given-names>D</given-names></name><name><surname>Piskorz</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name><name><surname>Hosking</surname><given-names>K</given-names></name><name><surname>Amirthanayagam</surname><given-names>A</given-names></name><name><surname>Cosulich</surname><given-names>S</given-names></name><name><surname>Carnevalli</surname><given-names>L</given-names></name><name><surname>Davies</surname><given-names>B</given-names></name><name><surname>Watkins</surname><given-names>TBK</given-names></name><name><surname>Funingana</surname><given-names>G</given-names></name><name><surname>Bolton</surname><given-names>H</given-names></name><name><surname>Haldar</surname><given-names>K</given-names></name><name><surname>Latimer</surname><given-names>J</given-names></name><name><surname>Baldwin</surname><given-names>P</given-names></name><name><surname>Crawford</surname><given-names>R</given-names></name><name><surname>Eldridge</surname><given-names>M</given-names></name><name><surname>Basu</surname><given-names>B</given-names></name><name><surname>Jimenez-Linan</surname><given-names>M</given-names></name><name><surname>Mcpherson</surname><given-names>AW</given-names></name><name><surname>McGranahan</surname><given-names>N</given-names></name><name><surname>Litchfield</surname><given-names>K</given-names></name><name><surname>Shah</surname><given-names>SP</given-names></name><name><surname>McNeish</surname><given-names>I</given-names></name><name><surname>Caldas</surname><given-names>C</given-names></name><name><surname>Evan</surname><given-names>G</given-names></name><name><surname>Swanton</surname><given-names>C</given-names></name><name><surname>Brenton</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>6360</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-33870-0</pub-id><pub-id pub-id-type="pmid">36289203</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menghi</surname><given-names>F</given-names></name><name><surname>Inaki</surname><given-names>K</given-names></name><name><surname>Woo</surname><given-names>X</given-names></name><name><surname>Kumar</surname><given-names>PA</given-names></name><name><surname>Grzeda</surname><given-names>KR</given-names></name><name><surname>Malhotra</surname><given-names>A</given-names></name><name><surname>Yadav</surname><given-names>V</given-names></name><name><surname>Kim</surname><given-names>H</given-names></name><name><surname>Marquez</surname><given-names>EJ</given-names></name><name><surname>Ucar</surname><given-names>D</given-names></name><name><surname>Shreckengast</surname><given-names>PT</given-names></name><name><surname>Wagner</surname><given-names>JP</given-names></name><name><surname>MacIntyre</surname><given-names>G</given-names></name><name><surname>Murthy Karuturi</surname><given-names>KR</given-names></name><name><surname>Scully</surname><given-names>R</given-names></name><name><surname>Keck</surname><given-names>J</given-names></name><name><surname>Chuang</surname><given-names>JH</given-names></name><name><surname>Liu</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The tandem duplicator phenotype as a distinct genomic configuration in cancer</article-title><source>PNAS</source><volume>113</volume><fpage>E2373</fpage><lpage>E2382</lpage><pub-id pub-id-type="doi">10.1073/pnas.1520010113</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Morrill</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2023">2023</year><data-title>Organoids_Compositional_Analysis</data-title><version designator="swh:1:rev:ce0a7d8a1293685287cc1c5d453f51696f0478b0">swh:1:rev:ce0a7d8a1293685287cc1c5d453f51696f0478b0</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:b00cefb84e26cfcb90f08b455d2257fdd2bcaeb6;origin=https://github.com/lm687/Organoids_Compositional_Analysis;visit=swh:1:snp:2abd6b6eaded35c48fba0677d5b3f8293c45e5b2;anchor=swh:1:rev:ce0a7d8a1293685287cc1c5d453f51696f0478b0">https://archive.softwareheritage.org/swh:1:dir:b00cefb84e26cfcb90f08b455d2257fdd2bcaeb6;origin=https://github.com/lm687/Organoids_Compositional_Analysis;visit=swh:1:snp:2abd6b6eaded35c48fba0677d5b3f8293c45e5b2;anchor=swh:1:rev:ce0a7d8a1293685287cc1c5d453f51696f0478b0</ext-link></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>L</given-names></name><name><surname>Tighe</surname><given-names>A</given-names></name><name><surname>Golder</surname><given-names>A</given-names></name><name><surname>Littler</surname><given-names>S</given-names></name><name><surname>Bakker</surname><given-names>B</given-names></name><name><surname>Moralli</surname><given-names>D</given-names></name><name><surname>Murtuza Baker</surname><given-names>S</given-names></name><name><surname>Donaldson</surname><given-names>IJ</given-names></name><name><surname>Spierings</surname><given-names>DCJ</given-names></name><name><surname>Wardenaar</surname><given-names>R</given-names></name><name><surname>Neale</surname><given-names>B</given-names></name><name><surname>Burghel</surname><given-names>GJ</given-names></name><name><surname>Winter-Roach</surname><given-names>B</given-names></name><name><surname>Edmondson</surname><given-names>R</given-names></name><name><surname>Clamp</surname><given-names>AR</given-names></name><name><surname>Jayson</surname><given-names>GC</given-names></name><name><surname>Desai</surname><given-names>S</given-names></name><name><surname>Green</surname><given-names>CM</given-names></name><name><surname>Hayes</surname><given-names>A</given-names></name><name><surname>Foijer</surname><given-names>F</given-names></name><name><surname>Morgan</surname><given-names>RD</given-names></name><name><surname>Taylor</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>A living biobank of ovarian cancer ex vivo models reveals profound mitotic heterogeneity</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>e2</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-14551-2</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patch</surname><given-names>A-M</given-names></name><name><surname>Christie</surname><given-names>EL</given-names></name><name><surname>Etemadmoghadam</surname><given-names>D</given-names></name><name><surname>Garsed</surname><given-names>DW</given-names></name><name><surname>George</surname><given-names>J</given-names></name><name><surname>Fereday</surname><given-names>S</given-names></name><name><surname>Nones</surname><given-names>K</given-names></name><name><surname>Cowin</surname><given-names>P</given-names></name><name><surname>Alsop</surname><given-names>K</given-names></name><name><surname>Bailey</surname><given-names>PJ</given-names></name><name><surname>Kassahn</surname><given-names>KS</given-names></name><name><surname>Newell</surname><given-names>F</given-names></name><name><surname>Quinn</surname><given-names>MCJ</given-names></name><name><surname>Kazakoff</surname><given-names>S</given-names></name><name><surname>Quek</surname><given-names>K</given-names></name><name><surname>Wilhelm-Benartzi</surname><given-names>C</given-names></name><name><surname>Curry</surname><given-names>E</given-names></name><name><surname>Leong</surname><given-names>HS</given-names></name><collab>The Australian Ovarian Cancer Study Group</collab><name><surname>Hamilton</surname><given-names>A</given-names></name><name><surname>Mileshkin</surname><given-names>L</given-names></name><name><surname>Au-Yeung</surname><given-names>G</given-names></name><name><surname>Kennedy</surname><given-names>C</given-names></name><name><surname>Hung</surname><given-names>J</given-names></name><name><surname>Chiew</surname><given-names>Y-E</given-names></name><name><surname>Harnett</surname><given-names>P</given-names></name><name><surname>Friedlander</surname><given-names>M</given-names></name><name><surname>Quinn</surname><given-names>M</given-names></name><name><surname>Pyman</surname><given-names>J</given-names></name><name><surname>Cordner</surname><given-names>S</given-names></name><name><surname>O’Brien</surname><given-names>P</given-names></name><name><surname>Leditschke</surname><given-names>J</given-names></name><name><surname>Young</surname><given-names>G</given-names></name><name><surname>Strachan</surname><given-names>K</given-names></name><name><surname>Waring</surname><given-names>P</given-names></name><name><surname>Azar</surname><given-names>W</given-names></name><name><surname>Mitchell</surname><given-names>C</given-names></name><name><surname>Traficante</surname><given-names>N</given-names></name><name><surname>Hendley</surname><given-names>J</given-names></name><name><surname>Thorne</surname><given-names>H</given-names></name><name><surname>Shackleton</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>DK</given-names></name><name><surname>Arnau</surname><given-names>GM</given-names></name><name><surname>Tothill</surname><given-names>RW</given-names></name><name><surname>Holloway</surname><given-names>TP</given-names></name><name><surname>Semple</surname><given-names>T</given-names></name><name><surname>Harliwong</surname><given-names>I</given-names></name><name><surname>Nourse</surname><given-names>C</given-names></name><name><surname>Nourbakhsh</surname><given-names>E</given-names></name><name><surname>Manning</surname><given-names>S</given-names></name><name><surname>Idrisoglu</surname><given-names>S</given-names></name><name><surname>Bruxner</surname><given-names>TJC</given-names></name><name><surname>Christ</surname><given-names>AN</given-names></name><name><surname>Poudel</surname><given-names>B</given-names></name><name><surname>Holmes</surname><given-names>O</given-names></name><name><surname>Anderson</surname><given-names>M</given-names></name><name><surname>Leonard</surname><given-names>C</given-names></name><name><surname>Lonie</surname><given-names>A</given-names></name><name><surname>Hall</surname><given-names>N</given-names></name><name><surname>Wood</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>DF</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Fink</surname><given-names>JL</given-names></name><name><surname>Waddell</surname><given-names>N</given-names></name><name><surname>Drapkin</surname><given-names>R</given-names></name><name><surname>Stronach</surname><given-names>E</given-names></name><name><surname>Gabra</surname><given-names>H</given-names></name><name><surname>Brown</surname><given-names>R</given-names></name><name><surname>Jewell</surname><given-names>A</given-names></name><name><surname>Nagaraj</surname><given-names>SH</given-names></name><name><surname>Markham</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>PJ</given-names></name><name><surname>Ellul</surname><given-names>J</given-names></name><name><surname>McNally</surname><given-names>O</given-names></name><name><surname>Doyle</surname><given-names>MA</given-names></name><name><surname>Vedururu</surname><given-names>R</given-names></name><name><surname>Stewart</surname><given-names>C</given-names></name><name><surname>Lengyel</surname><given-names>E</given-names></name><name><surname>Pearson</surname><given-names>JV</given-names></name><name><surname>Waddell</surname><given-names>N</given-names></name><name><surname>deFazio</surname><given-names>A</given-names></name><name><surname>Grimmond</surname><given-names>SM</given-names></name><name><surname>Bowtell</surname><given-names>DDL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Whole-genome characterization of chemoresistant ovarian cancer</article-title><source>Nature</source><volume>521</volume><fpage>489</fpage><lpage>494</lpage><pub-id pub-id-type="doi">10.1038/nature14410</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petljak</surname><given-names>M</given-names></name><name><surname>Alexandrov</surname><given-names>LB</given-names></name><name><surname>Brammeld</surname><given-names>JS</given-names></name><name><surname>Price</surname><given-names>S</given-names></name><name><surname>Wedge</surname><given-names>DC</given-names></name><name><surname>Grossmann</surname><given-names>S</given-names></name><name><surname>Dawson</surname><given-names>KJ</given-names></name><name><surname>Ju</surname><given-names>YS</given-names></name><name><surname>Iorio</surname><given-names>F</given-names></name><name><surname>Tubio</surname><given-names>JMC</given-names></name><name><surname>Koh</surname><given-names>CC</given-names></name><name><surname>Georgakopoulos-Soares</surname><given-names>I</given-names></name><name><surname>Rodríguez-Martín</surname><given-names>B</given-names></name><name><surname>Otlu</surname><given-names>B</given-names></name><name><surname>O’Meara</surname><given-names>S</given-names></name><name><surname>Butler</surname><given-names>AP</given-names></name><name><surname>Menzies</surname><given-names>A</given-names></name><name><surname>Bhosle</surname><given-names>SG</given-names></name><name><surname>Raine</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>DR</given-names></name><name><surname>Teague</surname><given-names>JW</given-names></name><name><surname>Beal</surname><given-names>K</given-names></name><name><surname>Latimer</surname><given-names>C</given-names></name><name><surname>O’Neill</surname><given-names>L</given-names></name><name><surname>Zamora</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>E</given-names></name><name><surname>Patel</surname><given-names>N</given-names></name><name><surname>Maddison</surname><given-names>M</given-names></name><name><surname>Ng</surname><given-names>BL</given-names></name><name><surname>Graham</surname><given-names>J</given-names></name><name><surname>Garnett</surname><given-names>MJ</given-names></name><name><surname>McDermott</surname><given-names>U</given-names></name><name><surname>Nik-Zainal</surname><given-names>S</given-names></name><name><surname>Campbell</surname><given-names>PJ</given-names></name><name><surname>Stratton</surname><given-names>MR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC Mutagenesis</article-title><source>Cell</source><volume>176</volume><fpage>1282</fpage><lpage>1294</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.02.012</pub-id><pub-id pub-id-type="pmid">30849372</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritz</surname><given-names>C</given-names></name><name><surname>Baty</surname><given-names>F</given-names></name><name><surname>Streibig</surname><given-names>JC</given-names></name><name><surname>Gerhard</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dose-response analysis using R</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0146021</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0146021</pub-id><pub-id pub-id-type="pmid">26717316</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheinin</surname><given-names>I</given-names></name><name><surname>Sie</surname><given-names>D</given-names></name><name><surname>Bengtsson</surname><given-names>H</given-names></name><name><surname>van de Wiel</surname><given-names>MA</given-names></name><name><surname>Olshen</surname><given-names>AB</given-names></name><name><surname>van Thuijl</surname><given-names>HF</given-names></name><name><surname>van Essen</surname><given-names>HF</given-names></name><name><surname>Eijk</surname><given-names>PP</given-names></name><name><surname>Rustenburg</surname><given-names>F</given-names></name><name><surname>Meijer</surname><given-names>GA</given-names></name><name><surname>Reijneveld</surname><given-names>JC</given-names></name><name><surname>Wesseling</surname><given-names>P</given-names></name><name><surname>Pinkel</surname><given-names>D</given-names></name><name><surname>Albertson</surname><given-names>DG</given-names></name><name><surname>Ylstra</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly</article-title><source>Genome Research</source><volume>24</volume><fpage>2022</fpage><lpage>2032</lpage><pub-id pub-id-type="doi">10.1101/gr.175141.114</pub-id><pub-id pub-id-type="pmid">25236618</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swisher</surname><given-names>EM</given-names></name><name><surname>Lin</surname><given-names>KK</given-names></name><name><surname>Oza</surname><given-names>AM</given-names></name><name><surname>Scott</surname><given-names>CL</given-names></name><name><surname>Giordano</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Konecny</surname><given-names>GE</given-names></name><name><surname>Coleman</surname><given-names>RL</given-names></name><name><surname>Tinker</surname><given-names>AV</given-names></name><name><surname>O’Malley</surname><given-names>DM</given-names></name><name><surname>Kristeleit</surname><given-names>RS</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Bell-McGuinn</surname><given-names>KM</given-names></name><name><surname>Brenton</surname><given-names>JD</given-names></name><name><surname>Cragun</surname><given-names>JM</given-names></name><name><surname>Oaknin</surname><given-names>A</given-names></name><name><surname>Ray-Coquard</surname><given-names>I</given-names></name><name><surname>Harrell</surname><given-names>MI</given-names></name><name><surname>Mann</surname><given-names>E</given-names></name><name><surname>Kaufmann</surname><given-names>SH</given-names></name><name><surname>Floquet</surname><given-names>A</given-names></name><name><surname>Leary</surname><given-names>A</given-names></name><name><surname>Harding</surname><given-names>TC</given-names></name><name><surname>Goble</surname><given-names>S</given-names></name><name><surname>Maloney</surname><given-names>L</given-names></name><name><surname>Isaacson</surname><given-names>J</given-names></name><name><surname>Allen</surname><given-names>AR</given-names></name><name><surname>Rolfe</surname><given-names>L</given-names></name><name><surname>Yelensky</surname><given-names>R</given-names></name><name><surname>Raponi</surname><given-names>M</given-names></name><name><surname>McNeish</surname><given-names>IA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 part 1): An international, multicentre, open-label, phase 2 trial</article-title><source>The Lancet Oncology</source><volume>18</volume><fpage>75</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(16)30559-9</pub-id><pub-id pub-id-type="pmid">27908594</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamura</surname><given-names>N</given-names></name><name><surname>Shaikh</surname><given-names>N</given-names></name><name><surname>Muliaditan</surname><given-names>D</given-names></name><name><surname>Soliman</surname><given-names>TN</given-names></name><name><surname>McGuinness</surname><given-names>JR</given-names></name><name><surname>Maniati</surname><given-names>E</given-names></name><name><surname>Moralli</surname><given-names>D</given-names></name><name><surname>Durin</surname><given-names>M-A</given-names></name><name><surname>Green</surname><given-names>CM</given-names></name><name><surname>Balkwill</surname><given-names>FR</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Curtius</surname><given-names>K</given-names></name><name><surname>McClelland</surname><given-names>SE</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Specific mechanisms of chromosomal instability indicate therapeutic sensitivities in high-grade serous ovarian carcinoma</article-title><source>Cancer Research</source><volume>80</volume><fpage>4946</fpage><lpage>4959</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-19-0852</pub-id><pub-id pub-id-type="pmid">32998996</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>SL</given-names></name><name><surname>Bakhoum</surname><given-names>SF</given-names></name><name><surname>Compton</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Mechanisms of chromosomal instability</article-title><source>Current Biology</source><volume>20</volume><fpage>R285</fpage><lpage>R295</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2010.01.034</pub-id><pub-id pub-id-type="pmid">20334839</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorvaldsdóttir</surname><given-names>H</given-names></name><name><surname>Robinson</surname><given-names>JT</given-names></name><name><surname>Mesirov</surname><given-names>JP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Integrative genomics viewer (IGV): High-performance genomics data visualization and exploration</article-title><source>Briefings in Bioinformatics</source><volume>14</volume><fpage>178</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1093/bib/bbs017</pub-id><pub-id pub-id-type="pmid">22517427</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thu</surname><given-names>KL</given-names></name><name><surname>Papari-Zareei</surname><given-names>M</given-names></name><name><surname>Stastny</surname><given-names>V</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Peyton</surname><given-names>M</given-names></name><name><surname>Martinez</surname><given-names>VD</given-names></name><name><surname>Zhang</surname><given-names>Y-A</given-names></name><name><surname>Castro</surname><given-names>IB</given-names></name><name><surname>Varella-Garcia</surname><given-names>M</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Xing</surname><given-names>C</given-names></name><name><surname>Kittler</surname><given-names>R</given-names></name><name><surname>Milchgrub</surname><given-names>S</given-names></name><name><surname>Castrillon</surname><given-names>DH</given-names></name><name><surname>Davidson</surname><given-names>HL</given-names></name><name><surname>Reynolds</surname><given-names>CP</given-names></name><name><surname>Lam</surname><given-names>WL</given-names></name><name><surname>Lea</surname><given-names>J</given-names></name><name><surname>Gazdar</surname><given-names>AF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A comprehensively characterized cell line panel highly representative of clinical ovarian high-grade serous carcinomas</article-title><source>Oncotarget</source><volume>8</volume><fpage>50489</fpage><lpage>50499</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.9929</pub-id><pub-id pub-id-type="pmid">28881577</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turajlic</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Litchfield</surname><given-names>K</given-names></name><name><surname>Rowan</surname><given-names>A</given-names></name><name><surname>Chambers</surname><given-names>T</given-names></name><name><surname>Lopez</surname><given-names>JI</given-names></name><name><surname>Nicol</surname><given-names>D</given-names></name><name><surname>O’Brien</surname><given-names>T</given-names></name><name><surname>Larkin</surname><given-names>J</given-names></name><name><surname>Horswell</surname><given-names>S</given-names></name><name><surname>Stares</surname><given-names>M</given-names></name><name><surname>Au</surname><given-names>L</given-names></name><name><surname>Jamal-Hanjani</surname><given-names>M</given-names></name><name><surname>Challacombe</surname><given-names>B</given-names></name><name><surname>Chandra</surname><given-names>A</given-names></name><name><surname>Hazell</surname><given-names>S</given-names></name><name><surname>Eichler-Jonsson</surname><given-names>C</given-names></name><name><surname>Soultati</surname><given-names>A</given-names></name><name><surname>Chowdhury</surname><given-names>S</given-names></name><name><surname>Rudman</surname><given-names>S</given-names></name><name><surname>Lynch</surname><given-names>J</given-names></name><name><surname>Fernando</surname><given-names>A</given-names></name><name><surname>Stamp</surname><given-names>G</given-names></name><name><surname>Nye</surname><given-names>E</given-names></name><name><surname>Jabbar</surname><given-names>F</given-names></name><name><surname>Spain</surname><given-names>L</given-names></name><name><surname>Lall</surname><given-names>S</given-names></name><name><surname>Guarch</surname><given-names>R</given-names></name><name><surname>Falzon</surname><given-names>M</given-names></name><name><surname>Proctor</surname><given-names>I</given-names></name><name><surname>Pickering</surname><given-names>L</given-names></name><name><surname>Gore</surname><given-names>M</given-names></name><name><surname>Watkins</surname><given-names>TBK</given-names></name><name><surname>Ward</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>A</given-names></name><name><surname>DiNatale</surname><given-names>R</given-names></name><name><surname>Becerra</surname><given-names>MF</given-names></name><name><surname>Reznik</surname><given-names>E</given-names></name><name><surname>Hsieh</surname><given-names>JJ</given-names></name><name><surname>Richmond</surname><given-names>TA</given-names></name><name><surname>Mayhew</surname><given-names>GF</given-names></name><name><surname>Hill</surname><given-names>SM</given-names></name><name><surname>McNally</surname><given-names>CD</given-names></name><name><surname>Jones</surname><given-names>C</given-names></name><name><surname>Rosenbaum</surname><given-names>H</given-names></name><name><surname>Stanislaw</surname><given-names>S</given-names></name><name><surname>Burgess</surname><given-names>DL</given-names></name><name><surname>Alexander</surname><given-names>NR</given-names></name><name><surname>Swanton</surname><given-names>C</given-names></name><collab>PEACE</collab><collab>TRACERx Renal Consortium</collab></person-group><year iso-8601-date="2018">2018</year><article-title>Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal</article-title><source>Cell</source><volume>173</volume><fpage>581</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.057</pub-id><pub-id pub-id-type="pmid">29656895</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>KM</given-names></name><name><surname>Deshpande</surname><given-names>V</given-names></name><name><surname>Beyter</surname><given-names>D</given-names></name><name><surname>Koga</surname><given-names>T</given-names></name><name><surname>Rusert</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Arden</surname><given-names>K</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name><name><surname>Nathanson</surname><given-names>DA</given-names></name><name><surname>Kornblum</surname><given-names>HI</given-names></name><name><surname>Taylor</surname><given-names>MD</given-names></name><name><surname>Kaushal</surname><given-names>S</given-names></name><name><surname>Cavenee</surname><given-names>WK</given-names></name><name><surname>Wechsler-Reya</surname><given-names>R</given-names></name><name><surname>Furnari</surname><given-names>FB</given-names></name><name><surname>Vandenberg</surname><given-names>SR</given-names></name><name><surname>Rao</surname><given-names>PN</given-names></name><name><surname>Wahl</surname><given-names>GM</given-names></name><name><surname>Bafna</surname><given-names>V</given-names></name><name><surname>Mischel</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity</article-title><source>Nature</source><volume>543</volume><fpage>122</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1038/nature21356</pub-id><pub-id pub-id-type="pmid">28178237</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vlachogiannis</surname><given-names>G</given-names></name><name><surname>Hedayat</surname><given-names>S</given-names></name><name><surname>Vatsiou</surname><given-names>A</given-names></name><name><surname>Jamin</surname><given-names>Y</given-names></name><name><surname>Fernández-Mateos</surname><given-names>J</given-names></name><name><surname>Khan</surname><given-names>K</given-names></name><name><surname>Lampis</surname><given-names>A</given-names></name><name><surname>Eason</surname><given-names>K</given-names></name><name><surname>Huntingford</surname><given-names>I</given-names></name><name><surname>Burke</surname><given-names>R</given-names></name><name><surname>Rata</surname><given-names>M</given-names></name><name><surname>Koh</surname><given-names>DM</given-names></name><name><surname>Tunariu</surname><given-names>N</given-names></name><name><surname>Collins</surname><given-names>D</given-names></name><name><surname>Hulkki-Wilson</surname><given-names>S</given-names></name><name><surname>Ragulan</surname><given-names>C</given-names></name><name><surname>Spiteri</surname><given-names>I</given-names></name><name><surname>Moorcraft</surname><given-names>SY</given-names></name><name><surname>Chau</surname><given-names>I</given-names></name><name><surname>Rao</surname><given-names>S</given-names></name><name><surname>Watkins</surname><given-names>D</given-names></name><name><surname>Fotiadis</surname><given-names>N</given-names></name><name><surname>Bali</surname><given-names>M</given-names></name><name><surname>Darvish-Damavandi</surname><given-names>M</given-names></name><name><surname>Lote</surname><given-names>H</given-names></name><name><surname>Eltahir</surname><given-names>Z</given-names></name><name><surname>Smyth</surname><given-names>EC</given-names></name><name><surname>Begum</surname><given-names>R</given-names></name><name><surname>Clarke</surname><given-names>PA</given-names></name><name><surname>Hahne</surname><given-names>JC</given-names></name><name><surname>Dowsett</surname><given-names>M</given-names></name><name><surname>de Bono</surname><given-names>J</given-names></name><name><surname>Workman</surname><given-names>P</given-names></name><name><surname>Sadanandam</surname><given-names>A</given-names></name><name><surname>Fassan</surname><given-names>M</given-names></name><name><surname>Sansom</surname><given-names>OJ</given-names></name><name><surname>Eccles</surname><given-names>S</given-names></name><name><surname>Starling</surname><given-names>N</given-names></name><name><surname>Braconi</surname><given-names>C</given-names></name><name><surname>Sottoriva</surname><given-names>A</given-names></name><name><surname>Robinson</surname><given-names>SP</given-names></name><name><surname>Cunningham</surname><given-names>D</given-names></name><name><surname>Valeri</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Patient-derived organoids model treatment response of metastatic gastrointestinal cancers</article-title><source>Science</source><volume>359</volume><fpage>920</fpage><lpage>926</lpage><pub-id pub-id-type="doi">10.1126/science.aao2774</pub-id><pub-id pub-id-type="pmid">29472484</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>YK</given-names></name><name><surname>Bashashati</surname><given-names>A</given-names></name><name><surname>Anglesio</surname><given-names>MS</given-names></name><name><surname>Cochrane</surname><given-names>DR</given-names></name><name><surname>Grewal</surname><given-names>DS</given-names></name><name><surname>Ha</surname><given-names>G</given-names></name><name><surname>McPherson</surname><given-names>A</given-names></name><name><surname>Horlings</surname><given-names>HM</given-names></name><name><surname>Senz</surname><given-names>J</given-names></name><name><surname>Prentice</surname><given-names>LM</given-names></name><name><surname>Karnezis</surname><given-names>AN</given-names></name><name><surname>Lai</surname><given-names>D</given-names></name><name><surname>Aniba</surname><given-names>MR</given-names></name><name><surname>Zhang</surname><given-names>AW</given-names></name><name><surname>Shumansky</surname><given-names>K</given-names></name><name><surname>Siu</surname><given-names>C</given-names></name><name><surname>Wan</surname><given-names>A</given-names></name><name><surname>McConechy</surname><given-names>MK</given-names></name><name><surname>Li-Chang</surname><given-names>H</given-names></name><name><surname>Tone</surname><given-names>A</given-names></name><name><surname>Provencher</surname><given-names>D</given-names></name><name><surname>de Ladurantaye</surname><given-names>M</given-names></name><name><surname>Fleury</surname><given-names>H</given-names></name><name><surname>Okamoto</surname><given-names>A</given-names></name><name><surname>Yanagida</surname><given-names>S</given-names></name><name><surname>Yanaihara</surname><given-names>N</given-names></name><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Mungall</surname><given-names>AJ</given-names></name><name><surname>Moore</surname><given-names>R</given-names></name><name><surname>Marra</surname><given-names>MA</given-names></name><name><surname>Gilks</surname><given-names>CB</given-names></name><name><surname>Mes-Masson</surname><given-names>A-M</given-names></name><name><surname>McAlpine</surname><given-names>JN</given-names></name><name><surname>Aparicio</surname><given-names>S</given-names></name><name><surname>Huntsman</surname><given-names>DG</given-names></name><name><surname>Shah</surname><given-names>SP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes</article-title><source>Nature Genetics</source><volume>49</volume><fpage>856</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1038/ng.3849</pub-id><pub-id pub-id-type="pmid">28436987</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willis</surname><given-names>NA</given-names></name><name><surname>Frock</surname><given-names>RL</given-names></name><name><surname>Menghi</surname><given-names>F</given-names></name><name><surname>Duffey</surname><given-names>EE</given-names></name><name><surname>Panday</surname><given-names>A</given-names></name><name><surname>Camacho</surname><given-names>V</given-names></name><name><surname>Hasty</surname><given-names>EP</given-names></name><name><surname>Liu</surname><given-names>ET</given-names></name><name><surname>Alt</surname><given-names>FW</given-names></name><name><surname>Scully</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mechanism of tandem duplication formation in BRCA1-mutant cells</article-title><source>Nature</source><volume>551</volume><fpage>590</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.1038/nature24477</pub-id><pub-id pub-id-type="pmid">29168504</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zack</surname><given-names>TI</given-names></name><name><surname>Schumacher</surname><given-names>SE</given-names></name><name><surname>Carter</surname><given-names>SL</given-names></name><name><surname>Cherniack</surname><given-names>AD</given-names></name><name><surname>Saksena</surname><given-names>G</given-names></name><name><surname>Tabak</surname><given-names>B</given-names></name><name><surname>Lawrence</surname><given-names>MS</given-names></name><name><surname>Zhsng</surname><given-names>C-Z</given-names></name><name><surname>Wala</surname><given-names>J</given-names></name><name><surname>Mermel</surname><given-names>CH</given-names></name><name><surname>Sougnez</surname><given-names>C</given-names></name><name><surname>Gabriel</surname><given-names>SB</given-names></name><name><surname>Hernandez</surname><given-names>B</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Laird</surname><given-names>PW</given-names></name><name><surname>Getz</surname><given-names>G</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Beroukhim</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Pan-cancer patterns of somatic copy number alteration</article-title><source>Nature Genetics</source><volume>45</volume><fpage>1134</fpage><lpage>1140</lpage><pub-id pub-id-type="doi">10.1038/ng.2760</pub-id><pub-id pub-id-type="pmid">24071852</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>C-Z</given-names></name><name><surname>Spektor</surname><given-names>A</given-names></name><name><surname>Cornils</surname><given-names>H</given-names></name><name><surname>Francis</surname><given-names>JM</given-names></name><name><surname>Jackson</surname><given-names>EK</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Pellman</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Chromothripsis from DNA damage in micronuclei</article-title><source>Nature</source><volume>522</volume><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.1038/nature14493</pub-id><pub-id pub-id-type="pmid">26017310</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.83867.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Qifeng</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/056ef9489</institution-id><institution>Qilu Hospital of Shandong University</institution></institution-wrap><country>China</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.09.01.506155" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.09.01.506155"/></front-stub><body><p>This fundamental work substantially advances our understanding of patient-derived organoids as a useful model to evaluate chromosome instability and identify novel therapeutic strategies to combat HGSOC. The study is comprehensive, and the evidence supporting the conclusions is compelling, which would further benefit the related research about the mechanisms of genomic instability in HGSOC.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.83867.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Yang</surname><given-names>Qifeng</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/056ef9489</institution-id><institution>Qilu Hospital of Shandong University</institution></institution-wrap><country>China</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Sengupta</surname><given-names>Kundan</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/028qa3n13</institution-id><institution>Indian Institute of Science Education and Research Pune</institution></institution-wrap><country>India</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Nachtigal</surname><given-names>Mark</given-names></name><role>Reviewer</role></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.09.01.506155">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.09.01.506155v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;High-grade serous ovarian carcinoma organoids as models of chromosomal instability&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Tony Ng as the Senior Editor. The following individuals involved in the review of your submission have agreed to reveal their identity: Kundan Sengupta (Reviewer #1); Mark Nachtigal (Reviewer #3).</p><p>The reviewers have discussed their reviews with one another, and revisions are necessary for the manuscript. For your guidance, the reviewers' comments are appended below. If you decide to revise your manuscript, please revise your work guided by the reviewers' suggestions, and provide a point-by-point response to the following suggestions and concerns.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>1. The basis for categorizing CIN into S1 through S7 needs to be explained with better clarity.</p><p>2. Page#1: The point that &quot;recurrent somatic substitutions are rare and involve &lt;10 driver genes&quot;, if these mutations involve mutator genes, this is likely to involve many additional genes. For instance, how would mutations in MSH2, or p53 contribute to additional mutations?</p><p>3. Page#3: While it is interesting to note that mutations were found in BRCA1/2, were mutations also detected across passages of the organoids in p53 and BRCA1/2?</p><p>4. Page#3, Line 79-81: Remarkably, all 8 PDOs resulted in solid implants. Did these PDX also recapitulate mutations as found in the PDOs?</p><p>5. Page#4: From the spectrum of mutations highlighted, it seems obvious that the PDOs show conserved mutations, while PDOs also show considerable heterogeneity. Would this finding then contradict the premise that PDOs clonally evolve and may not necessarily recapitulate mutations inherent in the HSCOGs?</p><p>6. Page#7: Do most PDOs show a ploidy of 2 and 3.5? Does the ploidy increase correlate with an increase in the diverse subtypes of CIN?</p><p>7. From this data, it is unclear how significant these changes/alterations in CIN are.</p><p>8. Figure#1: What is the extent of heterogeneity across the PDOs? this is not evident from this data.</p><p>9. Figure#2: Transcriptomic analyses of the PDOs reveals critical aspects of how expression profiles of HSCOGs correlate with their transcriptome. Is there a mechanistic basis for the enrichment of the HR against the NHEJ pathway in certain PDOs?</p><p>10. Figure#3: The PDO drug screening is an interesting and revealing experiment. However, the explanation is rather confusing, since the demarcation between sensitive and resistant PDOs does not include all the PDOs under each category. Figure 3A: Could include representatives from sensitive and resistant categories with a label accordingly for each of the two categories. Figure 3C: Is this data derived from each PDO from the sensitive and resistant categories? or is this pooled data? this is not clear from the Results section. Although the GSEA enrichment analyses enrich for MYC targets, E2F and G2/M checkpoint targets.</p><p>11. Figure#4: This figure is not numbered. It would be useful to indicate and explain each panel. Label the left panels as A-C and insert the legend on the X and Y-axis respectively. Likewise, label the columns on the right and label as D-F.</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>1. The authors performed single-cell whole genome sequencing on three PDOs (PDO2, PDO3, PDO6). It is not clear why the authors chose these three PDOs for single-cell whole-genome sequencing. This method is good for organoid intratumoural heterogeneity study if the authors provide more samples of single-cell whole genome sequencing.</p><p>2. In line 147, the authors said PDOs consist of 100% tumour cells, are you sure?</p><p>3. In the PDO drug screening part, the authors performed gene expression and pathway analysis on sensitive and resistant groups. How about the mutations and CNAs?</p><p><italic>Reviewer #3 (Recommendations for the authors):</italic></p><p>This was very challenging to read due to lack of information (e.g., Figure 1d, Supplementary Figure 3b, and Supplementary Table 4 were not included with the manuscript), and limited or lacking justification for the inclusion of data. Some of the figures do not adequately transmit the intended information and the figure legends should be revised to provide more comprehensive information to the reader. Justification for some analytical approaches (e.g., selection of gene expression and CN comparison groups) would enhance the manuscript. Please see specific comments below.</p><p>Organoids are typically composed of numerous cell types to recapitulate an organ, whereas spheroids are typically constituted of a single cell type grown in a 3-dimensional format. A weakness of the manuscript is the lack of evidence demonstrating the composition of the PDOs and the lack of an operational definition of an organoid. Without further evidence, these 3D cultures should be referred to as tumourspheres or spheroids. Some of the most informative research on the development of multicellular models to recapitulate high-grade serous ovarian cancer are from the Balkwill laboratory (see Malacrida at al. Building in vitro 3D multicellular models of high-grade serous ovarian cancer. STAR Protocols 3(1): 101086. DOI: 10.1016/j.xpro.2021.101086). In general, the epithelial ovarian cancer field accepts the definition of organoids as those with multiple cell types (e.g., tumour cells, mesothelial cells, and lymphocytes).</p><p>CIN is a type of genomic instability that is broadly defined as an increased rate of chromosome gains or losses and is best identified through analysis of single cells (e.g., karyotype analysis), something that bulk whole genome sequencing cannot determine since it is a reflection of cell populations and not individual cells. It is recognized that the authors' previous publication (reference #6) attempted to resolve the definition of CIN and has added further evidence that HGSOC cells are aneuploid, but the reader would benefit from an operational definition of CIN in this manuscript, and a clearer definition of whether the techniques used to identify alterations in the genome are reflective of CIN or genomic instability. Line 52 refers to &quot;the whole spectrum of CIN&quot;, again highlighting the need to define CIN for the reader. Previous research operationally defined and described CIN in epithelial ovarian cancer using serial ascites samples from epithelial ovarian cancer patients: Penner-Goeke et al. The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples. PLOS Genetics 13(4):e1006707, 2017. doi: 10.1371/journal.pgen.1006707; and, Morden et al. Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samples. Gynecologic Oncology 161(3): 769-778, 2021. doi: 10.1016/j.ygyno.2021.02.038. Identifying whether the manuscript is examining genomic instability rather than CIN will help reduce the confusion in the literature brought about by individuals using the terms interchangeably.</p><p>Lines 24-25, &quot;HGSOC is a heterogeneous, chromosomally unstable cancer with predominant somatic copy number alterations (SCNAs) and other structural variants including large-scale chromosomal rearrangements.&quot; It would benefit the reader if references were included to support this statement and provide them with background evidence.</p><p>Line 29, the references need to be separated by a comma (&quot;56&quot; change to &quot;5,6&quot;).</p><p>Line 33, &quot;remove &quot;are&quot; from &quot;…are generally are molecularly…&quot;</p><p>Lines 41-43 &quot;Despite the relatively high prevalence of HRD and BRCA1/2 mutations in the clinic, there are only very few relevant models suggesting selection against cell lines and PDO that carry BRCA1 and BRCA2 deleterious mutations.&quot; This sentence might read better if it were split into two sentences, e.g., &quot;Despite the relatively high prevalence of HRD and BRCA1/2 mutations in the clinic, there are only very few relevant models. This suggests selection against cell lines and PDOs that carry BRCA1 and BRCA2 deleterious mutations.&quot;</p><p>Lines 53-53, &quot;PDOs showed…transcriptional heterogeneity between models.&quot; Is &quot;models&quot; supposed to represent data obtained from PDOs from different patients, PDOs from the same patient, or some other model system? It seems that &quot;samples&quot; be a more accurate descriptor than models.</p><p>Lines 56-57 &quot;The PDO models we present thus shed light on evolutionary characteristics of HGSOC …&quot;. It is unclear how these models provide information about the evolutionary characteristics of HGSOC unless they were taken from the same patient at different time points in their care.</p><p>Lines 62-64, &quot;We tested the effect of two published media compositions on 15 independent cultures and found similar PDO viability (Figure 1b).&quot; Figure 1b shows copy number signatures and does not indicate viability. Also, the legend states &quot;b Stacked bar plots show copy number signature activities for organoids and the matched ascites tissue sample from which they were derived&quot;; ascites is not a tissue, and therefore more accurate language to describe cells isolated from ascites must be used.</p><p>Line 65 &quot;The efficiency of establishing PDOs was dependent on the type of tissue sample used for derivation…&quot;. This data should be shown in the main article or as Supplemental information.</p><p>Line 68, &quot;…serially passaged &gt;5 times…&quot;; it would be helpful to understand if any of the genomic or drug sensitivity data were obtained from later passage PDOs or if this was done using early passage PDOs alone. This would help clarify how long the parental tumour phenotype was maintained in serially passaged PDOs. Indeed, unpublished reports from the epithelial ovarian cancer research community working on 3D tumoursphere and PDO development indicate selection towards cellular homogeneity is typically observed at later passages. It is critical to demonstrate whether the histotype and major mutations or IHC markers of the original tumour are maintained at later passages.</p><p>Line 75 &quot;Supplementary Figure 3b&quot; was not included in the manuscript; only 3a is shown. Also, &quot;value&quot; is not defined.</p><p>Line 76, Line 75 &quot;Supplementary Table 4&quot; was not included in the manuscript.</p><p>Lines 86-88, S4 is not defined.</p><p>The authors mention on line 108 that signature s5 is not well represented. While this signature is represented in a number of samples present in public tumour datasets (Figure 1c), the authors state on line 109 that this is consistent with previous observations, but do not provide a reference for this. It would be helpful for the authors to expand on why the signature may be rare in the tumourspheres included in this study.</p><p>The authors mention that the tumourspheres represent good models to study the different CNV signatures. It would be helpful to note what proportion of a signature is required for the organoid to be considered a good model to study a particular signature.</p><p>Line 127, Figure 1d was not included in the manuscript.</p><p>Supplementary Table 1. It is not clear which patient samples were used to establish the PDOs. If all of these were used to establish a PDO, this can be clarified in the Table title or legend. To what does &quot;Line&quot; refer? Were PDOs created from each line? If not, which line was used to generate the successful PDO that is reported in the manuscript? Having treatment dates listed in the table is a potential identifier (they would not be acceptable to our local human ethics board). These should be removed and the number of months or weeks should be considered as an acceptable alternative. The term &quot;End of treatment&quot; is truncated in the table.</p><p>Figure 2b, PCA is used to cluster samples based on the similarity of gene expression profiles. There is no information on the methods relating to how these analyses were performed. Do the samples that clustered together based on gene expression also have similar CNV signatures? This information should also be provided for Figure 2e.</p><p>Figure 2d, A rationale for why the three organoids with the lowest gene expression and CN were selected as the comparator group should be provided.</p><p>Line 179 &quot;We compared drug sensitivity between PDOs and their parental uncultured patient-ascites.&quot; It is not clear what this means. Was drug sensitivity compared to the patient chart data showing response to chemotherapy, or do the authors have a means of testing drug sensitivity in uncultured cells present in ascites? Please clarify.</p><p>Lines 179-181 &quot;Using 13 anti-cancer compounds… we found moderate to high correlation between the plasma drug concentration-time…&quot;; what are these compounds? Define &quot;plasma drug concentration-time&quot;; this infers that there is data on drug pharmacokinetics from these patients (plasma).</p><p>Lines 182-184, specifically &quot;we observed no effect with the targeted therapies&quot;; which targeted therapies – this information is not included in the manuscript. Overall, the section on PDO drug screening is poorly described and not well integrated into the manuscript.</p><p>Figure 3c. The term &quot;Normalized GSEA Score&quot; is truncated in the figure; it is not clear if the &quot;padj&quot; scale is also truncated.</p><p>For the single-cell whole genome sequencing analyses, the authors should include information relating to how they selected which organoids they would include in these analyses.</p><p>Supplementary Table 2 does not add any useful information to the manuscript and the information can simply be stated in the text.</p><p>Supplementary Table 3. The organization of this Table is unusual and it would be easier to review if the PDO numbers were shown in numerical progression (e.g., starting with #1) rather than randomly. The term &quot;Sample name&quot; at the top of the column is truncated. Sample type, A or O, must be defined in the Table legend. The terms &quot;cDNA effect&quot; and &quot;Protein effect&quot; are unusual. More common terms such as &quot;cDNA modification&quot; or &quot;protein modification&quot; should be considered, and an indication of what type of consequence the change produces (e.g., inactivating mutation, variant of unknown significance, etc.) should be added.</p><p>Additional comments related to Methods:</p><p>For bulk shallow whole-genome sequencing (lines 317-323), it would be helpful to mention the sequencing coverage.</p><p>It is unclear why single-end sequencing was used for the bulk whole genome sequencing (line 321), while paired-end sequencing was used for the single cell whole genome sequencing (line 345). This must be clarified.</p><p>Absolute copy number signature analysis (lines 324-325) can be combined with the previous section as this section is only one sentence long.</p><p>TCGA, Britroc, and PCWAG (line 326) – this title could be more informative and provide information relating to the analyses performed.</p><p>For single-cell shallow whole genome sequencing (lines 339-345), the quality control steps that were performed prior to CNV calling should be indicated.</p><p>Line 377 – justification for why GRCh38 was used here, but the remaining analyses use GRCh37 must be provided.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.83867.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>1. The basis for categorizing CIN into S1 through S7 needs to be explained with better clarity.</p></disp-quote><p>Thank you for highlighting this. We have made modifications to the introduction to clarify our approach for deriving copy number signatures.</p><disp-quote content-type="editor-comment"><p>2. Page#1: The point that &quot;recurrent somatic substitutions are rare and involve &lt;10 driver genes&quot;, if these mutations involve mutator genes, this is likely to involve many additional genes. For instance, how would mutations in MSH2, or p53 contribute to additional mutations?</p></disp-quote><p>This statement refers specifically to <italic>recurrent</italic> somatic substitutions that have been described in high-grade serous ovarian carcinoma. The purpose of this sentence is to explain that only a relatively few genes are recognized as common drivers. We provide references to support this assertion and explain in the introduction that driver <italic>TP53</italic> mutations may be permissive for diverse causes of CIN.</p><disp-quote content-type="editor-comment"><p>3. Page#3: While it is interesting to note that mutations were found in BRCA1/2, were mutations also detected across passages of the organoids in p53 and BRCA1/2?</p></disp-quote><p>The aim of our experiments was to demonstrate efficiency and relevance of PDO to the understanding of clinically relevant mechanisms of chromosomal instability. We have not conducted longitudinal studies in these models to address the question you raise.</p><disp-quote content-type="editor-comment"><p>4. Page#3, Line 79-81: Remarkably, all 8 PDOs resulted in solid implants. Did these PDX also recapitulate mutations as found in the PDOs?</p></disp-quote><p>The aim of these experiments was to demonstrate that PDO are excellent tools for developing PDX models. Our work shows preservation of driver mutations between donor patients and derived PDOs. We have not conducted longitudinal evolutionary studies in the PDXs.</p><disp-quote content-type="editor-comment"><p>5. Page#4: From the spectrum of mutations highlighted, it seems obvious that the PDOs show conserved mutations, while PDOs also show considerable heterogeneity. Would this finding then contradict the premise that PDOs clonally evolve and may not necessarily recapitulate mutations inherent in the HSCOGs?</p></disp-quote><p>Figure 1 on page 4 shows that the PDO we have generated nearly fully represent the considerable heterogeneity between patients and have stable copy number signatures as compared to donor tissue. We have not examined clonal evolution in PDO but we clearly show that PDO retain driver mutations and copy number signatures from the donor and contain different clonal populations.</p><disp-quote content-type="editor-comment"><p>6. Page#7: Do most PDOs show a ploidy of 2 and 3.5? Does the ploidy increase correlate with an increase in the diverse subtypes of CIN?</p></disp-quote><p>Diploid samples appear to show fewer active signatures compared to samples of higher ploidy (2.5-3), but these findings don't reach statistical significance (linear regression of the fraction of inactive signatures as a function of ploidy, coef=-0.09, p-value=0.169). PDO1 is an example of a high-ploidy PDO with two inactive signatures.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Correlation between ploidy and the number of inactive signatures in PDOs.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-sa2-fig1-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>7. From this data, it is unclear how significant these changes/alterations in CIN are.</p></disp-quote><p>We are unsure what this assertion refers to. Please could you clarify which data you are referring to and what is meant by “significant”. Do you use “CIN” to refer to copy number signature exposures? We had shown in the barplots of Figure 1 that PDO retain copy number signatures from the donor. We have now added new results showing that there is no statistical differential abundance of copy number signatures between ascites and PDOs, by use of a multivariate compositional model.</p><disp-quote content-type="editor-comment"><p>8. Figure#1: What is the extent of heterogeneity across the PDOs? this is not evident from this data.</p></disp-quote><p>Figure 1c (now Figure 1d in the updated manuscript) shows how the three major clades observed in patient cancer samples from clustering of their copy number signature exposures are well represented by our PDO patient-derived organoids. The clustering shows significant heterogeneity within the three major clades.</p><disp-quote content-type="editor-comment"><p>9. Figure#2: Transcriptomic analyses of the PDOs reveals critical aspects of how expression profiles of HSCOGs correlate with their transcriptome. Is there a mechanistic basis for the enrichment of the HR against the NHEJ pathway in certain PDOs?</p></disp-quote><p>The mechanistic basis for the low HR scores (indicating HR deficiency) is explained by mutations in genes in the HR pathway. For example, PDO8, which has the lowest HR score, contains a clinically pathogenic mutation in <italic>BRCA1</italic> (Figure 1—figure supplement 3). Although the KEGG ssGSEA scores shown in Figure 2e (now Figure 3e) are useful to compare samples to each other, scores from different pathways are not directly comparable, and one must be careful when attributing a functional category to a sample based solely on enrichment scores.</p><disp-quote content-type="editor-comment"><p>10. Figure#3: The PDO drug screening is an interesting and revealing experiment. However, the explanation is rather confusing, since the demarcation between sensitive and resistant PDOs does not include all the PDOs under each category. Figure 3A: Could include representatives from sensitive and resistant categories with a label accordingly for each of the two categories. Figure 3C: Is this data derived from each PDO from the sensitive and resistant categories? or is this pooled data? this is not clear from the Results section. Although the GSEA enrichment analyses enrich for MYC targets, E2F and G2/M checkpoint targets.</p></disp-quote><p>The purpose of the line fitting of response data in Figure 3a (now Figure 4a) is to show that there is a very high correlation for drug response between uncultured donor cells from the patient and the derived PDOs for all treatments. This data establishes that PDO retain appropriate sensitivity and resistance. In Figure 3b (now Figure 4b) we have now indicated sensitive PDOs with a blue dot and resistant PDOs with a red dot and explained in the text that the data shown only includes organoids with successful RNA-Seq data. Figure 3c (now Figure 4c) is derived from the comparison between sensitive and resistant PDOs as pooled data. The figure caption has been rewritten to improve clarity.</p><disp-quote content-type="editor-comment"><p>11. Figure#4: This figure is not numbered. It would be useful to indicate and explain each panel. Label the left panels as A-C and insert the legend on the X and Y-axis respectively. Likewise, label the columns on the right and label as D-F.</p></disp-quote><p>Thank you. These suggestions have been implemented and this is now Figure 5.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>1. The authors performed single-cell whole genome sequencing on three PDOs (PDO2, PDO3, PDO6). It is not clear why the authors chose these three PDOs for single-cell whole-genome sequencing. This method is good for organoid intratumoural heterogeneity study if the authors provide more samples of single-cell whole genome sequencing.</p></disp-quote><p>For the single-cell shallow whole genome sequencing three organoids were selected arbitrarily as representative models and we included two fast-growing PDOs (PDO2 and PDO3) and one slow-growing model (PDO6).</p><disp-quote content-type="editor-comment"><p>2. In line 147, the authors said PDOs consist of 100% tumour cells, are you sure?</p></disp-quote><p>As shown in our targeted-gene mutation analysis, all our PDOs contain a <italic>TP53</italic> allelic fraction between 80-95% and this information is now included in the text for clarification. Moreover, in our single cell DNAseq data we do not observe any normal copy number profiles that would indicate normal cells.</p><disp-quote content-type="editor-comment"><p>3. In the PDO drug screening part, the authors performed gene expression and pathway analysis on sensitive and resistant groups. How about the mutations and CNAs?</p></disp-quote><p>As HGSOC is predominantly driven by CNA not by somatic substitutions, we investigate gene expression driven by CNA in Figure 3c and 3d. We also present whole genome correlations between copy number and expression in Figure 2—figure supplement 1, along with CNA data in Figure 2 together with Figure 1—figure supplement 6. Our mutational analysis is described in Figure 1—figure supplement 3. We compared PDO sensitive and resistant groups for ploidy and number of copy number segments and did not observe any significant differences (the average number of segments is 167 for sensitive and 183 resistant PDOs, and the average ploidies are 2.8 for sensitive and 2.46 for resistant PDOs; p-value = 0.7441 and p-value = 0.2374 respectively; Welch Two Sample t-test). These data have been added to the manuscript.</p><disp-quote content-type="editor-comment"><p>Reviewer #3 (Recommendations for the authors):</p><p>This was very challenging to read due to lack of information (e.g., Figure 1d, Supplementary Figure 3b, and Supplementary Table 4 were not included with the manuscript), and limited or lacking justification for the inclusion of data. Some of the figures do not adequately transmit the intended information and the figure legends should be revised to provide more comprehensive information to the reader. Justification for some analytical approaches (e.g., selection of gene expression and CN comparison groups) would enhance the manuscript. Please see specific comments below.</p><p>Organoids are typically composed of numerous cell types to recapitulate an organ, whereas spheroids are typically constituted of a single cell type grown in a 3-dimensional format. A weakness of the manuscript is the lack of evidence demonstrating the composition of the PDOs and the lack of an operational definition of an organoid. Without further evidence, these 3D cultures should be referred to as tumourspheres or spheroids. Some of the most informative research on the development of multicellular models to recapitulate high-grade serous ovarian cancer are from the Balkwill laboratory (see Malacrida at al. Building in vitro 3D multicellular models of high-grade serous ovarian cancer. STAR Protocols 3(1): 101086. DOI: 10.1016/j.xpro.2021.101086). In general, the epithelial ovarian cancer field accepts the definition of organoids as those with multiple cell types (e.g., tumour cells, mesothelial cells, and lymphocytes).</p></disp-quote><p>We have addressed this comment above in the public review section. In the Malacrida MS (and associated methods you cite), HGSOC cell lines were cocultured with other cells on specific matrices.</p><disp-quote content-type="editor-comment"><p>CIN is a type of genomic instability that is broadly defined as an increased rate of chromosome gains or losses and is best identified through analysis of single cells (e.g., karyotype analysis), something that bulk whole genome sequencing cannot determine since it is a reflection of cell populations and not individual cells. It is recognized that the authors' previous publication (reference #6) attempted to resolve the definition of CIN and has added further evidence that HGSOC cells are aneuploid, but the reader would benefit from an operational definition of CIN in this manuscript, and a clearer definition of whether the techniques used to identify alterations in the genome are reflective of CIN or genomic instability. Line 52 refers to &quot;the whole spectrum of CIN&quot;, again highlighting the need to define CIN for the reader. Previous research operationally defined and described CIN in epithelial ovarian cancer using serial ascites samples from epithelial ovarian cancer patients: Penner-Goeke et al. The temporal dynamics of chromosome instability in ovarian cancer cell lines and primary patient samples. PLOS Genetics 13(4):e1006707, 2017. doi: 10.1371/journal.pgen.1006707; and, Morden et al. Chromosome instability is prevalent and dynamic in high-grade serous ovarian cancer patient samples. Gynecologic Oncology 161(3): 769-778, 2021. doi: 10.1016/j.ygyno.2021.02.038. Identifying whether the manuscript is examining genomic instability rather than CIN will help reduce the confusion in the literature brought about by individuals using the terms interchangeably.</p></disp-quote><p>Thank you. We addressed this comment in the public review section and have included text to clarify these issues.</p><disp-quote content-type="editor-comment"><p>Lines 24-25, &quot;HGSOC is a heterogeneous, chromosomally unstable cancer with predominant somatic copy number alterations (SCNAs) and other structural variants including large-scale chromosomal rearrangements.&quot; It would benefit the reader if references were included to support this statement and provide them with background evidence.</p></disp-quote><p>Thank you. References supporting this assertion have been added.</p><disp-quote content-type="editor-comment"><p>Line 29, the references need to be separated by a comma (&quot;56&quot; change to &quot;5,6&quot;).</p></disp-quote><p>Thank you, this has been changed.</p><disp-quote content-type="editor-comment"><p>Line 33, &quot;remove &quot;are&quot; from &quot;…are generally are molecularly…&quot;</p></disp-quote><p>Amended.</p><disp-quote content-type="editor-comment"><p>Lines 41-43 &quot;Despite the relatively high prevalence of HRD and BRCA1/2 mutations in the clinic, there are only very few relevant models suggesting selection against cell lines and PDO that carry BRCA1 and BRCA2 deleterious mutations.&quot; This sentence might read better if it were split into two sentences, e.g., &quot;Despite the relatively high prevalence of HRD and BRCA1/2 mutations in the clinic, there are only very few relevant models. This suggests selection against cell lines and PDOs that carry BRCA1 and BRCA2 deleterious mutations.&quot;</p></disp-quote><p>Thank you. We have improved the wording.</p><disp-quote content-type="editor-comment"><p>Lines 53-53, &quot;PDOs showed…transcriptional heterogeneity between models.&quot; Is &quot;models&quot; supposed to represent data obtained from PDOs from different patients, PDOs from the same patient, or some other model system? It seems that &quot;samples&quot; be a more accurate descriptor than models.</p></disp-quote><p>We have changed models to PDO as we are not referring to the patient samples.</p><disp-quote content-type="editor-comment"><p>Lines 56-57 &quot;The PDO models we present thus shed light on evolutionary characteristics of HGSOC …&quot;. It is unclear how these models provide information about the evolutionary characteristics of HGSOC unless they were taken from the same patient at different time points in their care.</p></disp-quote><p>Even though three pairs of organoids were taken from the same patients, the single cell analysis is only performed on singleton samples. Therefore, we have reworded this sentence to “The PDO models we present thus shed light on the diversity of chromosomal landscapes of HGSOC”.</p><disp-quote content-type="editor-comment"><p>Lines 62-64, &quot;We tested the effect of two published media compositions on 15 independent cultures and found similar PDO viability (Figure 1b).&quot; Figure 1b shows copy number signatures and does not indicate viability. Also, the legend states &quot;b Stacked bar plots show copy number signature activities for organoids and the matched ascites tissue sample from which they were derived&quot;; ascites is not a tissue, and therefore more accurate language to describe cells isolated from ascites must be used.</p></disp-quote><p>We apologise for the mis-referencing, as it is Supplementary Figure 1b (now Figure 1—figure supplement 1A) which indicates viability. Regarding the terminology used in the caption, we had adopted the use of the word &quot;tissue&quot; to refer to ascites following the Human Tissue Act definition of 'relevant material' as any material from a human body that consists of, or includes, cells. However, following the reviewer’s comment we have changed this to simply &quot;ascites sample&quot;.</p><disp-quote content-type="editor-comment"><p>Line 65 &quot;The efficiency of establishing PDOs was dependent on the type of tissue sample used for derivation…&quot;. This data should be shown in the main article or as Supplemental information.</p></disp-quote><p>This has been changed as suggested.</p><disp-quote content-type="editor-comment"><p>Line 68, &quot;…serially passaged &gt;5 times…&quot;; it would be helpful to understand if any of the genomic or drug sensitivity data were obtained from later passage PDOs or if this was done using early passage PDOs alone. This would help clarify how long the parental tumour phenotype was maintained in serially passaged PDOs. Indeed, unpublished reports from the epithelial ovarian cancer research community working on 3D tumoursphere and PDO development indicate selection towards cellular homogeneity is typically observed at later passages. It is critical to demonstrate whether the histotype and major mutations or IHC markers of the original tumour are maintained at later passages.</p></disp-quote><p>All data generated in this paper was done with PDOs at passages 5–15. Clarification has been added to the main text.</p><disp-quote content-type="editor-comment"><p>Line 75 &quot;Supplementary Figure 3b&quot; was not included in the manuscript; only 3a is shown. Also, &quot;value&quot; is not defined.</p></disp-quote><p>We apologise for this – only the first subfigure of Supplementary Figure 3 (now Figure 1—figure supplement 3) had been labelled. “value” has been replaced by “patient”.</p><disp-quote content-type="editor-comment"><p>Line 76, Line 75 &quot;Supplementary Table 4&quot; was not included in the manuscript.</p></disp-quote><p>We apologise for this omission and it is now included.</p><disp-quote content-type="editor-comment"><p>Lines 86-88, S4 is not defined.</p></disp-quote><p>S4 has now been defined in the main text.</p><disp-quote content-type="editor-comment"><p>The authors mention on line 108 that signature s5 is not well represented. While this signature is represented in a number of samples present in public tumour datasets (Figure 1c), the authors state on line 109 that this is consistent with previous observations, but do not provide a reference for this. It would be helpful for the authors to expand on why the signature may be rare in the tumourspheres included in this study.</p></disp-quote><p>In line 108 we point out that the general abundance of s5 is low in organoids, as it is in the general mutational spectrum of samples, but not that it is underrepresented. We mention that its general low abundance is due to chromothripsis being a rare event, for which we have added citations.</p><disp-quote content-type="editor-comment"><p>The authors mention that the tumourspheres represent good models to study the different CNV signatures. It would be helpful to note what proportion of a signature is required for the organoid to be considered a good model to study a particular signature.</p></disp-quote><p>We would be more cautious about what these data indicate to date: the organoids presented successfully represent primary tissue when characterized according to CNV signatures, and the availability and characterization of organoids can help us decipher further the biological mechanisms behind each signature. Finding the precise thresholds to classify tumours according to the presence of mutational processes is still ongoing work. In unpublished results, and in the case of WGD, s4 (especially in combination with s3) show excellent performance in classifying tumours between WGD and non-WGD using a support vector machine. Similar analyses for the remaining signatures are pending, but we advise against finding threshold using proportions of signatures, as these data are compositional.</p><disp-quote content-type="editor-comment"><p>Line 127, Figure 1d was not included in the manuscript.</p></disp-quote><p>We apologise for the typo – Line 127 should have referred to Figure 1c, but now correctly refers to Figure 1d.</p><disp-quote content-type="editor-comment"><p>Supplementary Table 1. It is not clear which patient samples were used to establish the PDOs. If all of these were used to establish a PDO, this can be clarified in the Table title or legend. To what does &quot;Line&quot; refer? Were PDOs created from each line? If not, which line was used to generate the successful PDO that is reported in the manuscript? Having treatment dates listed in the table is a potential identifier (they would not be acceptable to our local human ethics board). These should be removed and the number of months or weeks should be considered as an acceptable alternative. The term &quot;End of treatment&quot; is truncated in the table.</p></disp-quote><p>Tables have now been changed as suggested.</p><disp-quote content-type="editor-comment"><p>Figure 2b, PCA is used to cluster samples based on the similarity of gene expression profiles. There is no information on the methods relating to how these analyses were performed. Do the samples that clustered together based on gene expression also have similar CNV signatures? This information should also be provided for Figure 2e.</p></disp-quote><p>The PCA in Figure 2b (now Figure 3b) was created using all genes, normalised using the DESeq2 method based on gene-specific geometric means – this has now been added to the Methods section. These first two principal components are not obviously related to CN aberrations. PDO2 and PDO10, which appear together in the PCA, have markedly different CNV signatures, and no other trend regarding signatures is observed.</p><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>Correlation of number of segments and ploidy with PC1 and PC2 values.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-sa2-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>Figure 2d, A rationale for why the three organoids with the lowest gene expression and CN were selected as the comparator group should be provided.</p></disp-quote><p>The three organoids, out of eleven, with the lowest expression have been selected with the idea that it is a number high enough not to include solely outliers, but that it leaves out a high enough number of organoid samples (eight) in which we can observe the variability in their copy number and gene expression. There is a very high correlation between these averaged GE values when using the lowest three organoids, and when using the lowest two, or four.</p><fig id="sa2fig3" position="float"><label>Author response image 3.</label><caption><title>Comparing average gene expression values when summarising the lowest two or three organoids (left) and three or four (right).</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-83867-sa2-fig3-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>Line 179 &quot;We compared drug sensitivity between PDOs and their parental uncultured patient-ascites.&quot; It is not clear what this means. Was drug sensitivity compared to the patient chart data showing response to chemotherapy, or do the authors have a means of testing drug sensitivity in uncultured cells present in ascites? Please clarify.</p></disp-quote><p>We performed in vitro drug testing using uncultured primary patient ascites cells using standard of care drugs and targeted therapies. The drugs used are now listed in the Methods section.</p><disp-quote content-type="editor-comment"><p>Lines 179-181 &quot;Using 13 anti-cancer compounds… we found moderate to high correlation between the plasma drug concentration-time…&quot;; what are these compounds? Define &quot;plasma drug concentration-time&quot;; this infers that there is data on drug pharmacokinetics from these patients (plasma).</p></disp-quote><p>All the compounds are now stated in the Methods section. Apologies for the typo but “plasma” was an error and has been removed from the text.</p><disp-quote content-type="editor-comment"><p>Lines 182-184, specifically &quot;we observed no effect with the targeted therapies&quot;; which targeted therapies – this information is not included in the manuscript. Overall, the section on PDO drug screening is poorly described and not well integrated into the manuscript.</p></disp-quote><p>We tested uncultured ascites cells from the donor patient and compared this to the response of the patient-derived organoids from which they were derived. We have expanded on and clarified this section.</p><disp-quote content-type="editor-comment"><p>Figure 3c. The term &quot;Normalized GSEA Score&quot; is truncated in the figure; it is not clear if the &quot;padj&quot; scale is also truncated.</p></disp-quote><p>This figure is no longer cropped.</p><disp-quote content-type="editor-comment"><p>For the single-cell whole genome sequencing analyses, the authors should include information relating to how they selected which organoids they would include in these analyses.</p></disp-quote><p>As stated in Reviewer 2 Point 1, three organoids were selected at random to ensure an unbiased analysis. Those we were two PDOs that grew fast (PDO2 and PDO3) and one slow growing model (PDO6).</p><disp-quote content-type="editor-comment"><p>Supplementary Table 2 does not add any useful information to the manuscript and the information can simply be stated in the text.</p></disp-quote><p>The information has been added to the main text and Supplementary Table 2 has been deleted.</p><disp-quote content-type="editor-comment"><p>Supplementary Table 3. The organization of this Table is unusual and it would be easier to review if the PDO numbers were shown in numerical progression (e.g., starting with #1) rather than randomly. The term &quot;Sample name&quot; at the top of the column is truncated. Sample type, A or O, must be defined in the Table legend. The terms &quot;cDNA effect&quot; and &quot;Protein effect&quot; are unusual. More common terms such as &quot;cDNA modification&quot; or &quot;protein modification&quot; should be considered, and an indication of what type of consequence the change produces (e.g., inactivating mutation, variant of unknown significance, etc.) should be added.</p></disp-quote><p>Table has been changed according to the reviewer suggestions (now Supplementary File 2).</p><disp-quote content-type="editor-comment"><p>Additional comments related to Methods:</p><p>For bulk shallow whole-genome sequencing (lines 317-323), it would be helpful to mention the sequencing coverage.</p></disp-quote><p>Our shallow whole-genome samples have an approximate coverage of 0.25-0.3, assuming a diploid genome (an assumption which is often broken). This has been added to the manuscript.</p><disp-quote content-type="editor-comment"><p>It is unclear why single-end sequencing was used for the bulk whole genome sequencing (line 321), while paired-end sequencing was used for the single cell whole genome sequencing (line 345). This must be clarified.</p></disp-quote><p>The analysis pipeline to call absolute copy number and then signatures is based on the R package QDNAseq, which requires single read data, and this is the reason behind using single-end sequencing in shallow whole-genome sequencing data.</p><p>The library for single cells was made using 10X CNV and we used their recommendation for sequencing to use paired-end sequencing of 150bp per read – the pipeline for copy number calling is completely different from that above in which QDNAseq is used.</p><disp-quote content-type="editor-comment"><p>Absolute copy number signature analysis (lines 324-325) can be combined with the previous section as this section is only one sentence long.</p></disp-quote><p>This change has been made.</p><disp-quote content-type="editor-comment"><p>TCGA, Britroc, and PCWAG (line 326) – this title could be more informative and provide information relating to the analyses performed.</p></disp-quote><p>The title has been changed to “Comparison of organoid copy number signatures to those of TCGA, BriTROC-1 and PCAWG”.</p><disp-quote content-type="editor-comment"><p>For single-cell shallow whole genome sequencing (lines 339-345), the quality control steps that were performed prior to CNV calling should be indicated.</p></disp-quote><p>We have added the following sentence: “The Cell Ranger pipeline was used for quality control, trimming and alignment.”</p><disp-quote content-type="editor-comment"><p>Line 377 – justification for why GRCh38 was used here, but the remaining analyses use GRCh37 must be provided.</p></disp-quote><p>GRCh37 was used for bulk sWGS signature analysis following the pipeline from Macintyre et al. At the used resolution of 30 kb the difference in using GRCh37 or GRCh38 is minimal. However, in the gene-specific analyses such as RNA-Seq, in which changes in the <italic>gtf</italic> files might be more important, the most recent version GRCh38 was used.</p></body></sub-article></article>